The impact of mRNA structure on tRNA selection and ribosome rescue by Thomas, Erica Nicole
Washington University in St. Louis 
Washington University Open Scholarship 
Arts & Sciences Electronic Theses and 
Dissertations Arts & Sciences 
Summer 8-15-2019 
The impact of mRNA structure on tRNA selection and ribosome 
rescue 
Erica Nicole Thomas 
Washington University in St. Louis 
Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds 
 Part of the Biochemistry Commons, and the Molecular Biology Commons 
Recommended Citation 
Thomas, Erica Nicole, "The impact of mRNA structure on tRNA selection and ribosome rescue" (2019). 
Arts & Sciences Electronic Theses and Dissertations. 1952. 
https://openscholarship.wustl.edu/art_sci_etds/1952 
This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open 
Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an 
authorized administrator of Washington University Open Scholarship. For more information, please contact 
digital@wumail.wustl.edu. 
WASHINGTON UNIVERSITY IN ST. LOUIS 
Division of Biology and Biomedical Sciences 
Plant and Microbial Biosciences 
 
Dissertation Examination Committee: 









The Impact of mRNA Structural Alterations on tRNA Selection and Ribosome Rescue 
by 
Erica N. Thomas 
 
 
A dissertation presented to  
The Graduate School  
of Washington University in 
partial fulfillment of the 
requirements for the degree 























  Table of Contents 
List of Figures ................................................................................................................................. v 
List of Tables ................................................................................................................................ vii 
Acknowledgments........................................................................................................................ viii 
Abstract ........................................................................................................................................... x 
Alterations and disruption of tRNA selection in bacteria ............................................................... 1 
Abstract ....................................................................................................................................... 2 
Introduction ................................................................................................................................. 3 
Translation Elongation and tRNA Selection........................................................................... 4 
Peptide Release ....................................................................................................................... 7 
Structural Determinants of tRNA Selection ........................................................................... 8 
Altering the Accuracy of tRNA Selection ................................................................................ 11 
Aminoglycoside Antibiotics ................................................................................................. 11 
Ribosomal Mutations ............................................................................................................ 12 
tRNA Modifications.............................................................................................................. 12 
mRNA Modifications and Structure ..................................................................................... 13 
Nucleobase Modifications and Adducts ........................................................................... 16 
Sugar and Backbone Structure and Modifications ............................................................ 19 
Ribosomal Rescue in Bacteria: Trans-Translation ................................................................... 20 
Conclusion ................................................................................................................................ 24 
Questions Addressed by the Thesis Work ................................................................................ 24 
References ................................................................................................................................. 26 
Alkylative damage of mRNA leads to ribosome stalling and rescue by trans-translation in 
bacteria .......................................................................................................................................... 35 
Abstract ..................................................................................................................................... 36 
Introduction ............................................................................................................................... 37 
Results ....................................................................................................................................... 41 
Treatment of E. coli with MMS or MNNG causes significant increases in alkylative damage 
of RNA .................................................................................................................................. 41 
N1-methyladenosine stalls ribosomes and behaves as a non-cognate codon in vitro ........... 44 
N1-methyladenosine does not interfere with trans-translation in vitro ................................ 49 
Alkylative damage of RNA increases tmRNA activity in vivo ............................................ 51 
The ability to rescue stalled ribosomes is important for cellular recovery after alkylative 
damage .................................................................................................................................. 59 
iii 
 
Discussion ................................................................................................................................. 62 
Experimental Procedures .......................................................................................................... 68 
References ................................................................................................................................. 75 
Insights into the base-pairing preferences of 8-oxoguanosine on the ribosome ........................... 80 
Abstract ..................................................................................................................................... 81 
Introduction ............................................................................................................................... 82 
Materials and Methods .............................................................................................................. 88 
Results ....................................................................................................................................... 91 
8-oxoG interferes with the initial phase of tRNA selection .................................................. 91 
8-oxoG impairs decoding in a manner similar to a mismatch with subtle but important 
distinctions ............................................................................................................................ 92 
The base-pairing preferences of 8-oxoG at the first position of the codon are slightly 
different from those observed at the second position ......................................................... 100 
Error-prone and hyperaccurate ribosomes suppress and exaggerate the effects of 8-oxoG on 
decoding, respectively......................................................................................................... 106 
Discussion ............................................................................................................................... 108 
References ............................................................................................................................... 115 
Decoding on the ribosome depends on the structure of the mRNA phosphodiester backbone .. 120 
Abstract ................................................................................................................................... 121 
Significance Statement............................................................................................................ 122 
Introduction ............................................................................................................................. 123 
Results ..................................................................................................................................... 128 
Experimental approach ....................................................................................................... 128 
Phosphorothioate substitutions at the interface of the P and A site result in stringent tRNA 
selection. ............................................................................................................................. 130 
The accuracy of the initial phase of tRNA selection is not significantly impacted by the 
phosphorothioate substitutions. .......................................................................................... 134 
Phosphorothioate substitutions increase the fidelity of RFs ............................................... 134 
The effects of the phosphorothioate substitutions are not dependent on the A-site codon 
identity ................................................................................................................................ 135 
Phosphorothioate modification reduces peptide-bond formation for a subset of cognate aa-
tRNAs ................................................................................................................................. 138 
Peptide release is not impacted by phosphorothioate modification of the mRNA ............. 140 
Phosphorothioate substitutions between the first and second nucleotide of the A-site codon 
also result in a hyperaccurate phenotype ............................................................................ 141 
Phosphorothioate substitutions between the second and third nucleotide of the A-site codon 
has little effect on the accuracy of tRNA selection ............................................................. 143 
iv 
 
The presence of a deoxyribose sugar between the A and P-site codons results in a 
hyperaccurate phenotype .................................................................................................... 145 
Discussion ............................................................................................................................... 148 
Experimental Procedures ........................................................................................................ 152 
References ............................................................................................................................... 157 
Conclusions and Future Directions ............................................................................................. 163 
Abstract ................................................................................................................................... 164 
The impact of N(1)-methyladenosine on peptidyl transfer in vitro ........................................ 165 
Ribosome rescue from alkylated transcripts in bacteria ......................................................... 166 
The base pairing preference of 8-oxoguanosine on the ribosome .......................................... 170 
The importance of the phosphodiester backbone kink structure during decoding ................. 173 
Conclusions of the thesis ........................................................................................................ 175 
References ............................................................................................................................... 177 
Appendix I .................................................................................................................................. 180 
Chapter 2 Rate and Endpoint Data .......................................................................................... 181 
Chapter 3 Rate and Endpoint Data .......................................................................................... 182 





List of Figures 
Chapter 1 
Figure 1.1 Schematic of tRNA selection .............................................................................6 
Figure 1.2 Active monitoring of tRNA-mRNA interactions by rRNA residues ...............10 
Figure 1.3 Structures of modified nucleobases ..................................................................15 
Figure 1.4 Schematic depicting trans-translation ..............................................................21 
 
Chapter 2 
Figure 2.S1 LC-MS calibration curves for modified and unmodified nucleosides ...........42 
Figure 2.1 Treatment of E. coli with MMS and MNNG results in significant accumulation of 
detrimental alkylative damage adducts in RNA ................................................................44 
Figure 2.2 N(1)-methyladenosine (m1A) in mRNA significantly decreases the rate and endpoint 
of translation in vitro ..........................................................................................................46 
Figure 2.3 Paromomycin does not rescue the impact of m1A on peptide bond formation..48 
Figure 2.4 Specific miscoding events are not observed for a codon containing m1A .......49 
Figure 2.5 m1A does not significantly interfere with the recognition of initiation complexes by 
trans-translation in vitro ....................................................................................................50 
Figure 2.6 Alkylative damage of RNA in E. coli induces ribosome rescue through the trans-
translation pathway ............................................................................................................52 
Figure 2.S2 WT and ∆ssrA E. coli exhibit similar survival phenotypes after treatment with MMS  
54 
Figure 2.S3 Deletion of ClpAP, ClpXP, and Lon proteases results in further accumulation of His6 
after alkylative damage ......................................................................................................54 
Figure 2.S4 Different His antibodies display unique banding patterns on western blots...56 
Figure 2.S5 Ciprofloxacin, but not mitomycin C, increases His6 levels ............................59 
Figure 2.7 Ribosome rescue by tmRNA is important for cellular recovery after treatment with 
alkylating agents ................................................................................................................61 
Figure 2.S6 Optimal His6, Ada, and RecA levels are achieved after 20 minutes of MMS 
treatment ........................................................................................................................... 69 
Figure 2.S7 Significant transcriptional runoff is achieved after 10 seconds of rifampicin 
treatment ........................................................................................................................... 70 
 
Chapter 3 
Figure 3.1 8-oxoG alters the base-pairing properties of the nucleotide .............................86 
Figure 3.2 8-oxoG inhibits GTP hydrolysis by EF-Tu ......................................................93 
Figure 3.3 8-oxoG in the second position of the codon changes the base pairing properties of 
guanosine on the ribosome.................................................................................................95 
Figure 3.4 The addition of antibiotics increases the kpep and Fp for cognate and a subset of near-
cognate tRNAs in the presence of 8-oxoG at the second position of the codon. ...............98 
vi 
 
Figure 3.S1 Streptomycin and paromomycin suppress the effects of 8-oxoG on kpep for a complex 
displaying the G8oxoGC codon in the A site .......................................................................99 
Figure 3.5 Antibiotics suppress the effects of 8-oxoG in the first position of the codon..102 
Figure 3.6 Antibiotics drastically increase kpep and Fp for reactions between the 
8oxoGUU 
complex with Phe-tRNAPhe (8-oxoG•A base pair), and only slightly for reactions with Val-
tRNAVal (8-oxoG•C). .......................................................................................................105 




Figure 4.1 Structure of the mRNA on the ribosome and preparation of phosphorothioate-
modified mRNAs .............................................................................................................129 
Figure 4.2 Phosphorothioate mRNAs suppress the incorporation of near-cognate amino acids
..........................................................................................................................................131 
Figure 4.3 The Sp-phosphorothioate substitution of the kink oxygen results in a severe 
hyperaccurate phenotype .................................................................................................133 
Figure 4.S1 Reactions with a different mRNA yield similar results ...............................137 
Figure 4.5 Substitution of the pro-S oxygen reduces the rate of peptide-bond formation in the 
presence of atypical tRNA-mRNA interactions ..............................................................137 
Figure 4.6 Peptide release is not impacted by phosphorothioate modification at interface of the P-
site and A-site codons ......................................................................................................141 
Figure 4.7 Phosphorothioate modification at the second position of the A-site codon results in a 
hyperaccurate phenotype .................................................................................................143 











List of Tables 
 
Chapter 2 




Table 1: m1A Glu Rate and Endpoint Data ......................................................................179 
Table 2: 8-oxoG Val Rate and Endpoint Data .................................................................180 
Table 3: 8-oxoG Arg Rate and Endpoint Data .................................................................182 
Table 4: 8-oxoG Arg Ribosomal Mutant Rate and Endpoint Data ..................................184 
 
Appendix II 







The work described in this dissertation was supported by funding from the Bayer Graduate 
Research Fellowship (to E.N.T.) and the National Institutes of Health (R01GM112641 to 
H.S.Z.).  
 
Erica N. Thomas 



















ABSTRACT OF THE DISSERTATION 
 
The impact of mRNA structure on tRNA selection and ribosome rescue 
by 
Erica N. Thomas 
Doctor of Philosophy in Biology and Biomedical Sciences 
Plant and Microbial Biosciences 
Washington University in St. Louis, 2019 
Professor Hani S. Zaher, Chair 
 
The faithful and rapid translation of proteins from genetic information is an essential feature of 
the ribosome. The general process of tRNA selection is governed by the ability of the ribosome 
to select for the aminoacylated tRNA (aa-tRNA) that matches the codon in its A-site. The 
efficiency and accuracy of this selection depends on the ability of nucleotides to form proper 
hydrogen bonds. While much is known about how chemical alterations of tRNA and rRNA can 
impact the fidelity of translation, less is known about how similar changes to mRNA affect 
decoding. In this work, we describe several studies aimed at investigating the impact of mRNA 
structural alterations on translation. We examine the impact of alkylative damage of mRNA both 
in vitro and in vivo and show that the accumulation of these adducts increases ribosomal stalling 
and subsequent rescue by the trans-translation pathway in bacteria. Additionally, we characterize 
the base pairing preferences of the most common oxidative damage adduct of mRNA, 8-
oxoguanosine, on the ribosome. Finally, we show that the kink structure adopted by the 
phosphodiester backbone of mRNA on the ribosome impacts translation under sub-optimal base 
xi 
 
pairing conditions. Together, this works offers novel insight into the importance of mRNA 





Alterations and disruption of tRNA selection in bacteria  
 





Translation is a fundamental step of the central dogma, during which the ribosome 
decodes an mRNA transcript to produce protein. During the elongation phase, multiple 
mechanisms work to ensure that the mRNA codon pairs with the proper aminoacyl-tRNA (aa-
tRNA). The speed and accuracy of this process can be altered through various means, such as 
addition of aminoglycoside antibiotics, introduction of ribosomal mutations, and alterations to 
tRNA modifications. However, fewer studies have focused on how changes to mRNA structure 
impact tRNA selection. Here, we discuss what is known about tRNA selection, how it could be 




The accuracy and efficiency of translation is vital to the production of functional proteins 
in all living organisms. On average, translation proceeds with only one misincorporation per 103 
to 104 events (1–3). The accuracy of this template-driven process depends on the ability of the 
ribosome to properly select the aminoacyl-tRNA (aa-tRNA) that is the correct match for the 
mRNA codon in the A site. Proper decoding relies on Watson-Crick hydrogen bonding between 
nucleotides at all three positions of the codon, with the exception of some permissible wobble 
hydrogen bonding in the third position (4). Interestingly, the energetics of the hydrogen bonding 
alone cannot explain the observed accuracy of decoding (5, 6). During the process of tRNA 
selection, the ribosome plays an active role in correctly recognizing the specific geometry of 
Watson-Crick base pairs before proceeding with peptidyl transfer (7, 8). This intricate process 
allows for the ribosome to discriminate between substrates with very small differences in the free 
energy of binding (9).  
The bacterial ribosome is composed of two main subunits: the small subunit, or the 30S, 
and the large subunit, known as the 50S. These two subunits come together during initiation to 
form the 70S ribosome. Throughout translation, the ribosome utilizes three different tRNA 
binding sites: 1) the A site, or the aminoacyl-tRNA site, 2) the P site, or the peptidyl-tRNA site, 
and 3) the E site, or the exit site. During elongation, a ternary complex composed of an aa-tRNA, 
elongation factor-Tu (EF-Tu), and GTP is delivered to the A site. Several downstream reactions 
occur, resulting ultimately in the reaction of the newly delivered amino acid with the peptidyl-
tRNA in the P site. To complete the cycle, translocation occurs, which is a reaction catalyzed by 
EF-G that uses the energy of GTP hydrolysis to promote the movement of peptidyl-tRNA into 
the P site, and the deacylated tRNA into the E site. Translation termination in bacteria begins 
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when stop codons enter the A site and are recognized by either release factor 1 or 2 (RF1 and 
RF2) which hydrolyze the peptidyl-tRNA and release the peptide chain (10).  
 
Translation Elongation and tRNA Selection  
 During tRNA selection, the ribosome must distinguish between the aa-tRNAs that match 
the codon in the A site, known as cognate aa-tRNAs, and near-cognate aa-tRNAs, which have 
one mismatch between the codon and anticodon. In order to select the cognate over the near-
cognate aa-tRNA, the ribosome recognizes the small energetic differences between them 
multiple times through mechanisms known as kinetic proofreading and induced fit (11, 12). This 
repeated exploitation of free energy (∆∆G) separated by a functionally irreversible reaction 
compounds the effects, resulting in the observed high accuracy of tRNA selection. Kinetic 
proofreading during this process is possible because the aa-tRNA is delivered to the A site in a 
complex with GTP and EF-Tu, and the hydrolysis of GTP by EF-Tu serves as the functionally 
irreversible reaction that separates the two independent interactions between the aa-tRNA and 
the ribosome. The first utilization of the ∆∆G of binding between the cognate and non-cognate 
aa-tRNAs occurs during the initial encounter between the ribosome and the GTP form of the 
ternary complex. The second utilization of the ∆∆G of binding occurs during the association of 
the ribosome with either the GDP state of the ternary complex or free form the of tRNA after 
dissociation of EF-Tu. These independent steps of evaluation between the aa-tRNA and the 
ribosome can lead to greater discrimination, particularly if equilibrium is rapidly attained during 
the steps before the relatively slow steps of GTPase activation and accommodation (9).  
 The initial step of tRNA selection is a codon-independent interaction between the 
ribosome and the ternary complex (Figure 1). This interaction is governed by rate constants k1 
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and k -1, and these rates are similar between cognate (no mismatch), near-cognate (one 
mismatch), and non-cognate (greater than one mismatch)  aa-tRNAs (13, 14). The rate of binding 
between the ribosome and ternary complex is high and has been shown to be dependent on EF-
Tu. It is hypothesized that the positive charge and the large size of the L7/L12 stalk of the 
ribosome interacts with EF-Tu, thus explaining the fast rate of binding between the two (15). The 
next step is codon recognition (k2), which is similar for cognate and near-cognates, but is very 
slow for non-cognates (14). The first step that distinguishes between cognates and near-cognates 
is dissociation during initial codon recognition (k -2) (16). On average, the rate of dissociation for 
near-cognates compared to cognates is about one thousand-fold faster under high-fidelity 
conditions, which is a larger difference than is expected when only considering the free energy 
differences of tRNA-mRNA binding between cognates and near-cognates (16). This observation 
suggests that the ribosome plays an active role in stabilizing the cognate interaction through 
induced fit.  
 The next steps of tRNA selection are dependent on the GTPase activity of EF-Tu. During 
GTPase activation (k3), which is the rate-limiting step of GTP hydrolysis (kGTP), the active site of 
EF-Tu undergoes a conformational change (17). The forward rate of GTPase activation depends 
on the properties of the decoding helix, i.e. the pairing interaction between the codon and the 
anticodon. Therefore, the rate of GTPase activation is faster for cognate aa-tRNAs than for near-
cognate aa-tRNAs (16, 18, 19). The inorganic phosphate is released (kpi) after GTP hydrolysis, 
and EF-Tu is rearranged to its GDP-bound state before dissociating from the aa-tRNA (k6) (19). 
This irreversible reaction is followed by a kinetic partitioning that occurs during the second 
encounter between the ribosome and the aa-tRNA. During this stage, which is known as 
proofreading, the aa-tRNA either moves completely into the A site during accommodation (k5) 
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or dissociates from the ribosome during rejection (k7). The rate of accommodation is accelerated 
for cognate aa-tRNAs, while the rate of rejection is accelerated for near-cognate aa-tRNAs in 
order to maintain the accuracy of translation. If the aa-tRNA is accommodated, it will proceed 
with peptidyl transfer (kpep) in the large ribosomal subunit where it gets incorporated into the 
growing peptide chain. (19–21).  
 
Figure 1.1: Schematic of tRNA selection (10). Green arrows indicate reactions that are 
accelerated for cognate aa-tRNAs, while red arrows indicate reactions that are accelerated for 
near-cognate aa-tRNAs. Selection begins with codon-independent initial binding of the ternary 
complex to the ribosome, governed by k1 and k-1. Codon recognition is codon dependent and is 
governed by k2 and k-2. GTPase activation follows, during which EF-Tu undergoes a 
conformational change governed by k3 and k-3. The next step is the irreversible hydrolysis of 
GTP (kGTP). The dissociation of EF-Tu leads into the proofreading stage, where the kinetic 
partitioning between accommodation (k5) and rejection (k7) occurs. Peptidyl transfer (kpep) 




Peptide Release  
 Termination of translation occurs when one of the nearly universal stop codons, including 
UAA, UAG, and UGA, enters the A site. Unlike tRNA selection, which depends on RNA-RNA 
interactions, peptide release is dependent on protein-RNA interactions. In bacteria, stop codons 
are recognized by protein factors known as class I release factors (RFs) that subsequently trigger 
the release of the elongating peptide. RF1 decodes UAG while RF2 decodes UGA, and both of 
the factors decode UAA (22). Bacteria also depend on RF3, which is a GTPase class II release 
factor that helps to complete termination. This likely occurs via downstream reactions through 
coupling the energy of GTP hydrolysis to the removal of the class I RF after peptide release (23). 
The RFs cannot utilize Watson-Crick base pairing, so they rely on RNA-protein interactions to 
achieve their low error-frequency of approximately 1 in 105 events (24).  
 Class I release factors share several functional similarities to aa-tRNAs. Both class I RFs 
and aa-tRNAs have a domain for recognizing the appropriate codons with high specificity in the 
small subunit of the ribosome. For aa-tRNAs and RFs, these regions are the anticodon and 
domain 2, respectively. Additionally, they each have another domain involved in promoting 
catalysis in the peptidyl transfer center (PTC) of the large subunit. For aa-tRNAs and RFs, these 
regions are the acceptor stem and domain 3, respectively (10). Although these bifunctional 
species share similarities, they work through fundamentally different mechanisms. For one, 
instead of Watson-Crick RNA-RNA base pairs, RNA-protein interactions are utilized during 
peptide release. “Tripeptide anticodons” were identified as the region of RFs that are critical for 
stop codon recognition (25). These motifs are proline-any amino acid-threonine (PxT) for RF1 
and serine-proline-phenylalanine (SPF) for RF2. Several structural studies provide clear 
evidence that these regions occupy the decoding center near the mRNA in the A site (26–31). 
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RFs also work through different mechanisms than aa-tRNAs to achieve their specificity. Because 
RF3 cannot provide the irreversible step necessary for kinetic proofreading, class I RFs derive 
specificity from relatively large apparent binding (Km) contribution for stop codons over sense 
codons (32). This indicates that all sense codons trigger decreased class I RF binding. 
Contributions to specificity are also derived from kcat effects that range from 2- to 1000-fold 
depending on the sense codon and RF, suggesting that class I RFs bind in a qualitatively 
different fashion to stop and sense codons (32). These binding strategies may be exploited for 
specificity by RFs because of the inherently larger differences in ∆∆G of binding available for 
protein-RNA interactions relative to RNA-RNA interactions or because proofreading 
mechanisms do not exist for RFs (10).  
 
Structural Determinants of tRNA Selection  
Several ribosomal proteins and nucleotides have been shown to play vital roles in 
monitoring the interaction between the anticodon and codon in the decoding center, which 
encompasses functionally important residues of the 16S rRNA, including nucleotides 1400-1500 
of helix 44, 1050-1200 of helix 43, and the 530 loop of helix 18 (33, 34). The specific residues 
that are critical for tRNA binding to the A-site include G529, G530, A1492, and A1493 (35, 36). 
Residues A1492 and A1493 monitor the geometry of the codon-anticodon helix in the first two 
positions, while C518, G530, and portions of ribosomal protein S12 monitor the second and third 
positions (4, 37). The Watson-Crick geometries of the first two positions are more strictly 




In the apo-structure of the ribosome, A1492, A1493, and G530 exist in a conformation 
where their hydrogen bonding interfaces are facing out of the A-site. Upon binding of the aa-
tRNA to the codon, A1492 and A1493 move from an intrahelical position in helix 44 to an 
extrahelical position while G530 flips from a syn to an anti-conformation. These nucleotides 
congregate together to inspect the minor groove of the decoding helix and increase the specificity 
for Watson-Crick base pairs (4). This active monitoring of the codon-anticodon helix by the 
ribosome explains the level of tRNA selection accuracy that cannot be achieved by hydrogen 
bonding between codons and anticodons alone. Once the proper codon-anticodon interaction is 
detected by the ribosome, downstream signals trigger large conformational changes of the 
ribosome in a process known as domain closure (38). These movements include the rotation of 
the head towards the shoulder domain of the 30S subunit as well as the rotation of the shoulder 
domain towards the inter-subunit space. This brings the shoulder domain close to EF-Tu, which 
in turn positions the catalytically important His84 of EF-Tu for GTP hydrolysis so tRNA 






Figure 1.2: Active monitoring of tRNA-mRNA interactions by rRNA residues. A) First-
position monitoring of the codon-anticodon interaction by A1493. B) Second-position 
monitoring by G530 and A1492. C) Third-position monitoring by G530. Note that this figure 
depicts accurate hydrogen bonds, but the exact stereochemistry of the nucleotides is not 





Altering the Accuracy of tRNA Selection  
Aminoglycoside Antibiotics 
 Several mechanisms exist to either restrict or relax the accuracy of tRNA selection. A 
particular class of antibiotics, known as the aminoglycosides, relax tRNA selection conditions 
and increase the rate of ribosomal miscoding (41). This class encompasses a large range of 
molecules including paromomycin, streptomycin, neomycin, kanamycin, and gentamycin that 
can induce a wide array of miscoding events by working through distinct mechanisms. 
Paromomycin and streptomycin have been particularly instrumental in helping to elucidate 
structural changes that occur during tRNA selection (10). Paromomycin accelerates both of the 
forward reaction rates in tRNA selection, GTPase activation (k3) and accommodation (k5), while 
reducing the rate of near-cognate tRNA dissociation from the A site during codon recognition (k-
2) and rejection (k7) (42, 43). Specifically, paromomycin pushes A1492 and A1493 into an 
intermediate position where they are able to engage the minor groove of the codon-anticodon 
helix (44). This conformation looks very similar to the one that is assumed when a cognate aa-
tRNA is bound to the A-site codon (45). In this way, it switches the ribosome into a highly 
activated state regardless of the codon-anticodon interaction in the A site and kpep increases for 
both near-cognate and cognate aa-tRNAs (43, 46).  
Streptomycin also increases miscoding on the ribosome, but through a mechanism 
independent of paromomycin. The antibiotic has been shown to substantially reduce the forward 
rates of GTPase activation (k3) for cognate tRNAs while only slightly stimulating these values 
for near-cognate tRNAs (47). Structural studies show that streptomycin generates these kinetic 
changes by inducing a lateral shift of helix 44 (h44), which contains A1492 and A1493. This 
lateral shift appears to be sufficient to stabilize near-cognate tRNAs. Additionally, this shift 
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increases the energetic barriers associated with domain closure for cognate tRNAs, resulting in 
an overall increase in miscoding (48).  
 
Ribosomal Mutations 
 Several ribosomal mutants in E. coli cause tRNA selection to become either more 
restrictive or promiscuous. The mutations that cause tRNA selection to be more restrictive were 
discovered in auxotrophic mutants that displayed a dependency on streptomycin (7). Several of 
these mutations mapped to the gene encoding the small ribosomal protein S12 (rpsL), 
specifically at the contact points between S12 and the 16S RNA helix 44 and helix 27 that are 
important for domain closure (49, 50). The mutations disrupt these interactions, thereby 
destabilizing the closed conformation and increasing accuracy during tRNA selection. 
Ribosomal ambiguity (ram) mutants are those that increase ribosomal promiscuity and 
miscoding (51). These mutations frequently alter the small ribosomal subunit proteins S4 (rpsD) 
and S5 (rpsE). The two proteins form an interface that is disrupted during domain closure. The 
mutations reduce the number of bonds that must be broken, thereby lowering the energetic 
barrier necessary for this disruption to occur and increasing ribosomal miscoding (52, 53).  
 
tRNA Modifications  
The energetics of hydrogen bonding as well as the active monitoring of the codon-
anticodon helix by the ribosome cannot still not fully explain the ability of the ribosome to 
discriminate between closely related codons. In these cases, accurate decoding relies on the 
chemical modifications of anticodons to fine-tune their base-pairing properties (54, 55). 
Modifications can either expand or restrict the decoding capacity of anticodons, and the 
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expression levels of hundreds of proteins can be altered by variations in these modifications. 
Specifically, base modifications are common at positions 34 and 37 of the tRNA (56). Position 
34 of the tRNA base pairs with the third position wobble base of the codon and allows for it to 
have an expanded decoding capacity (57, 58). For example, to avoid mispairing with the AUG 
Met codon, the AUA Ile tRNA utilizes a C that is modified to lysidine (k2C) in position 34 of the 
anticodon. In this way, the Ile tRNA avoids a U•G wobble with the AUG Met codon at the third 
position and instead forms a k2C•A base pair with the AUA codon (59). Position 37 of the 
anticodon is adjacent to the 3’ site of the anticodon and modifications at this site play a critical 
role in the stabilization of the first base pair of the codon-anticodon helix. For example, modified 
m1G37 in the anticodons of bacteria prevents frameshifting, whereby the mRNA slips during 
translation by one or more base pairs in either the 5’ (-1) or 3’ (+1) direction (60). In this way, 
modifications of tRNA are critical for accurate decoding.  
 
mRNA Modifications and Structure  
 While much is known about how tRNA modifications modulate tRNA selection, less is 
known about how modifications and structural alterations to mRNA can impact translation. More 
than 100 distinct chemical modifications of RNA are known; however, it remains unclear which 
chemical modifications are intentional, and which are the result of nucleic acid damage (61). 
Nucleic acids are susceptible to multiple types of chemical damage, including alkylation, 
deamination, oxidation, and depurination. Sources of damage include reactive oxygen species, 
UV radiation, ionizing radiation, alkylating agents, and possibly even the aberrant activity of 
tRNA modifying enzymes. If these damage-induced adducts interfere with the ability of the 
nucleotide to form proper base pairs, they can have a negative impact on the speed and accuracy 
14 
 
of translation. Intentional modifications can also be the result of alkylating enzymes; therefore, it 





Figure 1.3: Structures of modified nucleobases discussed in this thesis. Altered residues are 
indicated in red. Damaged nucleobases are those that are generated from exogenous and 
endogenous chemical damage, while modified nucleotides are intentional regulatory marks 
introduced by the cell. Resonance structures are indicated for m1A and m3C.  
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Nucleobase Modifications and Adducts 
 There are several indications that certain mRNA modifications are intentional and 
dynamic regulatory marks. One indication is that the modification has specific proteins serving 
as its readers, writers, and erasers that can act on mRNA. For example, N6-methyladenosine 
(m6A), which is the most abundant internal modification in eukaryotic mRNA and is also found 
in bacterial mRNA, is a reversible modification (64). It has dedicated methyltransferases, 
including methyltransferase-like 3 and 14 (METTL3 and METTL14) as well as Wilms tumor 1-
associated protein (WTAP) (65–69). Importantly, it also has dedicated demethylases, including 
fat mass and obesity associated protein (FTO) and AlkB homologue 5 (ALKBH5) to remove the 
modification (70, 71). Through these writers and erasers, the levels of m6A on mRNA can be 
modulated. Additionally, m6A possess multiple readers including YTHDF1, YTHDF2, 
YTHDF3, and YTHDC1 that can recognize this modification and perform downstream functions 
(72–74). Another indication that a modification is intentional is its specific enrichment in certain 
regions of mRNA. For example, m6A is found in over 25% of human transcripts with enrichment 
in long exons, 3’UTRs, and near stop codons (73). This targeted enrichment suggests that the 
modification could be serving a function in some aspect of mRNA metabolism (64).  
 While m6A serves as an intriguing candidate for an intentional mRNA modification to 
regulate translation elongation, previous work has shown that it does not significantly interfere 
with the tRNA selection process (75, 76). This is expected, as the methylated nitrogen still 
retains one hydrogen to participate in proper base pairing; therefore, it is not likely to be 
intentionally utilized to modulate the speed or accuracy of tRNA selection. Previous studies have 
instead suggested that m6A in mRNA may play a role in a wide variety of processes related to 
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mRNA metabolism, including the enhancement of nuclear processing and export, the promotion 
of translation, and mRNA maturation (64).  
 There are many more mRNA adducts that are the result of nucleotide damage compared 
to those that serve as intentional modifications (63). These adducts can directly impact the WC 
interface between nucleotides, generate new hydrogen bonding interfaces, or cause internal 
rearrangements of atoms such that the original WC interface is altered. Two of the most common 
types of nucleotide damage that impact base pairing are oxidative and alkylative damage. 
Oxidative damage is generated from both endogenous and exogenous processes. For example, 
cellular respiration produces superoxide radical O2- during electron transport through the 
reduction of molecular oxygen by components of the electron transport chain (77, 78). 
Additionally, O2- is intentionally produced to kill invading microbes by immune cells using the 
enzyme NADPH oxidase (79). In order to control cellular levels of O2-, superoxide dismutase 
catalyzes the metal-dependent dismutation of superoxide into O2 and H2O2 (80). Because H2O2 
can react with intracellular iron through Fenton and Haber-Weiss chemistry to form highly 
reactive hydroxyl radicals, it is enzymatically reduced to water and molecular oxygen (81). 
Additionally, several exogenous sources of oxidative damage include ionizing and UV radiation, 
as well as toxic compounds (82). Less is known about the accumulation of alkylative damage; 
however, it is known that several chemotherapeutic agents are alkylating agents that may rely on 
RNA damage for their efficacy (83). Additionally, several known sources of endogenous 
alkylative damage are the aberrant activity of the universal methyl donor S-adenosyl methionine 
(SAM) and nitrosated bile adducts (84).  
Oxidative damage can cause myriad damage adducts, but one of the most abundant 
oxidative damage adducts of mRNA is 8-oxoguanosine (8-oxoG). Under normal conditions, 8-
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oxoG is present at approximately 1 in 105 residues in total RNA and can increase as much as 10-
fold under oxidative stress conditions (85, 86). Previous work has shown that when 8-oxoG is 
present in mRNA, it decreases the rate of peptidyl transfer in the presence of 8-oxoG•C base 
pairs while increasing the rate of miscoding in the presence of 8-oxoG•A base pairs (87). From 
structural studies performed using the DNA modification 8-oxodG, it was shown that the 
introduction of the O8 to the guanosine causes a steric clash of the nucleobase with the 
phosphate backbone of the nucleotide. As a result, the nucleobase changes conformation from its 
normal anti conformation to a syn conformation to relieve this steric hindrance. This opens a new 
hydrogen bonding interface and allows for 8-oxoG to mispair with adenosine (88).  
 Due to the susceptibility of oxygen and nitrogen to alkylative damage, there exists an 
extensive list of possible alkylative modifications to nucleotides. Several of the modifications 
can directly interfere with the WC interface between nucleotides, resulting in a decrease in the 
rate of decoding and in some cases even miscoding. For example, the introduction of a methyl 
group to the O6 of guanosine causes an internal rearrangement of electrons such that N1 is no 
longer covalently bound to the hydrogen used to base pair at the WC interface. This results in a 
significant reduction in the rate of peptidyl transfer in the presence of an O6-methylguanosine 
(m6G)•C base pair (75). Additionally, the alteration of N1 from a hydrogen bond donor to a 
hydrogen acceptor allows for m6G to base pair in the Watson-Crick conformation with uridine, 
resulting in an increase in the rate of miscoding in the presence of an m6G•U base pair (75, 76).  
 Another alkylative damage adduct of interest in N1-methyladenosine (m1A). In theory, 
this adduct should be disruptive to template-driven processes, as it directly interferes with the 
ability of N1 to form hydrogen bonds as well as introduces a resonance structure with a positive 
charge. Indeed, one study shows that the introduction of m1A into an mRNA increases ribosome 
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stalling at this lesion (76). Interestingly, several reports have implicated that m1A may serve as 
an intentional regulatory modification in mRNA (89). The modification is enriched around the 
start site of transcripts, upstream of the first splice site on highly translated transcripts (90, 91). 
The observation that m1A may serve as an intentional modification to promote translation (90) is 
difficult to reconcile if m1A does indeed increase ribosome stalling. Additionally, m1A lacks 
several of the characteristics of an intentional modification. For example, no readers, writers, or 
erasers specific to m1A in mRNA have been identified (89). Controversy also exists around the 
abundance of m1A in human cells, as several reports identified hundreds of sites in the 
transcriptome (90, 91) while another identified only nine (92). More evidence is needed to 
conclusively state that m1A serves as an intentional modification of mRNA.  
 
Sugar and Backbone Structure and Modifications  
 In contrast to the nucleobase, the other two components of an RNA nucleotide, including 
the ribose sugar and phosphate backbone, have fewer potential modifications and damage 
adducts. The only common modification of the 2’hydroxyl ribose moiety of all four nucleotides 
is 2’-O-methylation (2’OMe) (93, 94). While its function remains unclear, it can inhibit 
adenosine to inosine RNA editing in vitro as well as drastically increase ribosome stalling in a 
position-dependent manner (95, 96). The importance of the 2’OH of the ribose sugar in decoding 
has also been investigated. The ribosomal RNA residues that monitor the interaction between the 
codon and anticodon in the A site not only interact with the O2 of the purine base and the N4 of 
the pyrimidine base, but they also hydrogen bond with the 2’OH of the ribose (4). Interestingly, 
substitutions of this moiety with deoxy or fluoro groups had minimal impact on tRNA selection 
but showed that it is required for the remodeling of mRNA during translocation (97).  
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Even less is known about the structural importance of the phosphate backbone during 
decoding. In the ribosome, mRNA displays a kink-like structure that is stabilized by electrostatic 
interactions and it is speculated that this structure prevents slippage and is therefore critical for 
frame maintenance (98, 99). No information was previously known about if and how this 
structure of the phosphate backbone contributed to tRNA selection.  
 
Ribosomal Rescue in Bacteria: Trans-Translation 
When translation elongation is disrupted, eukaryotes have three main cytoplasmic 
mRNA-surveillance processes that are utilized: 1) nonsense-mediated decay, 2) no-go decay, and 
3) non-stop decay (100). The pathway that is utilized to rescue ribosomes and degrade the faulty 
mRNA and incomplete peptide depends on the context of the disruption. For example, nonsense-
mediated decay recognizes premature stop codons (101) and non-stop decay is utilized when 
transcripts do not contain stop codons (102). No-go decay functions to rescue ribosomes stalled 
by physical blocks, including chemical damage and structural impediments such as pseudoknots 
and hairpins (103). Bacteria, on the other hand, utilize at least one quality control pathway, 
known as trans-translation, that can rescue ribosomes that have stalled at the 3’ end of a 
truncated transcript (104). In theory, the trans-translation pathway can rescue ribosomes under 
almost any circumstance, as truncated mRNAs are produced through a variety of processes, 
including endonucleolytic cleavage, ribosome stalling, chemical insults, and premature 
transcriptional termination (100). However, it has not been explicitly shown that that this 
pathway rescues ribosomes stalled by damaged transcripts.  
Through the process of trans-translation, one molecule known as transfer-messenger 
RNA (tmRNA), which is encoded by the highly conserved ssrA gene, acts as both a tRNA and 
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mRNA to ensure that stalled ribosomes complete the translation cycle and are recycled (105). 
Though some details of the process remain to be elucidated, we do know that tmRNA, which is 
aminoacylated by alanine (106), binds to the A site of the stalled ribosome (107). At this point, 
the nascent peptide is then transferred to tmRNA (108), and translation then switches from the 3’ 
end of the defective mRNA to the portion of tmRNA that contains an ssrA-coding sequence 
(105, 109), which resembles the degradation signal utilized by bacterial proteases (110). This 
sequence tags the C-terminus of the incomplete protein and signals for its degradation. Like aa-
tRNAs, tmRNA binds EF-Tu (111, 112) while also requiring another protein partner known as 
SmpB (113). The tmRNA molecule binds the A site in a quaternary complex with EF-Tu, SmpB, 
and GTP.  
 
Figure 1.4: Schematic depicting trans-translation. A) The ribosome reaches the 3’ end of a 
transcript lacking a stop codon. B) The tmRNA-SmpB-EF-Tu-GTP complex recognizes the 
stalled ribosome. C) The nascent peptide is transferred to tmRNA. Translation then resumes of 
the open reading frame (ORF) of ssrA which tags the incomplete peptide at its 3’ end. The 
mRNA is then released and degraded. D) Termination occurs when a release factor recognizes 
the stop codon in the ssrA ORF. E) The ribosome dissociates and the incomplete peptide is 
degraded (100).  
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One of the main questions with regards to trans-translation is how the selectivity of this 
process is governed. As is previously discussed, the specificity of peptidyl transfer is achieved by 
cognate codon-anticodon interactions between mRNA and tRNA during translation elongation, 
and these interactions are required to initiate conformational changes in the decoding center (10). 
Interestingly, tmRNA lacks an anticodon stem loop; therefore, it cannot form the same type of 
interactions as aa-tRNAs (114). However, crystal structures of the tRNA-like domain of tmRNA 
in complex with SmpB shows that the protein occupies the decoding center and that the complex 
adopts a structure which is similar to tRNA, with the N-terminal domain of the protein in place 
of the anticodon stem loop (115). These structural as well as biochemical studies suggest that 
SmpB is likely to interact with A1492, A1493, and G530 residues of the decoding center (116, 
117); however, the A-minor interactions that these residues have with aa-tRNA and mRNA 
cannot occur with the protein. Additionally, mutating any of the decoding center residues has no 
impact on tmRNA activity in a reconstituted system (118). One recent crystal structure of a T. 
thermophilus tmRNA-SmpB-EF-Tu complex shows that the decoding center adopts a 
conformation that is similar, but not identical to, that observed with normal elongation 
complexes (119). This supports the idea that SmpB induces rearrangement of A1492 and A1493, 
but their identities are not critical to the stabilization of the induced state of the ribosome.  
Another question with regards to the selectivity of trans-translation is how the process 
avoids targeting actively translating ribosomes. One common feature of tmRNA targets is that 
there is little-to-no mRNA downstream of the P site. In vitro studies have shown that complexes 
with greater than six nucleotides downstream of the P site are poorly recognized by tmRNA 
(120, 121). In solution, the C-terminal domain of SmpB is unstructured (122, 123), but in 
complex with the ribosome it forms a helical structure (119). This structure extends from the A 
23 
 
site towards the mRNA-entry tunnel where it makes contacts with the 16S rRNA, and early 
mutational analysis revealed that the ability of this region to form this structure is critical for 
ssrA tagging (118, 124). Overall, SmpB cannot bind the ribosome unless it has reached the 3’-
end of the mRNA because the C-terminus of the protein occupies the site that is normally 
occupied by the mRNA during translation elongation. This structural clash between SmpB and 
the mRNA ensures that the tmRNA does not bind the A site of the actively translating ribosome, 
and hence avoids prematurely terminating protein synthesis.  
While much is known about how the initial steps of trans-translation occur, more is yet to 
be uncovered about the process. For example, after the first peptidyl transfer reaction, 
translocation must occur to bring the tmRNA open reading frame (ORF) into the A site of the 
ribosome. The new ORF has to occupy the mRNA entry tunnel where SmpB initially binds; as a 
result, SmpB is predicted to change conformation to allow for template switching (125). This 
process, by which the resume codon of the tmRNA is positioned into the A-site, is still not well 
understood, but appears to be dependent on key interactions between SmpB and sequence 






 While much is known about how changes to the ribosome and tRNA can impact tRNA 
selection, less is known about how structural changes to mRNA can alter this process. Studies 
have been performed to investigate the impact of several nucleobase adducts that impact 
hydrogen bonding, as well as those that serve as intentional modifications; however, several 
open questions remain. For example, it is known from previous studies in DNA that the 
frequency at which 8-oxodG base pairs with A or C depends on the fidelity of the polymerase 
decoding the lesion (127–130). Previous work from our group shows that 8-oxoG in mRNA 
stalls the ribosome, but the conformation of 8-oxoG within the ribosome remained unclear (87). 
Additionally, previous work has shown that several alkylative damage adducts can increase 
ribosomal stalling, bypass, and/or miscoding (75, 76). The molecular pathways in eukaryotes to 
rescue stalled ribosomes is well characterized (100). In contrast, the bacterial system used to 
rescue stalled ribosomes from damaged transcripts was still unknown. Finally, the importance of 
the kink structure in the phosphate backbone of mRNA in the context of the ribosome remained 
uninvestigated. Addressing these and other questions will help to elucidate the importance of 
mRNA structure in translation.  
 
QUESTIONS ADDRESSED BY THIS THESIS WORK  
Although our understanding of how mRNA structure can impact translation has greatly 
increased in the last decade, there still exist significant gaps in knowledge of how the ribosome 
deals with alterations in mRNA structure. Broadly, my thesis work has focused on understanding 




• Does 8-oxoG in mRNA prefer to base pair in the syn or anti conformation in the 
context of the A-site of the ribosome? 
• Does the presence of m1A in mRNA cause ribosome stalling and/or specific 
miscoding events? 
• How do bacteria rescue ribosomes stalled by alkylative damage? 
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Alkylative damage of mRNA leads to ribosome stalling and rescue by trans-translation in 
bacteria 
 





The highly efficient and accurate process of translation can be disrupted by damage to nucleic 
acids. Several endogenous and exogenous damaging agents can cause the accumulation of 
alkylative adducts, which can disrupt the normal hydrogen bonding between nucleotides.  
Multiple alkylative adducts of nucleotides have been shown to impact the speed and/or accuracy 
of the decoding process in vitro, and several adducts are able to stall the ribosome. However, 
little is known about the cellular response to ribosome stalling by alkylative damage in vivo. In 
order to investigate the impact of alkylative damage of RNA on ribosome rescue, we treat E. coli 
with two common alkylating agents, methyl methanesulfonate (MMS) and 
methylnitronitrosoguanidine (MNNG), and observe the accumulation of several disruptive 
adducts, including N(1)-methyladenosine (m1A). Using a well-defined bacterial translation 
system, we confirm that m1A stalls ribosomes in vitro. In bacteria, ribosomal stalling is primarily 
relieved by trans-translation, which utilizes transfer-messenger RNA (tmRNA) to release the 
ribosome and tag the incomplete peptide for degradation. To assess if ribosomes use trans-
translation to rescue ribosomes stalled by alkylative damage in vivo, we utilize a previously 
generated mutant transfer-messenger RNA (tmRNA) that encodes a His6 tag in place of its 
peptide degradation signal. When E. coli expressing tmRNA- His6 are treated with alkylating 
agents, we observe an increase in tmRNA activity. These data demonstrate that alkylative 






Nucleic acids are consistently experiencing damage from numerous endogenous and 
exogenous insults, including reactive oxygen species, ultraviolet radiation, and alkylating agents 
(1, 2). In particular, the oxygen and nitrogen atoms of nucleobases are readily modified by 
alkylating agents. RNA is more susceptible to chemical insults than DNA, likely due to its exposed 
Watson-Crick (WC) hydrogen bonding interface (3, 4). Alkylation of the WC interface of mRNA 
is particularly disruptive during the process of decoding on the ribosome (5). The initial stage of 
tRNA selection, known as codon recognition, depends on the ability of the mRNA codon and the 
anticodon of the amino acyl tRNA (aa-tRNA) to form proper hydrogen bonds (6, 7). Watson-
Crick-base-pair conformations are accepted at all three positions of the codon-anticodon, while 
certain wobble conformations are also tolerated at the third position (8, 9). The introduction of 
alkylative damage to this interface is known to disrupt hydrogen bonding interactions and as a 
result, is highly likely to reduce translational speed and fidelity (10).  
Several alkylative damage adducts of mRNA have either been predicted or shown to be 
detrimental to the decoding process. For example, O6-methylguanosine (m6G), N1-
methylguanosine (m1G), 3-methylcytidine (m3C), and N1-methyladenosine (m1A) are of interest 
due to their potential to interfere with normal WC interfaces (10). Prior work has shown the 
presence of m6G in mRNA interferes with the speed and accuracy of decoding (11, 12). The 
introduction of a methyl group to the O6 of guanosine causes an internal rearrangement of 
electrons such that N1 is no longer covalently bound to the hydrogen used to base pair at the WC 
interface. This results in a significant reduction in the rate of peptidyl transfer in the presence of 
an m6G•C base pair (11). Additionally, the alteration of N1 from a hydrogen bond donor to a 
hydrogen acceptor allows for m6G to base pair in the Watson-Crick conformation with uridine, 
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resulting in an increase in the rate of miscoding in the presence of an m6G•U base pair (11). Due 
to the difficulty of incorporating the adduct into a synthesized transcript, the impact of m3C on 
decoding fidelity has remained elusive. However, we predict that this lesion causes ribosomal 
stalling, as it disrupts the N3 position that is directly involved in hydrogen bonding with guanosine. 
Recently, N1-methyladenosine has been the focus of several studies due to its potential 
role as a regulatory modification on mRNA (13). Depending on the m1A-seq technique used, N1-
methyladenosine abundance has been found on human transcripts ranging from 20% of the 
transcriptome (14, 15) to only nine sites in mRNA (16). The adduct has been shown to be enriched 
around the start codon of transcripts, upstream of the 1st splice site. Over half of the identified m1A 
adducts have been mapped to the coding region of transcripts (14, 15). A specific regulatory role 
of this modification has not been identified; on the contrary, studies generally support the 
hypothesis that m1A exists primarily as a damage adduct. For example, one study using crude  E. 
coli translation extracts showed that m1A significantly increased ribosome stalling when it was 
present at any of the three positions in the codon (12). This effect on translation is anticipated, 
considering that m1A is particularly disruptive to the hydrogen bonding interface, as it interferes 
with the ability of the N1 to hydrogen bond and introduces a resonance structure with a positive 
charge to the nucleotide (Figure 2A). Additionally, m1A can lead to local duplex melting in RNA 
which could impede the codon-anticodon helix (17).  
We hypothesize that an increase in the abundance of chemical damage that disrupts the 
hydrogen boding interface between mRNA and tRNA, such as alkylation, will result in increased 
ribosomal stalling in vivo. Eukaryotes have several mRNA-surveillance pathways to rescue stalled 
ribosomes from a variety of scenarios, including premature stop codons (nonsense-mediated 
decay) (18), transcripts lacking stop codons (non-stop decay) (19), and physical blocks (no-go 
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decay) (20). Bacteria, on the other hand, utilize at least one quality-control pathway, known as 
trans-translation, to rescue ribosomes stalled at the 3’ end of a truncated transcript (21, 22). During 
this process, one molecule known as transfer-messenger RNA (tmRNA), which is encoded by the 
highly conserved ssrA gene, acts as both a tRNA and mRNA to rescue stalled ribosomes and 
ensure that the incomplete peptide is tagged for degradation (22). The tmRNA molecule, in 
complex with EF-Tu and another protein partner known as SmpB, recognizes the stalled ribosome 
and binds to the A site (23), at which point the nascent peptide is transferred to tmRNA (24). 
Translation is then switched from the 3’ end of the defective mRNA to the portion of tmRNA that 
contains the ssrA-coding sequence (22, 25). This sequence codes for a tag that resembles the 
degradation signal utilized by bacterial proteases (26), and signals for the incomplete peptide to be 
degraded. The ssrA sequence also contains a stop codon which is recognized by release factors so 
the ribosome can complete the translation cycle and be recycled. Additionally, there is evidence 
to suggest that the tmRNA-SmpB complex recruits RNase R to degrade the damaged mRNA (27, 
28).  
In theory, the trans-translation pathway can rescue ribosomes stalled from a variety of 
obstacles, as truncated mRNAs are produced during several processes, including endonucleolytic 
cleavage, ribosome stalling, chemical insults, and premature transcriptional termination (1). 
However, trans-translation has not been specifically shown to rescue ribosomes stalled from 
chemically damaged transcripts. Here, we introduce alkylative damage to E. coli RNA and 
subsequently observe the activity of trans-translation. We first demonstrate that treating E. coli 
with common alkylating agents increases the levels of several disruptive alkylative adducts, 
including m1A. As previous data was generated using crude extracts to demonstrate that m1A 
resulted in ribosome stalling (12), we utilized our well-characterized reconstituted in vitro 
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translation system to obtain quantitative data with regards to the effect of m1A on peptidyl-transfer 
(29). Additionally, when we treat E. coli with alkylating agents, we observe increased levels of 
tmRNA activity, suggesting that trans-translation is responsible for rescuing ribosomes from 
damaged transcripts in bacteria. Furthermore, when we treat E. coli lacking functional tmRNA 
with alkylating agents, they exhibit delayed recovery compared to wild-type (WT) cells, 




Treatment of E. coli with MMS or MNNG causes significant increases in alkylative damage 
of RNA 
In order to investigate the impact of alkylative damage on ribosomal rescue in bacteria, we 
first established a method to introduce alkylative damage to RNA in E coli. We chose to treat cells 
with either methyl methanesulfonate (MMS) or methylnitronitrosoguanidine (MNNG), two agents 
that work through different nucleophilic substitution mechanisms to alkylate nucleotides. MMS 
alkylates its target through an SN2-type mechanism, while MNNG reacts through an SN1-type 
one (4); therefore, we expected to observe differences in the types and levels of adduct that each 
agent generated. After treatment with the alkylating agents, RNA was extracted, digested with P1 
nuclease into individual nucleotides, and subsequently treated with calf-intestinal phosphatase 
(CIP) to generate nucleosides which were analyzed by liquid chromatography – mass spectrometry 
(LC-MS). We generated standard curves for each of the unmodified nucleosides, as well as for 
N1-methyladenosine (m1A), N6-methyladenosine (m6A), N1-methylguanosine (m1G), O6-
methylguanosine (m6G), and N3-methylcytidine (m3C) in order to directly quantify the modified 




Supplementary Figure 2.S1: LC-MS calibration curves for modified and unmodified 
nucleosides 
A) The integrated peak area for absorbance at 260 nm was recorded for known micromolar 
concentrations of unmodified nucleoside standards. Peak area versus concentration was plotted 
and fit to a linear equation, which was used to calculate sample concentrations. B) The integrated 
peak area for cps intensity was recorded for known picomolar concentrations of modified 
nucleoside standards. Peak area versus concentration was plotted and fit to a linear equation, 
which was used to calculate sample concentrations.  
 
One previous study measured endogenous m6A/A levels of 0.3% in E. coli (30). In 
agreement with these experiments, we observe approximately 0.6% m6A/A in untreated RNA 
(Figure 1A). We did not measure an increase in m6A levels after treatment with either alkylating 
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agent (Figure 1A). This result was expected, as neither MMS nor MNNG alkylate the N6 position 
of adenosine (4). Additionally, MMS and MNNG have been shown to cause low levels of m1G 
accumulation in DNA (4); however, we do not measure significant increases in the levels of this 
modification (Figure 1B). This is likely because m1G is an intentional modification of E. coli tRNA 
and rRNA (31), so when the cells are treated with MMS and MNNG we do not detect substantial 
accumulation of this adduct over background. Indeed, the base level of m1G was at least 200-fold 
higher than m1A (Figure 1).  
Contrary to m6A and m1G levels, we measure 10 to 200-fold increases in m3C and m1A 
when we treat cells with MMS or MNNG (Figures 1C and 1D), and at least a 12-fold increase in 
m6G in those treated with MNNG (Figure 1E). This is consistent with previous studies which show 
that the O6 position of guanosine is primarily targeted by MNNG but not MMS, and that m3C and 
m1A are minor alkylative adducts in double-stranded DNA (32) but are substantially more reactive 
as nucleophiles in the absence of hydrogen bonding (33). This same increase in reactivity for m1G 
in single-stranded RNA is not observed because it is a secondary amine with an adjacent carbonyl 
group which is less reactive than m1A and m3C, both of which have the higher reactivity profiles 




Figure 2.1: Treatment of E. coli with MMS and MNNG results in significant accumulation 
of detrimental alkylative damage adducts in RNA 
A-E) Quantification of the integrated peak area of modified nucleosides in picomolar 
concentrations normalized to the integrated peak areas of absorbance at 260nm for their 
corresponding unmodified nucleosides in micromolar concentrations. Nucleosides were 
quantified from untreated cells (white), MMS-treated cells (black), and MNNG-treated cells 
(gray). The quantified nucleoside for each plot is indicted above.  
 
N1-methyladenosine stalls ribosomes and behaves as a non-cognate codon in vitro  
Having established a method of increasing the levels of alkylative adducts in E. coli 
mRNA, we next used our well-defined reconstituted bacterial translation system to quantify 
changes in peptidyl-transfer introduced by the presence of m1A in mRNA (29). Using this system, 
incorporation efficiency of any single amino acid can be measured. We generated ribosomal 
initiation complexes carrying f-[35S]-Met-tRNAfMet in the P site and displaying either an intact 
GAA codon, or an m1A adduct at the second position (Gm1AA) in the A site (Figure 2B). The intact 
GAA codon is normally decoded by Glu-tRNAGlu. Since m1A inhibits the ability of the N3 on 
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adenosine to form hydrogen bonds as well as introduces a positive charge in the hydrogen bonding 
interface, normal Watson-Crick interactions would be disrupted, and we predicted that this would 
lead to a reduction in the rate of translation and potentially miscoding events (Figure 2A).   
We reacted the intact and m1A-containing initiation complexes with cognate Glu-tRNAGlu 
ternary complexes at multiple timepoints and visualized the dipeptide products using an 
electrophoretic thin-layer chromatography (TLC) system. The points were fitted to a first-order 
rate equation, and the rate of each reaction was calculated. We found that the presence of m1A 
resulted in a 250-fold decrease in the rate of translation, as well as an almost 90% decrease in the 
endpoint (Figure 2C). These results demonstrate that m1A is highly detrimental to the decoding 





Figure 2.2: N(1)-methyladenosine (m1A) in mRNA significantly decreases the rate and 
endpoint of translation in vitro 
A) Chemical structure of m1A. The N1-methyl group is highlighted in red, and the resonance 
structure of the molecule is represented. B) Schematic representation of adenosine and m1A 
initiation complexes encoding for the dipeptide Met-Glu. Both complexes contain the initiator 
fMet-tRNAfMet in the P site; the A complex displays a GAA codon, while the m1A complex 
displays a Gm1AA codon in the A site. C) Represented time-courses of duplicate peptide-bond 
formation reactions between initiation complexes either containing (red) or lacking (blue) m1A 
and Glu-tRNAGlu cognate ternary complexes.  
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Having established that m1A disrupts the ability of the codon to form a cognate 
interaction, we next tested if the presence of m1A causes the codon to behave as a near-cognate 
codon, which harbors a single mismatch. When a cognate tRNA pairs with a corresponding 
undamaged codon, a series of local conformational changes occur so that specific residues of the 
ribosome make contacts with the codon-anticodon complex. These local rearrangements lead to 
global changes, resulting in the shift of the ribosome from an open to a closed conformation, a 
process known as ‘domain closure’, thus allowing the complex to proceed through the remainder 
of tRNA selection (34). This process is altered by the addition of the aminoglycoside antibiotic 
paromomycin, which forces the ribosomal residues involved in the conformational changes into 
an intermediate position between the open and closed conformations. This reduces the energic 
barriers necessary for the ribosome to undergo domain closure in the presence of near-cognate 
amino acyl-tRNAs (aa-tRNAs), thus resulting in an increase in the rate of miscoding (35, 36). If 
m1A causes the codon to behave like a near-cognate instead of a cognate codon in the presence 
of the cognate ternary complex, we expect that the addition of paromomycin to this reaction 
would increase the rate of peptide bond formation.  
We reacted the m1A -containing initiation complex described earlier with cognate Glu-
tRNAGlu ternary complexes in the presence and absence of paromomycin. We observed no 
significant difference between these reactions, demonstrating that paromomycin does not rescue 
the effect of m1A on peptide-bond formation (Figure 3). Since near-cognate interactions are 
rescued in the presence of antibiotics, this suggests that m1A disrupts the ability of the codon to 
form base-pairing interactions with the cognate anticodon so drastically it acts as a non-cognate. 
From these results, we predict that m1A is not only disrupting the ability of the A to form a 
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hydrogen bond, but also distorting the codon-anticodon helix significantly enough to disrupt the 
hydrogen bonds of its neighboring nucleotides.  
 
Figure 2.3: Paromomycin does not rescue the impact of m1A on peptide bond formation 
Representative time-course of duplicate peptide-bond formation reactions between initiation 
complexes containing m1A and Glu-tRNAGlu cognate ternary complexes. Reactions were 
performed either in the presence (red) or absence (blue) of the aminoglycoside antibiotic 
paromomycin.  
 
To provide further evidence to support the observation that m1A causes the codon to 
behave as a non-cognate, we investigated if m1A altered miscoding in the presence of near- and 
non-cognate tRNAs. We performed a tRNA survey, in which we reacted the previously 
described m1A-containing and lacking initiation complexes with all possible ternary complexes 
for two minutes, which is sufficient time to reach the endpoint of significant reactions (Figure 4). 
As anticipated for the codon containing the unmodified adenosine, we observed no significant 
dipeptide accumulation except for the reaction in the presence of the cognate ternary complex 
(Figure 4). For the codon containing m1A, no significant dipeptide accumulation occurred in the 





Figure 2.4: Specific miscoding events are not observed for a codon containing m1A 
Phosphorimager scan of electrophoretic TLCs used to follow dipeptide-formation reactions (two-
minute incubation time). TCs are indicated above and within each set, the reaction on the left 
was performed using an IC displaying an unmodified GAA codon while the reaction on the right 
was performed using an IC displaying a modified Gm1AA codon. 
 
N1-methyladenosine does not interfere with trans-translation in vitro 
The results thus far show that m1A is highly disruptive to peptidyl transfer in vitro. From 
this data, we hypothesized that alkylative damage to E. coli would cause ribosomal stalling in 
vivo. We predicted that the main ribosomal rescue system in bacteria, the trans-translation 
pathway, would be responsible for releasing stalled ribosomes from these damaged transcripts 
(21). However, if the presence of m1A in the A site disrupts the interaction between the codon 
and the anticodon of the ternary complex, it is possible that it interferes with the ability of 
tmRNA or SmpB to bind the A site and begin trans-translation. In this case, the ribosome would 
be unable to be rescued by trans-translation from transcripts damaged by m1A in vivo.  
 To test if m1A in the A site interferes with the binding of tmRNA or SmpB, we 
performed in vitro peptidyl transfer reactions in the presence of either a codon containing m1A or 
a codon with an unmodified A, and an in vitro reconstituted quaternary complex containing 
SmpB, tmRNA, EF-Tu, and GTP. Similar to tmRNA in vivo, the tmRNA used in this experiment 
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was amino-acylated with alanine (37). We utilized the same mRNA constructs that were used in 
the in vitro peptidyl transfer assays, as we had shown that the transcript containing m1A 
significantly interfered with peptidyl transfer. These transcripts are not ideal substrates for trans-
translation, as they contain twelve nucleotides downstream of the P site instead of seven, which 
has previously been shown to be the maximum number of downstream nucleotides for sufficient 
activation of trans-translation (38, 39). Even using sub-optimal substrates, we observe similar 
rates and endpoints of peptidyl transfer for codons containing either A or m1A (Figures 5A and 
5B). This data suggests that m1A does not significantly interfere with the binding of SmpB or 
tmRNA to the A site; therefore, the possibility remains that m1A leads to ribosomal stalling in 




Figure 2.5: m1A does not significantly interfere with the recognition of initiation complexes 
by trans-translation in vitro 
A) Phosphorimager scan of an electrophoretic TLC used to follow dipeptide-formation reactions. 
The timecourse on the left was performed using ICs displaying an unmodified GAA codon and 
trans-translation quaternary complexes. The timecourse on the right was performed using ICs 
displaying a modified Gm1AA codon and trans-translation quaternary complexes. B) 
Quantification of the timecourses performed in A.  
 
Alkylative damage of RNA increases tmRNA activity in vivo 
Having established a method to introduce alkylative damage adducts to E. coli RNA 
through treatment with MMS or MNNG, we took advantage of a previously generated tmRNA 
construct which contains an altered native degradation peptide tag sequence; specifically, the six 
C-terminal residues are substituted for an HHHHHH (His6) tag (tmRNA-H6), in order to assess 
the activity of tmRNA (40). Using this system, if ribosomes stall in vivo and tmRNA is activated, 
His6 tagging of incomplete peptides will increase.  
We treated E. coli expressing tmRNA-H6 with either 0.1% MMS or 5 μg/mL MNNG and 
performed a western blot to analyze the resulting total protein. As predicted, we observed 
approximately 2 to 3-fold increases in His6-tagging levels (Figures 6A and 6B). To show that the 
treatments were causing significant alkylative damage, we also probed for the activation of Ada, 
which is an enzyme that is involved in the adaptive response (41). Ada is normally present at 
very low levels in the cell, and it induces its own expression as well as the expression of other 
proteins involved in the adaptive response upon alkylative damage (42, 43). Indeed, we observe 
significant increases in Ada activation when we treat with MMS or MNNG, and along with the 






Figure 2.6: Alkylative damage of RNA in E. coli induces ribosome rescue through the trans-
translation pathway 
A) Western blot displaying total protein collected from E. coli expressing tmRNA-His6. Cells 
were either untreated or treated with MMS, MNNG, or ciprofloxacin. Additionally, cells either 
received (+) or did not receive (-) a pre-treatment with rifampicin before treatment with the 
indicated damaging agent. Blots were probed with α His, α Ada, α RecA, and α RF2. B) 
Quantification of the increase in His6 levels for each no rifampicin pre-treatment condition. His6 
samples were first normalized to their corresponding RF2 loading control, and then fold-
increases in His6 levels were calculated by dividing the treated samples by the untreated samples. 
Quantification was performed in triplicate ± SD. C) Quantification of the fold-decrease of His6 
levels upon pre-treatment with rifampicin. His6 samples were first normalized to their 
corresponding RF2 loading control. Fold-decreases in His6 levels were calculated by dividing the 
rif pre-treatment condition for each sample with its corresponding no-rif pre-treatment condition 
and subtracting this value from 1.  Quantification was performed in triplicate ± SD.  
 
 In order to show that the increase in tmRNA activity was due to alkylative damage rather 
than other potential effects from cell death, we treated E. coli with 0.1% MMS and performed a 
spot assay with the treated cells and do not observe significant death at this concentration 
(Supplemental Figure S2A and S2B). Additionally, a previous report has shown that when the 
ClpAP, ClpXP, and Lon proteases are inactive, the levels of his-tagging by the tmRNA system 
increase, as the incomplete peptide products are able to further accumulate (40). When E. coli 
with null alleles of clpP, clpX, and lon genes are treated with the alkylating agents, we observe 
even more extensive his-tagging as the incomplete peptides generated from alkylative damage 




Supplementary Figure 2.S2: WT and ∆ssrA E. coli exhibit similar survival phenotypes after 
treatment with MMS 
A) Spot assay of WT and ∆ssrA cells either after no treatment or treatment with 0.1% MMS for 
the indicated amount of time. B) Quantification of colony forming units in (A) performed in at 
least duplicates. C) Spot assay of WT and ∆ssrA cells either after no treatment or treatment with 
0.5% MMS for the indicated amount of time. D) Quantification of colony forming units in (C) 





Supplementary Figure 2.S3: Deletion of ClpAP, ClpXP, and Lon proteases results in 
further accumulation of His6 after alkylative damage 
Western blot displaying total protein collected from either WT E. coli, strains expressing 
tmRNA-His6, or strains expressing tmRNA-His6 with null alleles of clpP, clpX, and lon genes. 
Cells were either untreated or treated with MMS or MNNG. The blot was probed with α His, α 
Ada, and α RF2. 
 
As has been noted in a previous study, the his-tagging patterns between each of the 
samples appear almost identical (40). This was a surprising observation, as we expected the 
alkylative damage to be randomly located throughout the transcriptome, thereby causing a more 
uniform streak of his-tagging or banding patterns that varied from sample to sample. In order to 
investigate if this consistent banding pattern was an artifact of the His antibody we were using, 
we probed a western blot with His antibodies from three different manufacturers. Each antibody 
had a distinct His-tagging pattern (Supplemental Figure S4). This data suggests that the 
consistent His-tagging pattern is likely more due to an artifact of the His antibodies than a 




Supplementary Figure 2.S4: Different His antibodies display unique banding patterns on 
western blots 
Western blots displaying total protein collected from E. coli expressing tmRNA-His6. Cells were 
either untreated or treated with MNNG. Each treatment set contains a dilution series (1.0, 0.5, 
and 0.25) of total protein. Western blots were probed with three His antibodies from different 
manufacturers, including Santa Cruz Biotechnology, Abcam, or GenScript. α RF2 was used as a 
loading control.  
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The accumulation of His-tagged peptide products suggests that alkylative damage of 
RNA is stalling ribosomes in vivo and activating tmRNA. However, the alkylative damage from 
MMS and MNNG damages DNA as well as RNA (4). This is supported by the increase in RecA, 
which is a protein that is essential for the maintenance and repair of DNA (44), that we observe 
increasing via western blot when we treat with these alkylating agents (Figure 6A). Therefore, it 
was also possible that the resulting increase in His-tagging was primarily due to the production 
of truncated transcripts from damaged DNA. These truncated transcripts lack a stop codon; 
therefore, ribosomes will stall at the 3’ end of the transcript with an empty A site and this has 
been previously shown to activate the response of tmRNA (22). To ensure that the observed His 
-tagging was due to RNA damage rather than truncated RNA produced from damaged DNA, we 
pre-treated the cells with a rifampicin (Rif) approximately forty seconds before treating with 
damaging agents. Rif is an inhibitor of RNA polymerase initiation; therefore, the pretreatment 
with rif halts transcriptional initiation and allows us to separate the effects of DNA damage from 
RNA damage (45). In addition to MMS and MNNG, we also treated the cells with ciprofloxacin 
(cip) and mitomycin C (MMC). Cip is an antibiotic that inhibits the ligation activity of DNA 
gyrase and topoisomerase IV but not the cleavage activity, thereby causing the topoisomerases to 
create double stranded breaks in DNA (46). MMC causes intra- and inter-strand DNA crosslinks 
that can block the activities of DNA polymerase and RNA polymerase (47). We predict that 
these two agents, which specifically cause DNA damage, will produce truncated transcripts and 
cause His-tagging by tmRNA. We also expect to observe a decrease in His-tagging generated by 
DNA damaging agents, but not for the alkylating agents, after pre-treatment with rif if the 
tmRNA activity is due primarily to alkylative damage of RNA rather than truncated transcripts.  
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 When we pre-treat E. coli expressing tmRNA-H6 with rif and then with MMS, we 
observe a slight (10%) decrease in His-tagging levels compared to the no pre-treatment 
condition, suggesting that the His-tagging in this condition is primarily due to RNA damage 
(Figure 6C). When we treat the cells with MNNG, we do observe a slightly higher decrease 
(20%) in the amount of His-tagging for the rif pre-treatment condition compared to no pre-
treatment (Figure 6C). This suggests that a portion of the His-tagging is due to truncated 
transcripts produced from DNA damage; however, the levels of His-tagging in the rif pre-
treatment condition are still significantly higher than the samples with no alkylative damage. 
When we treat cells with cip, we observe significant His-tagging in the no rif pre-treatment 
condition, approximately the same fold-increase as MNNG and MMS (Figure 6B). This 
observation supports our initial hypothesis that DNA damage generates truncated transcripts that 
cause ribosomal stalling and activate tmRNA. However, when we pre-treat the cells with rif and 
then with cip, we observe a 40% decrease in His-tagging (Figure 6C). When we treated cells 
with MMC, we did observe increases in RecA activation but no significant increases in levels of 
His-tagging, demonstrating that the DNA crosslinking damage induced by MMC does not 
activate the tmRNA system (Supplemental Figure S4). While little is known about how RNA 
polymerase stalling is resolved from double-stranded breaks, from this data we predict that 
double-stranded breaks produce more truncated mRNA transcripts than crosslinking. Overall, we 
conclude that while truncated transcripts produced from damaged DNA do activate tmRNA, the 
predominate source of tmRNA activation in MMS- and MNNG- treated samples is the alkylative 




Supplementary Figure 2.S5: Ciprofloxacin, but not mitomycin C, increases His6 levels  
Western blot displaying total protein collected from E. coli expressing tmRNA-His6. Cells were 
either untreated or treated with ciprofloxacin (cip) or mitomycin C (MMC). Additionally, cells 
either received (+) or did not receive (-) a pre-treatment with rifampicin before treatment with 
the indicated damaging agent. The blot was probed with α His, α RecA, and α RF2. 
 
The ability to rescue stalled ribosomes is important for cellular recovery after alkylative 
damage 
 Even though the ssrA gene that encodes tmRNA is highly conserved in bacteria, previous 
studies have shown that ∆ssrA E. coli show no appreciable growth phenotype under standard 
laboratory conditions but do exhibit delayed growth under certain stress conditions (37, 48). 
Since we observed that tmRNA is utilized to rescue ribosomes stalled due to damaged RNA, we 
hypothesized that the ability for cells to rescue stalled ribosomes is important for cellular 
recovery upon treatment with alkylating agents. To test this, we treated ∆ssrA and WT cells with 
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either 0.5% MMS or 20 μg/mL MNNG, washed the cells to remove the alkylating agent, and 
allowed them to recover while monitoring growth. If trans-translation is responsible for rescuing 
ribosomes stalled by alkylative damage, we expect to observe a lag in the recovery time for 
∆ssrA cells compared to WT after treatment with alkylating agents. 
 As expected, in the absence of any pretreatment, ∆ssrA and WT cells recover at 
approximately the same rate. However, after treatment with MMS or MNNG, ∆ssrA cells have 
an approximately 1.5-hour lag in their recovery compared to WT cells (Figure 7). This data 
demonstrates that cells lacking tmRNA are more sensitive to alkylative damage. To rule out 
cellular death as a cause for the observed lag, we treated both ∆ssrA and WT cells with 0.5% 
MMS for 20, 40, and 60 minutes, washed the cells to remove the alkylating agents, and 
performed spot assays to quantify cell death. We observe similar rates of cell death for ∆ssrA and 
WT cells, suggesting that the previously observed lag in recovery time is not due to a difference 
in the number of cells killed, but rather the ability of the cells to quickly recover after treatment 
with alkylating agents (Supplementary Figure S2C and S2D). This data suggests that the ability 
for cells to efficiently recover post-alkylative damage depends on their ability to rescue stalled 







Figure 2.7: Ribosome rescue by tmRNA is important for cellular recovery after treatment 
with alkylating agents  
Average of three replicate growth assays plotting the recovery of E. coli post-alkylative damage. 
WT (blue) and ∆ssrA (red) cells either received no treatment or treatment with MMS or MNNG. 
The alkylating agents were washed from the samples and the OD600 of the cells was recorded 






 Several recent reports have shown that mRNA can be intentionally modified to control its 
function (49). For example, m6A is a reversible modification of mRNA that appears to play a 
role in the regulation of gene expression (50). Additionally, mRNA containing pseudouridine 
(Ψ) has been shown to produce significantly higher levels of functional protein than its 
unmodified counterpart (51). Although much has been revealed about the role that intentional 
modifications serve in regulating various aspects of mRNA metabolism, most chemical 
modifications of mRNA are disruptive damage adducts (10). Previous work had shown that 
several alkylative damage adducts, including m1A and m6G, drastically slow translation and 
cause increases in miscoding events in vitro (11, 12). However, little was known about how 
alkylative damage of mRNA elicits cellular responses in vivo. Additionally, the quantitative 
effects of m1A on the speed and accuracy of translation remained unknown. Here, we introduce 
alkylative damage to bacterial RNA and monitored cellular responses to translation. A priori, we 
hypothesized that the main ribosome rescue system in bacteria, the trans-translation pathway, 
works to release stalled ribosomes from transcripts containing alkylative damage. Indeed, we 
find that upon treatment of E. coli with alkylating agents, trans-translation activity significantly 
increased (Figure 5). Furthermore, we show that when cells lack functional trans-translation, 
they do not recover as efficiently after treatment with alkylating agents (Figure 6).  
 In order to assess the cellular response of bacteria to alkylative damage, we first 
established a method to reliably introduce alkylative damage adducts to E. coli in vivo. We chose 
two common alkylating agents, MMS and MNNG, which work through an SN2- and SN1-type 
nucleophilic substitution mechanism, respectively (4). We measured the levels of several 
modifications via LC-MS with and without treatment, and each of the observed changes is 
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supported by existing literature (4). As a negative control, we chose to measure changes in m6A 
levels, as exocyclic amino groups of guanine, cytosine, and adenine are known to be poor 
nucleophiles in methylation reactions. Indeed, we do not observe significant changes in m6A 
levels upon treatment with the agents (Figure 1A). We do observe increases in levels of m1A and 
m3C which are known targets of MMS and MNNG in single-stranded DNA and RNA (Figures 
1C and 1D) (4, 32). Additionally, we observe increases in m6G levels only in MNNG-treated 
samples (Figure 1E). This is consistent with studies showing that MNNG produces a greater 
percentage of O-methyl adducts (4).  
Our group had previously utilized an in vitro reconstituted bacterial translation system to 
investigate the impact of m6G on decoding (11); however, we had not analyzed the effects of 
m1A. We hypothesized that the positively charged resonance structure of m1A would not only 
disrupt its ability to base pair but would also distort the codon-anticodon helix significantly 
enough to disrupt the ability of its neighboring nucleotides to base pair. Structural studies of the 
A site show that the first and second position of the codon-anticodon helix are strictly monitored 
by rRNA residues as well as ribosomal proteins to ensure that only Watson-Crick base pairs are 
recognized as acceptable interactions (34, 52, 53). We chose to analyze m1A in the second 
position of the codon rather than the first because if our hypothesis held true, first position m1A 
may interfere with the ability of the nucleotide immediately 5’ of the transcript to base pair. In 
this experimental setup, the upstream codon is the start codon, so in theory this could reduce the 
efficiency of translation initiation, which was not the focus of this study.  
The rate and endpoint of peptide-bond formation in the presence of m1A was 
substantially less than those measured for the unmodified control (Figure 2C). This is supported 
by a previous study showing that m1A in mRNA increases ribosome stalling in crude extracts 
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(Figure 2C) (12). Furthermore, the addition of paromomycin to this reaction does not suppress 
the effect of m1A on peptide-bond formation (Figure 3) and the tRNA survey between the m1A-
containin codon and all potential near- and non-cognate aa-tRNAs shows no substantial 
reactivity (Figure 4), suggesting that the adduct causes the codon to behave like a non-cognate. 
Overall, the disruptive nature of m1A in the coding region does not support the idea that it is an 
intentional modification that promotes translation (14), but rather that it is a highly detrimental 
adduct of mRNA. 
Having confirmed that m1A is a disruptive adduct of mRNA in vitro, we then sought to 
investigate the cellular response to alkylative damage in vivo. We first demonstrated in vitro that 
m1A does not significantly interfere with the recognition of the IC by the trans-translation 
quaternary complex (Figure 5), suggesting that translating ribosomes stalled by alkylative lesions 
such as m1A can be targeted by trans-translation. Using a tmRNA modified to His-tag 
incomplete peptides from stalled translation complexes (40), we observe increased trans-
translation activity upon cellular treatment with alkylating agents (Figure 6A). This suggests that 
alkylative damage of RNA causes ribosomal stalling that is severe enough to elicit responses 
from ribosome rescue pathways. Because bacterial mRNAs do not contain poly-A tails like 
eukaryotic transcripts, it is difficult to purify bacterial mRNA from rRNA and tRNA; therefore, 
we cannot be certain that the observed effects on translation are due to mRNA damage 
exclusively. However, there exist several compelling reasons to support the hypothesis that the 
tmRNA response is primarily due to mRNA damage. For one, the complex folding of rRNA as 
well as its association with ribosomal proteins is thought to make it a poor target for alkylative 
damage (10). Specifically, the rRNA residues responsible for monitoring the base pairing in the 
decoding center are not exposed to the cytoplasm in translating ribosomes; therefore, it is 
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unlikely that they are damaged by the agents (54). Additionally, tRNA are susceptible to 
alkylative damage, but only 3 out of an average of 76 nucleotides directly participate in base 
pairing with the codon. This reduces the probability that damaged nucleotides in tRNA cause the 
observed ribosomal stalling. The secondary structure of tRNA does not protect it from damage, 
as it has been shown that tRNA accumulate damage to the same extent when they are folded as 
when they are denatured (55). However, the CCA enzyme in E. coli, which attaches the 
conserved CCA sequence at the 3’ end of all mature tRNAs, has been shown to have an innate 
ability to discriminate against tRNA backbone damage (56). Because the CCA sequence serves 
as the site of amino acid attachment for tRNAs, this suggests that damaged tRNAs would not be 
aminoacylated, thereby also reducing the probability that damaged tRNAs are utilized during 
translation.  
We also confirm that the majority of tmRNA activity is due to RNA damage rather than 
truncated transcripts produced by damaged DNA. One intriguing observation from these 
experiments is that ciprofloxacin, but not MMC, increases tmRNA activity in the no-rifampicin 
pre-treatment condition (Supplementary Figure S5). These DNA damaging agents work through 
independent mechanisms – ciprofloxacin produces double-strand breaks (46) while MMC 
generates crosslinks (47). When RNA polymerase encounters a DNA crosslink, it can change 
conformation and backtrack on the DNA which extrudes the 3’ end of the mRNA (57, 58). These 
backtracked polymerases are arrested, and their active sites no longer align with the 3’ hydroxyl 
end of the mRNA (58). They then can become targets for several pathways which work to 
restore transcription and repair the DNA (59, 60). The RNA and stalled RNA polymerase are 
only released after multiple attempts at restoring transcription (61).  This repair of DNA and 
restoration of transcription in the presence of crosslinks could explain why we do not observe 
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significant tmRNA activity, as the production of a truncated transcript from this scenario could 
be rare. Contrary to stalling on a crosslink, little is known about the fate of bacterial RNA 
polymerase when it encounters a double-stranded break. Based on our observation that 
ciprofloxacin significantly increases tmRNA activity, we hypothesize that double-stranded 
breaks are more likely to result in the production of truncated transcripts than DNA crosslinks.  
Several studies have shown that bacteria lacking a functional trans-translation pathway 
do not recover as efficiency after cellular stress, including nutrient and oxidative stress (37, 48). 
We observe that alkylative stress also causes a delayed recovery period in cells lacking tmRNA, 
likely because they are unable to efficiency rescue stalled ribosomes and resume growth (Figure 
7). The ∆ssrA cells are likely still able to eventually resume growth after alkylative damage 
because of the existence of several alternative ribosome-rescue factors. One factor, known as 
alternative ribosome-rescue factor A (ArfA) works by recruiting RF2 to hydrolyze the peptidyl-
tRNA and release the ribosome (62, 63). This factor acts as a backup for trans-translation, as its 
expression increases when tmRNA activity is limited (64, 65). Additionally, it is not as ideal of a 
system as trans-translation, as it does not tag the incomplete peptide for degradation. Another 
factor that can release stalled ribosomes is ArfB, although it does not appear to function solely as 
a backup for tmRNA and its physiological function remains to be elucidated (66, 67). 
Regardless, these alternative ribosome rescue factors in E. coli are likely responsible for the 
eventual recovery we observe.  
Our hypothesis that alkylative damage is detrimental enough to decoding to cause 
ribosomal stalling and rescue in vivo is also supported by the observation that bacteria contain at 
least one protein that can repair alkylative lesions of mRNA. For example, AlkB is an alpha-
ketoglutarate-dependent hydroxylase in E. coli that has been shown to repair alkylative lesions of 
67 
 
single-stranded DNA and RNA, including m1A, m3C, and m1G (68). We also predict that the 
targeting of stalled ribosomes by trans-translation results in the degradation of alkylated 
transcripts, as previous studies have suggested that tmRNA recruits RNaseR to degrade non-stop 
mRNA (27). Although the accumulation of alkylative damage under physiological conditions or 
disease states has not been the focus of many studies, our work supports the idea that it is 
important for cellular viability to rescue and prevent ribosomes from stalling on alkylated 
transcripts and that trans-translation is the main pathway through which bacteria alleviate this 








Strains were either derivatives of E. coli MG1655 (F- lambda- ilvG- rfb-50 rph-1) or X90 
(ara∆(lac-pro) nalA argE(Am) rif thi-1/F’ lacIq lac+ pro+) (69). We received the following 
strains from the lab of Dr. Sean Moore: SM694 (X90, ssrA::his6 - kan), SM876 (X90, ssrA::his6 - 
kan, clpPX-lon::cam), and SM20 (X90, ∆ssrA, cam) (40). We received the SKEC4 (MG1655, 
∆ssrA, ∆smpB, kan) strain from Dr. Allen Buskirk. P1 transduction was used to introduce kanR - 
linked tmRNA-H6 into MG1655.  
Western Analysis 
To prepare total protein for Western blot analysis, E. coli were precipitated, washed with LB, 
and resuspended in 2xSDS loading dye. The resuspension volume was adjusted to normalize for 
OD600 of the culture at the time of collection. Total protein was separated by SDS-PAGE and 
transferred to PVDF membrane in 1x Transfer buffer (25 mM Tris, 192 mM glycine, 20% 
Methanol) in a wet apparatus. After transfer, the membrane was shaken for one hour in PBST 
(3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl, 0.05% Tween 20, pH 7.4.) 
with 5% w/v powdered milk. The membrane was then washed with PBST and incubated with 
primary antibody overnight at 4°C. The following dilutions of primary antibodies were used: 
1:2500 anti-His (Abcam unless otherwise specified), 1:500 anti-Ada (Santa Cruz 
Biotechnologies), 1:10,000 anti-RecA (Abcam), and 1:1,000 anti-RF2 (purified as described in 
Zaher and Green Cell paper). The blot was then washed three times for 5 minutes, and then 
incubated with the corresponding HRP-conjugated secondary antibody (1:10,000) in PBST for 
one hour. After washing three times for 5 minutes, the membrane was treated with an HRP-
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reactive chemiluminescent reagent (Pierce ELC Western Blotting Substrate). Quantity One 
software was utilized to quantify Western blots.  
Treatment of E. coli with Damaging Agents 
For all Western blot analyses, E. coli were treated with the following concentrations of damaging 
agents: 0.1% MMS (Sigma-Aldrich), 5 μg/mL MNNG (TCI Products), 50 μg/mL ciprofloxacin 
(Sigma-Aldrich), or 6 μg/mL MMC (Sigma-Aldrich). To determine the treatment time that 
generated significant tmRNA activity and Ada activation, MG1655 cells containing tmRNA-His6 
were grown from OD 0.05 to mid-log phase (OD 0.3-0.4) and treated with MMS for several 
timepoints. The resulting total protein was analyzed via western blot (Supplemental Figure S6). 
We observed significant tmRNA activity and Ada activation after a 20-minute treatment, which 






Supplementary Figure 2.S6: Optimal His6, Ada, and RecA levels are achieved after 20 
minutes of MMS treatment  
Western blot displaying total protein collected from E. coli expressing tmRNA-His6. Cells were 
either untreated or treated with MMS for various lengths of time. The blot was probed with α 
His, α Ada, α RecA, and α RF2. 
 
To determine the optimal length of time for rifampicin pre-treatments, we treated MG1655 cells 
containing tmRNA-His6 with 6 ug/mL rifampicin for several timepoints followed by 20 min 
treatments with either MMS or ciprofloxacin. The resulting protein was analyzed via western 
blot (Supplemental Figure S7). We observed significant decreases in Ada activation in the MMS-
treated samples and significant decreases in tmRNA activity and RecA activation in the 
ciprofloxacin-treated samples after 10 seconds of rifampicin pre-treatment. We utilized a 10 to 
45-second rifampicin pre-treatment time for the remaining samples analyzed via western blot.  
 
Supplementary Figure 2.S7: Significant transcriptional runoff is achieved after 10 seconds 
of rifampicin treatment  
Western blots displaying total protein collected from E. coli expressing tmRNA-His6. A) Cells 
were either untreated, treated with only ciprofloxacin, or pre-treated with rifampicin for various 
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amounts of time before ciprofloxacin treatment. The blot was probed with α His, α RecA, and α 
RF2. B) Cells were either untreated, treated with only MMS, or pre-treated with rifampicin for 
various amounts of time before MMS treatment. The blot was probed with α His, α Ada, and α 
RF2. 
 
Quantification of Nucleosides via Liquid Chromatography – Mass Spectrometry 
 
Overnight cultures of MG1655 E. coli were diluted to OD 0.05 in LB and grown to an OD of 
0.3-0.4 at 37°C before 20 min treatment with either 0.1% MMS or 5 μg/mL MNNG. RNA was 
isolated using a hot phenol method as previously described (70). 10 μg of total RNA was 
digested by P1 nuclease (10 Units) at 50°C overnight. A final concentration of100mM Tris pH 
7.5 and 1:100 v/v dilution of calf intestinal phosphatase (CIP) were added to the samples, and the 
reaction was incubated for 1 hour at 37°C to convert 5’-monophosphates to nucleosides. The 
samples were diluted to 150 μL and filtered (0.22 μm pore size) before injecting 10 μL into an 
Agilent 1290 Infinity II UHPLC connected to an Agilent 6470 Triple Quadrupole mass 
spectrometer. Nucleosides were separated on a Zorbax Eclipse Plus C18 column (2.1 x 50 mm x 
1.8 micron) and then analyzed using multiple-reaction monitoring in positive-ion mode. 
Calibration curves were generated with known concentrations of standards. Unmodified 
nucleosides were monitored by absorbance at 260 nm. Modified nucleosides were monitored by 
MRM. The retention times and mass transitions of each nucleoside are listed in Supplemental 
Table S1. Free unmodified A, G, and C standards were purchased from Acros Organics and U 
was purchased from TCI Products. Free modified nucleosides m7G, m1G, and m3C were 
purchased from Carbosynth, m6G and m6A were purchased from Berry’s Associates, and m1A 
was purchased from Cayman Chemical Company. Data was analyzed using Agilent qualitative 












A 268.1 136 1.92 18 
C 244.1 112 0.48 14 
G 284.2 152 2.4 16 
U 245.2 152.1 1 14 
m1A 282.2 150.1 0.9 16 
m6A 282 150 4.08 16 
m3C 258.2 126 0.8 8 
m7G 298.2 166 1.5 10 
m1G 298 166 4.623 4.143 
m6G 298 166 4.84 4.84 
 
Supplementary Table 2.S1: Mass transitions, retention times, and collision energies for 
nucleoside standards  
 
Charging of Aminoacyl-tRNA  
[35S]-fMet-tRNAfMet was prepared as previously described (71). The tRNAs were aminoacylated 
by incubating total tRNA mix (Roche) at 150 μM with the appropriate amino acid (0.4 mM), 
tRNA synthetase (~5 μM) and ATP (2 mM) in charging buffer composed of 100 mM K-HEPES 
(pH 7.6), 20 mM MgCl2, 10 mM KCl, 1 mM DTT. After a 30-minute incubation at 37°C, the aa-
tRNAs were purified by phenol/chloroform extraction, ethanol precipitated, and resuspended in 
20 mM KOAc (pH 5.2) and 1 mM DTT.  
Formation of Ribosomal Initiation Complexes  
Protocols were performed as previously described (72). All initiation complex (IC) formation 
and peptidyl transfer reactions were performed in 1x polymix buffer (46 in 8oxoG paper), 
composed of 95 mM KCl, 5 mM NH4Cl, 5 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM putrescine, 1 
mM spermidine, 10 mM K2HPO4 (pH 7.5), 1 mM DTT. In order to generate ICs, 70S ribosomes 
(2µM), IF1, IF2, IF3, [35S]-fMet-tRNAfMet (3µM each), mRNA (6µM), and GTP (2 mM) in 1 × 
polymix buffer were incubated at 37°C for 30 min. The initiation complexes were purified from 
free tRNAs and initiation factors over a 500 µL sucrose cushion composed of 1.1 M sucrose, 20 
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mM Tris-HCl pH 7.5, 500 mM NH4Cl, 0.5 mM EDTA, and 10 mM MgCl2. The mixture was 
spun for 2 hours at 287,000 × g at 4°C, and the pellet was resuspended in 1 × polymix buffer 
and stored at -80°C. The fractional radioactivity that pelleted was used to determine the 
concentration of IC.  
Modified mRNAs containing m1A used in the IC formation reaction were purchased from The 
Midland Certified Reagent Company, and its sequence is as follows: C AGA GGA GGU AAA 
AAA AUG G(1-methyl-A)A UUG UAC AAA. The unmodified control mRNA was transcribed 
from a dsDNA template using T7 polymerase and purified via denaturing PAGE (74).  
Kinetics of Peptidyl Transfer 
In order to exchange bound GDP for GTP, EF-Tu (30 µM final) was initially incubated with 
GTP (2 mM final) in 1x polymix buffer for 15 mins at 37°C. The mixture was then incubated 
with aminacyl-tRNAs (~6 µM) for 15 mins at 37°C to form ternary complexes (TC). For 
reactions performed in the presence of paromomycin, 10 µg/mL final of the antibiotic were 
added to this mixture. Kinetics assays were also performed using trans-translation quaternary 
complexes (QCs), which were formed by incubating Ala-tRNAAla with SmpB, EF-Tu, and GTP 
in 1x polymix for 15 mins at 37°C. The TC or QC mixture was then combined with an 
equivalent volume of IC at 37°C either using RQF-3 quench-flow instrument or by hand. KOH 
to a final concentration of 500 mM was used to stop reactions at different time points. Dipeptide 
products and free fMet were separated using cellulose TLC plates that were electrophoresed in 
pyridine-acetate at pH 2.8 (50 in 8oxog paper). TLC plates were then exposed to a phosphor 
screen overnight, after which they were imaged using a Personal Molecular Imager (PMI) 
system. The images were quantified, and the fraction of dipeptide fMet at each time point was 
used to determine the rate of peptide bond formation using GraphPad Prism software.  
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Alkylative Damage Recovery Assays 
Overnight cultures of MG1655 and ∆ssrA MG1655 cells were diluted to OD600 0.05 and grown 
to 0.3 – 0.4 at 37°C before treating with either 0.5% MMS or 20 μg/mL MNNG for 20 mins. The 
OD600 of the cells was recorded at the time of collection, and the samples were washed twice 
with LB and resuspended in an adjusted volume of LB. Cells were diluted to an OD600 of 0.005 
at 100 μL final volume in a 96-well plate. Plates were shaken at 37°C for 20 hours in a BioTek 
Eon microtiter plate reader which measured the OD600 of each well every 10 mins. OD600 data 
over time was fit to an exponential function in Graphpad Prism to plot the growth curve.  
Spot Assays for Viability Analysis  
X90 and SM20 E. coli were grown from OD 0.5 to OD 0.3 at 37°C before treating with either 
0.1% or 0.5% MMS. At each time point, an aliquot of the culture was removed, washed with LB, 
and then serially diluted 1:10 eight times. 4 μL of each dilution were spotted on an LB plate. The 
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Insights into the base-pairing preferences of 8-oxoguanosine on the ribosome 
 
This chapter is currently published in Nucleic Acids Research as Erica N. Thomas, Carrie L. 
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Of the four bases, guanine is the most susceptible to oxidation, which results in the formation of 
8-oxoguanine (8-oxoGua). In protein-free DNA, 8-oxodG adopts the syn conformation more 
frequently than the anti one. In the syn conformation, 8-oxodG base pairs with dA. The equilibrium 
between the anti and syn conformations of the adduct are known to be altered by the enzyme 
recognizing 8-oxodG. We previously showed that 8-oxoG in mRNA severely disrupts tRNA 
selection, but the underlying mechanism for these effects was not addressed. Here, we use 
miscoding antibiotics and ribosome mutants to probe how 8-oxoG interacts with the tRNA 
anticodon in the decoding center. Addition of antibiotics and introduction of error-inducing 
mutations partially suppressed the effects of 8-oxoG. Under these conditions, rates and/or 
endpoints of peptide-bond formation for the cognate (8-oxoG•C) and near-cognate (8-oxoG•A) 
aminoacyl-tRNAs increased. In contrast, the antibiotics had little effect on other mismatches, 
suggesting that the lesion restricts the nucleotide from forming other interactions. Our findings 
suggest that 8-oxoG predominantly adopts the syn conformation in the A site. However, its ability 
to base pair with adenosine in this conformation is not sufficient to promote the necessary 
structural changes for tRNA selection to proceed.  
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Decoding of the genetic information is a remarkably accurate process that ensures the 
maintenance of faithful protein production. In all domains of life, the ribosome carries out this 
crucial task by utilizing multiple strategies to select for the aminoacyl-tRNA (aa-tRNA) that 
corresponds to mRNA in the A site (1, 2). This process of tRNA selection is divided into two 
phases: initial phase and proofreading, which are separated by the irreversible step of GTP 
hydrolysis by EF-Tu (3). During the initial selection phase, aa-tRNA binds the A site of the 
ribosome in a ternary complex with EF-Tu and GTP. During this stage, near-cognate aa-tRNAs, 
which harbor a single mismatch, are discriminated against due to their inability to fully base pair 
with the A-site codon. This results in the accelerated dissociation of the ternary complex. After 
this initial codon-recognition step, EF-Tu undergoes a conformational change before GTP is 
hydrolyzed (4). This step of GTPase activation is significantly accelerated for cognate aa-tRNAs, 
thereby contributing to the overall accuracy of the tRNA selection process. After GTP hydrolysis, 
GDP-bound EF-Tu undergoes additional conformational changes before dissociating from the 
ribosome (5, 6). During the subsequent proofreading stage, the selection process is partitioned into 
accommodation and rejection (7, 8). Cognate aa-tRNAs rapidly accommodate to then participate 
in peptidyl transfer (PT), whereas near-cognate aa-tRNAs are more likely to be rejected (9–11). 
This multi-step process of tRNA selection results in an overall misincorporation rate of 10-4 – 10-
3 per PT event (12–15) 
X-ray crystallography and cryo-EM reconstitution studies of various ribosome complexes 
have provided some important molecular rationale for the process of tRNA selection, especially 
during the initial selection stage (16–18). The EF-Tu-bound aa-tRNA binds the A site in a bent 
state, referred to as the A/T state, where its anticodon can sample the codon (19). Once base pairing 
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between the codon and the anticodon occurs, the conserved A1492, A1493, and G530 residues of 
the decoding center change conformation and interact with the minor groove of the codon-
anticodon helix in a recently-identified stepwise manner (17). These interactions are only possible 
if strict Watson-Crick base pairing is maintained at the first two positions of the codon. Additional 
contacts are made by other ribosomal RNA (rRNA) residues as well as ribosomal protein S12 (20). 
These local rearrangements in the decoding center trigger a global change in the small ribosomal 
subunit (30S) (21). This so-called “domain closure” moves the shoulder of the 30S as well as EF-
Tu closer to the large subunit (50S). As a result, the GTPase domain of EF-Tu binds the sarcin-
ricin loop (SRL), activating the factor for GTP hydrolysis through interactions with the catalytic 
histidine (22). It has been suggested that if the anticodon of the aa-tRNA is tightly bound in the 
decoding center following EF-Tu dissociation, accommodation ensues. On the other hand, if the 
tRNA is loosely bound then it is more likely to dissociate and be rejected (7, 23). 
Several antibiotics are known to affect the overall selection process by altering the 
interactions between the tRNA-mRNA complex and the decoding center. The most studied and 
well-understood group is the aminoglycoside class of antibiotics. Nearly all bind in the decoding 
center and reduce the energetics of “domain closure” by driving an “ON”-state of the decoding 
center nucleotides. For instance, paromomycin binds in a rRNA pocket close to A1492 and A1493 
and induces them to adopt a structure similar to that assumed in the presence of cognate tRNAs. 
This, in turn, reduces the energetic cost associated with “domain closure” of the 30S subunit and 
as a result, makes the process of tRNA selection more favorable in the presence of near-cognate 
aa-tRNAs (24, 25). In comparison, streptomycin, which decreases GTPase activation for cognate 
aa-tRNA and increases it for near-cognate aa-tRNAs, does not induce “domain closure”. Instead, 
the antibiotic induces a lateral shift of helix 44 (h44), which contains A1492 and A1493; this 
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rearrangement is distinct than that triggered by the addition of paromomycin. This lateral shift 
appears to be sufficient to stabilize near-cognate tRNAs, whereas the prevention of “domain 
closure” destabilizes cognate tRNAs, which results in an overall increase in miscoding (26, 27). 
These largely structure-based models for tRNA selection, whereby local changes in the 
decoding center drive global rearrangements in the small subunit, are also supported by genetic 
studies. In particular, mutations in the 30S subunit that destabilize interactions that are important 
for the transition from the “open” to “closed” state result in a hyperaccurate phenotype. These 
mutations are typically found on the ribosomal protein S12, specifically at its interface with 
h27/h44 of the 16S rRNA near the decoding center (28, 29). In contrast to the hyperaccurate 
mutants, error-prone (often referred to as ribosomal ambiguity (ram)) mutants reduce the 
energetics for transitioning to the “closed” state of the 30S by disrupting interactions important for 
maintaining the “open” state (30). Mutations of this class are associated with changes to the 
interfaces between ribosomal proteins S4 and S5 that are held together through electrostatic 
interactions in the “open” state. Therefore, disruption of these interactions eases the transition to 
the “closed” state, even in the presence of near-cognate tRNAs (31, 32).  
Under typical circumstances, the ribosome only encounters mRNA composed of the four 
canonical nucleobases. In contrast, the tRNA anticodon is often modified, and these modifications 
impact how the anticodon base pairs with the codon. Similarly, mRNA appears to be modified, 
albeit to a lesser extent than tRNAs. The most abundant of these mRNA modifications include N6-
methyladenosine (m6A), 5-methylcytosine (m5C), and pseudouridine (Ψ) (33). Although these 
modifications do not change the Watson-Crick-base-pairing capabilities of the nucleotides, they 
affect the decoding process. For example, m6A reduces the overall rate of peptide-bond formation 
by almost an order of magnitude (34, 35). In contrast, the introduction of Ψ to mRNA has little 
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effect on the speed of decoding but reduces accuracy on stop codons in vitro (36, 37). Regardless 
of their effect on decoding, the biological implications of these modifications are currently not 
fully understood, namely due to their low stoichiometries on mRNAs.  
In contrast to these potentially intentional modifications, chemical damage to the mRNA 
nucleobase is largely detrimental to the decoding process. Most damage adducts occur as a result 
of reactivity between the mRNA and endogenous or exogenous agents (38). Some of the most 
common nucleotide-damaging agents include ultraviolet light, alkylating agents, and reactive 
oxygen species (ROS). In particular, ROS are produced endogenously as byproducts of metabolic 
reactions and increase under stress conditions (39). Of the many potential ROS adducts, 8-
oxoguanosine (8-oxoG) is noteworthy due to its high abundance relative to other oxidized 
nucleotides and its association with neurodegenerative disease (40, 41). Furthermore, 8-oxoG 
significantly reduces the rate of peptide-bond formation to a point that it stalls protein synthesis 
and is likely to activate the process of no-go decay (NGD). Indeed, our group has shown that the 
introduction of 8-oxoG to the mRNA, independent of its position within the codon, slows down 
PT by three to four orders of magnitude (42). While the overall kinetic consequences of 8-oxoG 
on tRNA selection were recognized, the mechanistic details through which 8-oxoG interferes with 
translation remained unknown. Specifically, we were interested in understanding how 8-oxoG 
disrupted interactions with the anticodon within the decoding center of the ribosome.  
Previous data from studies of the oxidative damage of DNA show that 8-oxodG can alter 
the base pairing preferences of dG by changing the conformation of the nucleotide (43). When 8-
oxodG adopts the typical anti-conformation, the oxygen at carbon 8 is in steric clash with the 
phosphate backbone (Figure 1). In order to relieve this steric clash, the base can rotate around its 
glycosidic bond to the syn conformation, where it reveals a new hydrogen-bonding interface which 
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it uses to form a Hoogsteen base pair with dA (43). Different DNA polymerases read 8-oxodG as 
either a dG or dT at varying efficiencies, resulting in either accurate polymerization or a 
transversion. The efficiency of incorporating dCMP versus dAMP across 8-oxodG depends on the 
fidelity of the DNA polymerase. The steric constraints for base pairs in the active sites of high 
fidelity polymerases increase the frequency at which 8oxodG base pairs with dA, as this base pair 
is nearly identical in terms of its geometry to a normal Watson-Crick base pair than 8oxodG•C 
(44, 45). While much is known about the base pairing preferences of 8-oxodG during replication, 
the preference for the syn vs anti conformation of the base on the ribosome is not understood at 
all.  
 
Figure 3.1: 8-oxoG alters the base-pairing properties of the nucleotide  
A) Structure depicting the Watson-Crick base pair of unmodified guanosine and cytidine. B) 
Structure of 8-oxoG in the anti conformation forming a Watson-Crick base pair with cytidine, and 
C) in the syn conformation forming a Hoogsteen base pair with adenosine.  
 
In this study, we take advantage of a well-defined in vitro translation system to examine 
the mechanism through which 8-oxoG in mRNA interferes with translation (46). We find that 8-
oxoG significantly impacts the initial phase of tRNA selection, suggesting that 8-oxoG is 
interfering with the ability of the A-site codon to form a proper interaction with its corresponding 
anticodon. To address how 8-oxoG is disrupting this interaction in the context of the A site, we 
explored its base-pairing preferences by relaxing tRNA-selection conditions and reacting it with 
its cognate tRNA and all possible near-cognate tRNAs. Under these relaxed tRNA selection 
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conditions, we observed that 8-oxoG base pairs with either cytidine or adenosine independent of 
its location in either the first or second position of the codon. Our analysis also shows that 8-oxoG 
has a preference for base pairing with adenosine over cytidine under error-prone conditions, 
suggesting that it more frequently exists in the syn conformation than the anti one on the ribosome. 
Additionally, 8-oxoG disrupts the ability of the nucleotide to form base pairs with the remaining 
near-cognates (8oxoG•U and 8oxoG•G). Our results contribute to the mechanistic understanding 
of how 8-oxoG in mRNA disrupts translation.   
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MATERIALS AND METHODS 
 
Materials  
All reactions were performed in 1x polymix buffer (47), composed of 95 mM KCl, 5 mM 
NH4Cl, 5 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM putrescine, 1 mM spermidine, 10 mM K2HPO4 
(pH 7.5), 1 mM DTT.  
70S ribosomes were purified from MRE600 E. coli via a double pelleting technique (32). 
Translation factors were overexpressed and purified from E. coli (46).  
Modified mRNAs containing 8-oxoG were purchased from either IDT, Dharmacon, or The 
Midland Certified Reagent Company. Unmodified control mRNAs were transcribed from a 
dsDNA template using T7 RNA polymerase and purified via denaturing PAGE (48). The 
sequence for the first position 8-oxoG mRNA was as follows: CAGAGGAGGUAAAAAA AUG 
(8-oxo-rG)UU UUG UAC AAA. The sequence for the second position 8-oxoG-Arg mRNA was 
as follows: CAGAGGAGGUAAAAAA AUG C(8-oxo-rG)C UUGUACAAA. The sequence for 
the second position 8-oxo-Gly mRNA was as follows: CAGAGGAGGUAAAAAA AUG G(8-
oxo-rG)C UUG UAC AAA.  
Charging of Aminoacyl-tRNA  
[35S]-fMet-tRNAfMet was prepared as described (49). Pure tRNAs (tRNAVal, tRNAArg, or 
tRNAMet from ChemBlock) were aminoacylated by incubating them at 10 μM with the 
appropriate amino acid (0.4 mM), tRNA synthetase (~5 μM) and ATP (2 mM) in charging buffer 
composed of 100 mM K-HEPES (pH 7.6), 20 mM MgCl2, 10 mM KCl, 1 mM DTT. After 
incubation at 37°C for 30 minutes, the aa-tRNAs were purified by phenol/chloroform extraction 
and ethanol precipitated. The aa-tRNAs were resuspended in in 20 mM KOAc (pH 5.2) and 1 
mM DTT. Other tRNAs were aminoacylated by incubating total tRNA mix (Roche) at 150 μM 
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in the presence of the corresponding amino acid and tRNA synthetase as above. The incubation 
and purification were conducted as that done for the pure tRNAs. 
 
Formation of Ribosomal Initiation Complexes  
Protocols were performed as described (50). Briefly, to generate initiation complexes (IC), the 
following components were incubated at 37°C for 30 min: 70S ribosomes (2µM), IF1, IF2, IF3, 
[35S]-fMet-tRNAfMet (3µM each), mRNA (6µM) in 1 × polymix buffer in the presence of 2 mM 
GTP. The complexes were then purified away from free tRNAs and initiation factors over a 500 
µL sucrose cushion composed of 1.1 M sucrose, 20 mM Tris-HCl pH 7.5, 500 mM NH4Cl, 0.5 
mM EDTA, and 10 mM MgCl2. The mixture was spun at 287,000 × g at 4°C for 2 hrs, and the 
resulting pellet was resuspended in 1 × polymix buffer and stored at -80°C. In order to determine 
the concentration of IC, the fractional radioactivity that pelleted was measured.  
 
GTP Hydrolysis Assay 
To assemble the ternary complexes, the following components were combined and incubated at 
37°C for 15 minutes: 5 mCi/mL of [γ-32P]-GTP, 20 μM EF-Tu, and 5 μM of unlabeled GTP. An 
equal volume of 30 μM aa-tRNA was then added to the reaction and allowed to incubate again at 
37°C for 15 minutes. In order to purify away unbound GTP and aa-tRNA from the assembled 
ternary complexes, samples were passed twice over P-30 spin columns (Biorad). The ternary 
complex was then diluted to 1 μM in polymix buffer (0.5 μM in the final reaction) and mixed with 
an equal volume of 2 μM IC (1 μM in the final reaction) at 20°C in a quench-flow instrument 
(RQF-3, KinTek Corporation). The reactions were quenched through the addition of 40% formic 
acid. The inorganic phosphate product was separated from unreacted GTP using Polyethylenimine 
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(PEI) cellulose thin-layer chromatography (TLC) (Sigma) with 0.5 M potassium phosphate buffer 
pH 3.5 as a mobile phase. Fractional radioactivity corresponding to inorganic phosphate at each 
time-point was quantified using phosphorimaging and used to determine the observed rates of GTP 
hydrolysis. 
 
Kinetics of Peptidyl Transfer 
EF-Tu (30 µM final) was initially incubated with GTP (2 mM final) in polymix buffer for 15 mins 
at 37°C to exchange the bound GDP for GTP. To form the ternary complex, the mixture was 
incubated with aminoacyl-tRNAs (~6 µM) for 15 mins at 37°C. For reactions performed in the 
presence of antibiotics, streptomycin (100 µM final) or paromomycin (10 µg/mL final) were added 
to this mixture. The ternary complex mixture was then combined with an equivalent volume of IC 
at 37°C either by hand or using RQF-3 quench-flow instrument. The reaction was stopped at 
different time points using KOH to a final concentration of 500 mM. Dipeptide products were 
separated from free fMet using cellulose TLC plates that were electrophoresed in pyridine-acetate 
at pH 2.8 (51). The TLC plates were exposed to a phosphor screen overnight, and the screens were 
imaged using a Personal Molecular Imager (PMI) system. These images were quantified, and the 
fraction of dipeptide fMet at each time point was used to determine the rate of peptide bond 






8-oxoG interferes with the initial phase of tRNA selection 
Previous work from our group showed that the presence of 8-oxoG within the A-site codon, 
regardless of its position, has a drastic effect on the speed of translation and slight effect on 
accuracy. The modification reduced the PT rate by almost three orders of magnitude for cognate 
aa-tRNA, and slightly increased it for the near-cognate tRNAs interacting through 8-oxoG•A base 
pairs with the codon (42). We hypothesized that the adduct inhibits base pairing, and as a result, 
is likely to inhibit early stages of tRNA selection, particularly the codon-recognition step. For 
technical reasons, we could not directly measure the kinetics of this step. Instead, in order to 
address the potential effect of the modification on the initial phase of tRNA selection, we opted to 
measure the rate of GTP hydrolysis as it reports on the overall selectivity of initial selection (11). 
To accomplish this, we utilized a pre-steady-state-kinetics strategy in combination with our 
reconstituted in vitro bacterial translation system. This system allows us to monitor individual and 
specific amino-acid incorporation. Briefly, ternary complexes were generated by incubating EF-
Tu with a specific aa-tRNA in the presence of radio-labeled [γ-32P]-GTP. Purified ternary 
complexes were then incubated with initiation complexes programmed with intact mRNAs or 8-
oxoG-containing ones, and rates of GTP hydrolysis were determined by stopping the reaction at 
various points. 
In total, we analyzed 8 different complexes harboring 8-oxoG at different positions of the 
A-site codon and their corresponding unmodified mRNAs. In particular, we measured the rates of 
GTP hydrolysis for the following complexes: 8oxoGUU, C8oxoGC, G8oxoGC and GA8oxoG, and the 
corresponding intact ones; these complexes code for Val, Arg, Gly and Glu, respectively. As 
predicted, we measured rates of GTP hydrolysis that were significantly lower for the oxidized 
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mRNAs relative to the corresponding unmodified ones (> three orders of magnitude for three of 
the four complexes) More specifically, we measure rates of 42 s-1, 24 s-1, 47 s-1, and 86 s-1, 
respectively, whereas the same rates for the unmodified ones were <0.0001 s-1, 0.064 s-1, 0.033 s-
1, and 0.015 s-1, respectively (Figure 2). Interestingly, this change in rates of GTP hydrolysis 
mirrors what we documented for PT, suggesting that most of the effects of the adduct on tRNA 
selection are due to alteration to the initial phase of the selection process. 
 
8-oxoG impairs decoding in a manner similar to a mismatch with subtle but important 
distinctions  
Thus far, our data has shown that the presence of 8-oxoG affects early stages of tRNA 
selection by potentially interfering with the codon-anticodon interaction. More specifically, we 
expect the modification to inhibit base pairing, resembling a mismatch. This would result in PT 
reactions with oxidized complexes behaving in a manner analogous to reactions involving near-
cognate aa-tRNAs. To probe this prediction, we increased ribosomal promiscuity through the 
addition of aminoglycoside antibiotics to our in vitro PT reactions. This results in relaxed tRNA-
selection parameters, which increases the incorporation of near-cognate aa-tRNAs; and based on 
our model, aa-tRNA reactivities should also increase with the oxidized complexes in the presence 





Figure 3.2: 8-oxoG inhibits GTP hydrolysis by EF-Tu 
A-D) Representative time courses of GTP hydrolysis reactions between the indicated initiation 
and ternary complex (codon is shown at the bottom, while the anticodon is shown at the top). For 
each codon, time courses were performed in the presence of G (blue) or 8-oxoG (red) and the 
position of 8-oxoG within the codon is indicated in red. E) Bar graph showing the observed rate 
of GTP hydrolysis (kGTP) for initiation complexes programmed with the indicated codon in the A 
site. 8-oxoG was introduced at the position depicted in red. Blue bars represent observed rates with 
unmodified complexes; red bars represent rates with 8-oxoG complexes. Plotted is the average of 




We reacted the intact (CGC) complex and its oxidized counterpart (C8oxoGC) with its 
cognate Arg-tRNAArg ternary complex and every possible second-position-near-cognate ternary 
complex in the absence and presence of streptomycin or paromomycin. As expected, after 5 
seconds of incubation, significant dipeptide formation was observed only in the presence of the 
cognate ternary complex for the intact CGC complex (Figure 3). Additionally, as we had reported 
earlier, the presence of 8-oxoG severely inhibited the formation of the cognate fMet-Arg dipeptide 
while increasing the incorporation of Leu-tRNALeu, for which the second position A of the 
anticodon base pairs with the 8-oxoG. The addition of antibiotics had no effect on the cognate 
reaction in the presence of intact mRNA. However, and as anticipated, the antibiotic significantly 
increased the formation of only the near-cognate fMet-His dipeptide. This is rationalized by the 
fact that tRNAHis harbors U at the second position of its anticodon, which allows it to form a less 
deleterious wobble-base pair with the G of the mRNA’s codon (52). Consistent with our model 
that 8-oxoG changes the decoding process in a manner resembling that of a near-cognate, the 
addition of antibiotics to the C8oxoGC complex increased the formation of fMet-Arg dipeptide and 
that of fMet-Leu. Interestingly, the antibiotics appear to have little to no effect on the reactivity of 
the C8oxoGC complex with His-tRNAHis. Together, these observations suggest that the effects of 





Figure 3.3: 8-oxoG in the second position of the codon changes the base pairing properties 
of guanosine on the ribosome  
A) Phosphorimager scan of electrophoretic TLCs used to follow dipeptide-formation reactions (5-
second incubation time) in the presence of the indicated initiation and ternary complexes in the 
absence and presence of the indicated antibiotics. B) Quantification of the dipeptide yield as 
performed in (A). Plotted is the average of three independent experiments and the error bars 
represent the standard deviations around the means. 
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To add more quantitative support for these differential reactivity profiles, we conducted 
full-time courses of the PT reactions in the absence and presence of streptomycin or paromomycin. 
Performing full-time courses allowed for us to measure the observed rate of peptide-bond 
formation (kpep) which reports on the combined rates of aa-tRNA accommodation (k5) and rejection 
(k7), as well as the end point of each reaction (Fp), which reports on the effectiveness of 
proofreading (k5 relative to kpep) (9). In agreement with our end-point analysis, the antibiotics had 
little effect on the endpoints and the rate of the reactions between the native initiation complex and 
the cognate aa-tRNA (Figure 4A). This is in slight disagreement with previous reports showing 
that streptomycin reduces the rate of peptide bond formation for cognate reactions by 
approximately twofold (26, 53), whereas in our assays, streptomycin only slightly decreased these 
rates. We note that these earlier experiments utilized different buffer systems, for which the 
observed rate of peptide-bond formation in the presence of streptomycin is limited by GTP 
hydrolysis.  
Interestingly, the addition of the antibiotics to the same reaction with the 8-oxoG-
containing complex caused the observed rate of PT to increase twofold – we measured average 
rates of 0.0097 s-1, 0.022 s-1, and 0.049 s-1in the absence of antibiotic and in the presence of 
streptomycin or paromomycin, respectively (Figure 4B). Additionally, the endpoint of the 
reactions increased by approximately an order of magnitude in the presence of the antibiotics, with 
measured Fp values of 0.027, 0.37, and 0.52 for no antibiotic, streptomycin, and paromomycin, 
respectively. Next, we performed reactions in the presence of the near-cognate aa-tRNAs. We 
started with the G•A mismatch reaction involving the Leu-tRNALeu ternary complex. As our 
reactivity-survey assay indicated, the addition of antibiotics did not increase the rate or endpoint 
of PT with the intact complex but caused both to significantly increase for the oxidized complexes 
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(Figures 4C and 4D). For the G•G and 8-oxoG•G mismatches involving Pro-tRNAPro ternary 
complex, the addition of streptomycin had a barely detectable effect on the PT rate (Figures 4G 
and 4H). In contrast, the antibiotics increased the observed PT rate for the His-tRNAHis, which 
forms a wobble G•U mismatch with the mRNA, by more than an order of magnitude. Additionally, 
the Fp value for the same reaction increased by more than twofold as a result of antibiotic addition 
(Figure 4E). In contrast to the unmodified complex, His-tRNAHis failed to react with the 8-oxoG 
complex (Figure 4F). These observations suggest that the modification does not allow the mRNA 
to form a wobble base pair with U. Altogether, our findings suggest that oxidation of G changes 
the base-pairing preference for the modified nucleotides on the ribosome, likely due to its chemical 






Figure 3.4: The addition of antibiotics increases the kpep and Fp for cognate and a subset of 
near-cognate tRNAs in the presence of 8-oxoG at the second position of the codon  
A-H) Representative time courses of peptide-bond-formation reactions between the indicated 
initiation and ternary complexes in the absence and presence of the indicated antibiotics. The time 
courses shown on the right panel were carried out with the unmodified complex, whereas ones 
shown on the left panel were carried out with the modified complex (8-oxoG drawn in red). Time 
courses were conducted at least in duplicates. We note that the observed rates varied from 
experiment to experiment due to differences in different preparation of aa-tRNA in the tRNA mix; 
the fold difference as a result of antibiotic addition, however, was reproducible.  
 
To provide further support for our model that antibiotics can suppress the effect of 8-oxoG 
on decoding, we tested another set of complexes that displayed a different codon in the A site. In 
particular, we programmed ribosomes with the oxidized G8oxoGC codon and tested their reactivity 
with the cognate Gly-tRNAGly and near-cognate Val-tRNAVal ternary complexes. Similar to what 
we observed for the G8oxoGC complex, both streptomycin increased the rate of peptide-bond 
formation significantly (Supplementary Figure S1). These observations suggest that 
aminoglycosides suppress the effect of the modification independent of the codon identity. 
 
Supplementary Figure 3.S1: Streptomycin and paromomycin suppress the effects of 8-oxoG 
on kpep for a complex displaying the G8oxoGC codon in the A site 
A-B) Time courses of peptide-bond formation between the indicated initiation and ternary 





The base-pairing preferences of 8-oxoG at the first position of the codon are slightly different 
from those observed at the second position  
 
 Our data thus far shows that when 8-oxoG is in the second position of a codon, it changes 
the base-pairing preferences of G on the ribosome. In order to investigate if the base-pairing 
preferences of 8-oxoG that we observed were specific to the second position, we performed the 
same peptidyl-transfer experiments with a codon containing 8-oxoG at the first position. We 
reacted the complex containing intact codon (GUU) and the complex containing the 8-oxoG codon 
(8-oxoGUU) with the cognate Val-tRNAVal, as well as all possible first-position-near-cognate aa-
tRNAs in the presence of paromomycin or streptomycin. Once again, after 5 seconds of incubation 
with no antibiotic, significant amount of dipeptide was formed exclusively in the presence of the 
cognate ternary complex for the GUU codon, and the presence of 8-oxoG substantially decreased 
the formation of the cognate dipeptide (Figure 5). However, at this position and after 5 seconds of 
incubation, 8-oxoG did not result in any observable increase in the reactivity of the initiation 
complex with Phe-tRNAPhe, which has an A at the third position of the anticodon (Figure 5). This 
is contrary to what we observed in the second position, where dipeptide is formed in the presence 
of the 8-oxoG•A base pair without the addition of antibiotics (Figure 3). We note that our source 
of the tRNA mix often contained low levels of charged tRNAs, even after extensive attempts at  
deacylation. Therefore, we observed some residual reactivity with the cognate Val-tRNAVal in 
reactions containing the near-cognate tRNAs such as Phe-tRNAPhe, but that did not affect our 
quantification since the two peptides migrate differently on our TLCs, allowing us to distinguish 
them.  
Upon addition of antibiotics, we observed significant increases in dipeptide formation for 
the intact codon with two of the three near-cognate aa-tRNAs, namely Phe-tRNAPhe and Ile-
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tRNAIle, for which the third position of the anticodon is an A and a U, respectively. This differs 
from what we observed for the second-position mismatches, for which the addition of antibiotics 
increased the dipeptide formation only for the near-cognate tRNA with the G•U base pair. When 
we add the antibiotics to the reactions containing the 8-oxoG codon, we observe an increase in the 
incorporation of Val-tRNAVal and Phe-tRNAPhe, for which the first position of the anticodon is a 
C and A, respectively. This is similar to what we observe for 8-oxoG in the second position of the 
codon. In both the first and second position of the codon, our data shows that 8-oxoG base pairs 
with adenosine as well as cytidine when tRNA selection is relaxed, suggesting that it is able to 




Figure 3.5: Antibiotics suppress the effects of 8-oxoG in the first position of the codon  
A) Phosphorimager scan of electrophoretic TLCs used to follow dipeptide-formation reactions (5-
second incubation time) in the presence of the indicated initiation and ternary complexes in the 
absence and presence of the indicated antibiotics. B) Quantification of the dipeptide yield as 
performed in (A). Plotted is the average of three independent experiments and the error bars 
represent the standard deviations around the means. 
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Again, to provide additional quantitative support for our reactivity profiles, we performed 
full-time courses of the PT reactions in the absence and presence of the aminoglycoside antibiotics. 
As expected, the addition of the antibiotics had no significant effect on the reaction of the intact 
GUU codon with the cognate Val-tRNAVal (Figure 6A). We measured rates of 31 s-1, 21 s-1, and 
25 s-1 and Fp values of 0.69, 0.72, and 0.73 for the no treatment, streptomycin, and paromomycin 
conditions, respectively. For the reactions between near-cognate Phe-tRNAPhe and Ile-tRNAIle 
with the intact complex (G•A and G•U mismatches, respectively), the addition of antibiotics was 
found to result in an increase in the endpoint, but not the rate (Figures 6C and 6E). This is in direct 
contrast to what we observed for mismatches at the second position, for which the addition of the 
antibiotics substantially increased the rate and endpoint of PT for the G•U base pair only and no 
other mismatches (Figures 4E and 4C), consistent with the observations that decoding at the second 
position appears to be more stringent relative to that at the first one (34).  
For the 8-oxoG-containing codon, we measured a rate and endpoint with Val-tRNAVal (8-
oxoG•C base pair) of 0.044 s-1 and 0.308, respectively. Both of these values are much higher than 
those measured for Phe-tRNAPhe (8-oxoG•A mismatch); kpep of 0.018 s
-1 and Fp of 0.11 (Figures 
6B, 6D). This differs from what we observed with 8-oxoG in the second position, where the rate 
and endpoint were higher for the reaction involving an 8oxoG•A interaction relative to the 8-
oxoG•C (Figures 4B and 4D). These observations could be explained by at least two scenarios: 1) 
the frequency of rotation of 8-oxoG around its glycosidic bond might be different depending on 
its position within the codon; 2) the rate of dissociation of Phe-tRNAPhe from the 8-oxoGUU 
complex is slow, when 8-oxoG is in the syn conformation, allowing the tRNA to sample the anti 
conformation to form a Watson-Crick base pair and proceed with tRNA selection. Interestingly, 
the 8-oxoG•A Phe-tRNAPhe reaction was found to benefit much more from the addition of 
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antibiotics relative to the 8-oxoG•C Val-tRNAVal reaction. For the Val-tRNAVal reaction (8-
oxoG•C base pair), the observed rate and endpoint increased by a mere twofold to fourfold in the 
presence of streptomycin and paromomycin (Figure 4B). In contrast, in the presence of Phe-
tRNAPhe (8-oxoG•A base pair), the observed rate increased by more than an order of magnitude 
and the endpoint increased by approximately sixfold (Figure 4D). These observations are 
consistent with the second scenario, whereby 8-oxoG prefers the syn conformation in the decoding 
center, but the addition of antibiotics stabilizes the tRNA long enough to allow it to sample the 






Figure 3.6: Antibiotics drastically increase kpep and Fp for reactions between the 8oxoGUU 
complex with Phe-tRNAPhe (8-oxoG•A base pair), and only slightly for reactions with Val-
tRNAVal (8-oxoG•C)  
A-H) Representative time courses of peptide-bond-formation reactions between the indicated 
initiation and ternary complexes (codon is shown at the bottom, while the anticodon is shown at 
the top) in the absence and presence of the indicated antibiotics. The time courses shown on the 
right panel were carried out with the unmodified complex, whereas ones shown on the left panel 
were carried out with the modified complex (8-oxoG drawn in red). Time courses were conducted 
at least in duplicates; the fold difference as a result of antibiotic addition was reproducible. 
 
Error-prone and hyperaccurate ribosomes suppress and exaggerate the effects of 8-oxoG on 
decoding, respectively 
To provide further support for our model that altering tRNA selection parameters changes 
the effect of 8-oxoG on decoding independent of drug addition, we utilized error-prone as well as 
hyperaccurate ribosome mutants and assessed their effect on PT in the presence of 8-oxoG. We 
chose the well-studied rpsD12 and rpsL141 mutants as representatives for the error-prone and 
hyperaccurate types, respectively (54). As expected, the mutations had no effect on the observed 
PT rate or endpoints for the intact complex in the presence of the cognate aa-tRNA (Figure 7A). 
In contrast, and in agreement with our model, in the presence of 8-oxoG the error-prone mutation 
increased the observed rate of formation of fMet-Arg dipeptide by sevenfold, whereas the 
hyperaccurate decreased it by approximately fourfold (Figure 7B). Similarly, and consistent with 
their effect on decoding, the error-prone mutation slightly increased the observed PT rate for the 
near-cognate (G•A base pair), whereas the hyperaccurate one slightly decreased the rate (Figure 
7C). In the presence of 8-oxoG, the hyperaccurate mutation suppressed the modification-induced 
misincorporation of Leu-tRNALeu (8-oxoG•A base pair), for which we observe an almost ninefold 
decrease in the observed PT rate, while the error-prone mutation increased the misincorporation 
by fivefold (Figure 7D). These effects of ribosome mutations on peptide-bond formation in the 
presence of 8-oxoG appear not to depend on the identity of the codon. We measure similar effects 
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on complex programmed with the G8oxoGC codon (Supplementary Figure S2). Interestingly, for 
both the no antibiotic and antibiotic treatments, the endpoints for PT reactions involving the 
8oxoG•A interactions were at least twofold relative to those measured for ones involving the 
8oxoG•C base pairs (Figure 7B and 7D). Collectively our data utilizing drug- as well as mutation-
induced alteration of the tRNA-selection process support our model that 8-oxoG can base pair in 
either the syn or anti conformation in the context of the A site, with a preference for the syn 
conformation. Additionally, our data shows that 8-oxoG disrupts the ability of guanosine to 
mispair with uridine, suggesting that the lesion modifies the conformation in which guanosine can 
miscode.  
 
Figure 3.7: Hyperaccurate and error-prone ribosomes suppress and amplify the effects of 8-
oxoG, respectively 
A-D) Representative time courses of peptide-bond formation between the indicated initiation and 
ternary complexes with the depicted ribosome mutant. The time courses shown on the right panel 
were carried out with the unmodified complex, whereas ones shown on the left panel were carried 
out with the modified complex (8-oxoG drawn in red). Time courses were conducted at least in 





Recent reports from a number of groups have shown that modification of the mRNA occurs 
at levels that could potentially affect its function (33). Emerging from these studies are the 
observations that ribosomal function as well as the decoding process could be significantly altered 
as a consequence of these modifications. For some adducts, such as m6A which are deliberately 
modified by cellular enzymes, the modifications appear to play roles in regulating gene expression 
(55). In contrast, for most unintended adducts, like those that result from chemical damage, the 
modifications are a burden to the translation machinery and pose challenges to the speed and 
accuracy of the ribosome. We previously chose to study the effects of the oxidized base 8-oxoG 
due to its high prevalence, especially under certain conditions, as well as its unique chemical 
properties (40–43). Introducing the adduct to the mRNA, regardless of its position within the A-
site codon, slowed down PT significantly. Previous studies regarding the impact of 8-oxoG on 
DNA replication show that the modification can increase C to A transversions by preferentially 
mispairing with A (56). Interestingly, 8-oxoG was found to only slightly increase misincorporation 
of near-cognate aa-tRNAs during translation. These findings suggested that 8-oxoG interfered with 
tRNA selection. Here, we expanded on these studies by characterizing the mechanism by which 
8-oxoG affects the decoding process. A priori, we hypothesized that base-pairing interaction with 
the modified nucleotide resembles a mismatch. As a result, 8-oxoG fails to trigger the required 
conformational changes in the decoding center to proceed through the tRNA selection process. 
Consistent with this proposal, we find the modification to severely inhibit GTP hydrolysis by EF-
Tu, suggesting that it affects the initial phase of the selection process (Figure 2). Furthermore, the 
introduction of miscoding antibiotics or ribosomes with error-prone mutations was found to 
partially rescue the effect of the modification, as would be expected if 8-oxoG•C and 8-oxoG•A 
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base pairs were to resemble mismatches. Indeed, when we add the antibiotics to the reactions of 
intact codons and near-cognate aa-tRNAs, we see similar increases in kpep and/or Fp.  
While the 8-oxoG•C and 8-oxoG•A base pairs resemble mismatches in both the first and 
second position of the codon, we observe that 8-oxoG has distinct base pairing preferences based 
on its position within the codon. In the absence of antibiotics, 8-oxoG in the second position prefers 
to base pair with A, while 8-oxoG in the first position prefers to base pair with C (Figures 4 and 
6). Structural studies of the A site show that the interactions between the second position codon 
and its corresponding anticodon are monitored by the universally conserved A-minor interactions 
of A1492, as well as G530 of the 16S rRNA and S50 of the ribosomal protein S12. Meanwhile, 
the interactions between the first position codon and its corresponding anticodon are only 
monitored by the A-minor interactions of A1493. Monitoring at both positions work to ensure that 
only Watson-Crick base pairs are recognized as acceptable interactions (20, 21, 57). We speculate 
that the bulky conformation of the anti-8-oxoG•C base pair is not recognized as an acceptable 
interaction in the highly-monitored second position, thus explaining why we observe a preference 
for the syn-8oxoG•A. Alternatively, the anti conformation of the modified base might be very short 
lived that during codon recognition tRNAs harboring a C at the second position dissociate before 
they can sample it. In the less stringently monitored first position, we observed a preference for 
the anti-8-oxoG•C base pair in the absence of antibiotics, which could be explained by decreased 
dissociation rates for near-cognate tRNAs at this position (58).  
Upon addition of antibiotics, the average kpep and Fp for the 8oxoG•A in the first position 
exceeded that of 8-oxoG•C, more closely resembling the trends we observe in the second position 
of the codon (Figures 4 and 6). Additionally, we observe higher kpep and/or Fp values for 8oxoG•A 
than 8-oxoG•C in the presence of error-prone ribosomes. Previous studies have shown that 8-oxoG 
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prefers to exist in the syn conformation because of steric repulsion between the 8-oxo and the 
phosphate backbone (43). This is consistent with our model that 8-oxoG primarily exists in the syn 
conformation on the ribosome, and under normal conditions, is recognized as a mismatch when it 
base pairs with A and is rejected during codon recognition. When error-prone conditions, which 
suppress the effect of mismatches, are introduced in this case, the 8oxoG(syn)•A base pair can 
move through codon recognition and into proofreading, and its Fp values are almost restored to 
those observed in the presence of a G•U base pair (Figure 7). We speculate that 8-oxoG does not 
exist in the anti conformation as frequently, but upon addition of antibiotics, the codon-anticodon 
interaction is stabilized long enough to allow for the 8-oxoG to change from the syn to the anti 
conformation and proceed with codon recognition.  
The hypothesis that 8-oxoG primarily exists in the syn conformation on the ribosome is 
also supported by its ability to disrupt base pairing with U. We observe significant reductions in 
kpep and/or Fp values in the presence of an 8-oxoG•U base pair in error-prone conditions compared 
to G•U, regardless of its position within the codon (Figures 4E, 4F, 6E, and 6F). This was a 
surprising observation because the G•U wobble conformation should not be disrupted by the 
introduction of the oxygen at carbon 8; therefore, we expected to see an increase in 8-oxoG•U 
mispairing in the presence of antibiotics. In order to form a wobble base pair with U, 8-oxoG needs 
to be in the anti conformation (52). We speculate that the inability of the antibiotics to increase 
miscoding in the presence of 8-oxoG•U is due to 8-oxoG primarily existing in the syn conformation 
on the ribosome. Additionally, we cannot exclude the possibility that the 8-oxoG•U wobble base 
pair is structurally unfavorable in the A site; however, further studies would need to be performed 
to test this hypothesis.  
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Interestingly, circular dichroism (CD) analysis of RNA duplexes suggest that 8-oxoG 
modification has little to no effect on the geometry of the A helix adopted by the RNA (59). 
Similarly, X-ray and NMR analysis of DNA duplexes harboring 8-oxodG•dA or 8-oxodG•dC 
revealed little to no distortion of the helical structure of the molecule (60–62). However, thermal 
stability analysis of short modified RNAs shows that the lesion decreases the melting temperature 
of the 8-oxoG•C duplex by as much as 10°C relative to G•C suggesting that there are energetic 
penalties associated with this base pair (63). The 8-oxoG•A base pair, in contrast, is significantly 
stabilized relative to the G•A base pair. Even with this increased stability, the Tm of duplexes 
containing the 8-oxoG•A base pairs is on average 5°C lower than that of the canonical G•C base 
pair. These observations suggest that even though the geometry of the 8-oxoG•A base pair is not 
likely to change the overall structure of the codon-anticodon helix, the energetics of the interaction 
between the mRNA and tRNA is not as favorable as would be expected for a cognate one. 
In comparison to the ribosome, DNA polymerases display varying efficiencies for 
incorporating dCMP or dAMP opposite to 8-oxodG dependent on the type of the polymerase. For 
example, replicative polymerases incorporate dCMP across 8-oxodG with frequencies ranging 
from 1:14 to 90:1 relative to dAMP incorporation (44). In addition, these polymerases are more 
efficient at extending beyond the lesion when 8-oxodG is base paired with dA relative to dC, 
suggesting that the polymerases tolerate the mispair presumably due to its similarity to Watson-
Crick base pairs. Indeed, structural analysis of DNA polymerases bound with modified primer-
template complexes rationalized some of these observed effects on the accuracy of DNA 
replication as well as the variation in the efficiencies of misincorporation rates (64–66). These 
studies revealed that both base pairs are accommodated in the active site of the polymerases, but 
their conformations as well as their interactions with the side chains of the proteins are dependent 
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on the identity of the protein. For instance, in the case of T7 DNA polymerase, the 8-oxodG•A 
base pair adopts a geometry nearly identical to that of a Watson-Crick base pair, rationalizing the 
ability of the mispair to escape the proofreading function of the enzyme (67). In contrast to 
replicative polymerases, translesion enzymes, like those used to replicate over thymine dimers, 
tend to be relatively more accurate (68). At a structural level, this can be explained by the slightly 
larger active site employed by these enzymes to allow access for large adduct, which in turn allows 
for the formation of the 8-oxodG•C base pair. Although we lack equivalent structural data of the 
ribosome bound to 8-oxoG-containing mRNA, our data suggests that either base pair can form 
under normal conditions with a preference for 8-oxoG to base pair with A. However, the geometry 
of the base pair is slightly distorted such that it fails to trigger the required conformational changes, 
even in the presence of miscoding antibiotics. Furthermore, we hypothesize that the anti 
conformation of 8-oxoG, which is required for base pairing with C, rapidly rotates to the preferred 
syn conformation before EF-Tu is activated. In the presence of the antibiotic, the cognate tRNA is 
stabilized long enough for the adduct to adopt the canonical anti conformation, activating EF-Tu, 
and in doing so, suppressing the effect of the modification on tRNA selection.  
The ability of ribosomes to bypass oxidative lesions, such as 8oxoG, may serve as an 
advantage under oxidative stress conditions. Previous data from our group showed that the 
presence of 8-oxoG can cause ribosomal stalling and activation of No-Go Decay pathways (42). 
This stalling generates incomplete peptides that are recognized as such and degraded through 
proteolysis. In the presence of error-prone ribosomes, we observe increased decoding of the 8-
oxoG adduct as either a G or U. Previous work has shown that the ability of error-prone ribosomes 
to generate mistranslated proteins rather than stall may serve as a signal for the activation of stress 
response pathways in vivo (69). Indeed, E. coli that expressed error-prone ribosomes were better 
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able to survive hydrogen peroxide treatment than those expressing wild-type ribosomes. 
Interestingly, natural E. coli vary over 10-fold in their mistranslation rates, suggesting that 
miscoding is either tolerated or selected for in certain environments (70). The tendency towards 
error-prone translation in the presence of oxidative damage, such as 8-oxoG, may serve as an 
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 During translation, the ribosome plays an active role in ensuring that mRNA is decoded 
accurately and rapidly. Recently, biochemical studies have also implicated certain accessory 
factors in maintaining decoding accuracy. However, it is currently unclear whether the mRNA 
itself plays an active role in the process beyond its ability to base pair with the tRNA. Structural 
studies revealed that the mRNA kinks at the interface of the P and A sites. A magnesium ion 
appears to stabilize this structure through electrostatic interactions with the phosphodiester 
backbone of the mRNA. Here we examined the role of the kink structure on decoding using a well-
defined in vitro translation system. Disruption of the kink structure through site-specific 
phosphorothioate modification resulted in an acute hyperaccurate phenotype. We measure rates of 
peptidyl transfer for near-cognate tRNAs that are severely diminished and in some instances are 
almost one 100-fold slower than unmodified mRNAs. In contrast to peptidyl transfer, the 
modifications had little effects on GTP hydrolysis by elongation factor thermal unstable (EF-Tu), 
suggesting that only the proofreading phase of the tRNA selection process depends critically on 
the kink structure. Although the modifications appear to have no effect on typical cognate 
interactions, peptidyl transfer for a tRNA that uses atypical base pairing is compromised. These 
observations suggest that the kink structure is important for decoding in the absence of Watson-
Crick or G-U Wobble base pairing at the third position. Our findings provide evidence for a 
previously unappreciated role for the mRNA backbone in ensuring uniform decoding of the genetic 
code. 
 






Reading of the genetic code is an intricate process in which the ribosome plays an active role in 
ensuring that translation proceeds rapidly and accurately. Studies have revealed that the mRNA 
adopts an unusual structure between the P and A sites of the small ribosomal subunit, where it is 
significantly kinked. In this work we probed the role of the kink structure in decoding. 
Substitutions that disrupt this structure were found to increase the accuracy 
of decoding. Conversely, peptide bond formation on difficult-to-decode codons was severely 
reduced when this kink structure was perturbed. Our data suggests that the rigid nature of the 






The accurate decoding of the genetic code depends critically on the ability of the ribosome 
to select the aminoacyl tRNA (aa-tRNA) that matches the mRNA in its A site. During this process 
of tRNA selection, the ribosome employs multiple strategies to maintain the low error frequency 
of 10-4-10-3 per one amino-acid-incorporation event (1-4). The aa-tRNA is delivered to the 
ribosome in a ternary complex with elongation factor thermal unstable (EF-Tu) and GTP. The 
hydrolysis of GTP by EF-Tu essentially divides the tRNA selection processes into two stages: 
initial selection and proofreading (5). Dividing the selection process gives the ribosome two 
opportunities to reject the incorrect aa-tRNA. This mechanism of kinetic proofreading (6, 7) 
utilizes both thermodynamic differences as well as induced fit to accelerate the dissociation rates 
of incorrect aa-tRNAs and forward rates for correct aa-tRNAs (8-10). In particular, during the 
initial selection phase, near cognate ternary complexes rapidly fall off the ribosome, whereas GTP 
is rapidly hydrolyzed for cognate ternary complexes. Similarly, during the proofreading phase 
following the dissociation of EF-Tu, near-cognate aa-tRNAs are readily rejected, whereas cognate 
aa-tRNAs are readily accommodated into the active site to participate in peptidyl transfer (PT) (8). 
More than half a century of biochemical studies on the ribosome have defined many of the 
molecular elements responsible for the observed accuracy during protein synthesis (reviewed in) 
(11). The ribosome itself plays a critical role in dictating the overall fidelity of this process (12, 
13). Indeed, some of the first error-prone and hyperaccurate mutations to be identified mapped to 
ribosomal proteins. For instance, many mutations in the ribosomal proteins genes rpsD and rpsE 
have long been documented to confer a ribosome ambiguity phenotype (ram) (14-19). On the other 
hand, mutations in the rpsL gene result in a restrictive phenotype. Most of these mutations also 
confer resistance to, and in some cases dependence on, the error-inducing antibiotic streptomycin 
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(20, 21). In contrast to ribosomal proteins, mutations to the ribosomal RNA (rRNA) rarely appear 
naturally, due to incomplete penetrance of these mutations, as rRNA genes are typically found in 
numerous copies in the genome. Nonetheless, screens using high copy plasmids carrying the rrn 
operon of E. coli have been used to isolate rRNA variants that alter the decoding properties of the 
ribosome (22, 23). More recent studies using orthogonal ribosomes have also been successful in 
isolating mutants that otherwise would be dominant negative. Interestingly, most of these 
mutations appear to map to functionally important parts of the ribosome such as the decoding 
center or intersubunit bridges (24).  
In addition to the ribosome, translation factors play a critical role in maintaining the fidelity 
of protein synthesis. For example, mutations in elongation and release factors (RFs) have been 
found to increase the error frequency during translation (25, 26). In addition, tRNAs arguably play 
one of the most important roles in the decoding process during both the aminoacylation reaction 
as well as the tRNA selection process. This is best exemplified by suppressor tRNAs that decode 
stop codons and result in missense suppression. While the miscoding properties of most of these 
RNAs can be easily rationalized by alteration to the anticodon, which allows them to base pair 
with the incorrect codon, some, I which mutations far from the anticodon appear to be responsible 
for their phenotype, are more complex. For instance, the Hirsch tRNATrp suppressor tRNA (CCA 
anticodon) harbors a G24A mutation in the D arm enabling it to decode the tryptophan UGG and 
UGA stop codons (27). Biochemical studies of this tRNA showed that this variant tRNA 
accelerates forward rates of tRNA selection even in the presence of mismatched codon-anticodon 
interaction, underlining the critical role of the tRNA during the selection process (28).   
Emerging from recent structural studies of ribosomal complexes are some key hints about 
the molecular mechanics of the decoding process and how perturbation to the translation 
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machinery disrupts it (29, 30). In particular, during the tRNA selection process, the decoding 
center of the ribosome undergoes local conformational changes that in turn drive larger changes 
within the small ribosomal subunit (31, 32). This so-called “domain closure” of the small subunit 
is also accompanied by changes to the A-site tRNA that are manifested by a large conformational 
change in its structure. This structural change is likely responsible for relaying a signal to the 
GTPase activation center of the large ribosomal subunit, leading to the subsequent accommodation 
of the tRNA into the peptidyl-transferase center (33, 34). These structures also provided some 
important mechanistic clues about how classical mutations in the ribosome perturb decoding. They 
appear to alter the thermodynamics of the interchangeability between the “open” and “closed” 
state of the ribosome (32). The rpsD and rpsE mutations of error-prone ribosomes disrupt 
interactions that are necessary to maintain the open conformation, whereas the rpsL mutations of 
hyperaccurate ribosomes disrupt interactions necessary for the closed conformation. In addition to 
the ribosome, the accompanying conformational changes in the tRNA as it moves into the A site 
play an integral role during protein synthesis (33, 35). Structural studies of the Hirsch suppressor 
tRNA revealed tRNA distortion was critical for decoding (36). This increased flexibility of the 
tRNA allows increased GTPase activation of EF-Tu even in the presence of a near-cognate tRNA 
(28). 
What is clear from the abundance of biochemical and structural studies on the ribosome is 
that decoding is an intricate process that takes cues from almost every single factor of the 
translation machinery. What has been less understood is the extent to which the structure of the 
mRNA itself is important for this process. Nonetheless, biochemical studies on the role of the 
ribose backbone during decoding showed the substitutions of the 2’-OH groups of the A-site 
mRNA residue by deoxy or fluoro groups to have only modest effect on tRNA selection (37). This 
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is in contrast to structural studies, which showed the hydroxyl groups to be important for A-minor 
interactions with the decoding center nucleotides (31, 32). 
Equivalent studies of the role of the phosphodiester backbone of the mRNA on ribosome 
function are lacking. Interestingly, crystal structures of the ribosome revealed the mRNA adopts a 
kink-like structure between the P and A sites (38, 39). A magnesium ion stabilizes this structure 
through electrostatic interactions with  the non-bridging oxygens of the phosphodiester backbone 
of the mRNA (39). While the kink has been speculated to be critical for frame maintenance by 
preventing slippage (39), this has not been directly tested. Whether the structure contributes to 
tRNA selection is yet unknown. Here, we perturbed the mRNA structure by introducing 
stereospecific phosphorothioate substitutions in the mRNA at the interface of the P and A site and 
assessed their effect on decoding using a well-defined in vitro system. We found that substitution 
of either of the nonbridging oxygens results in a hyperaccurate phenotype; however, substitution 
of the pro-Sp oxygen, one of the oxygens involved in coordinating the divalent metal, with sulfur 
has a more drastic effect. In the presence of the Rp-phosphorothioate, PT rates for near-cognate 
aa-tRNAs were reduced by about 10-fold relative to the native mRNA. In contrast, the same rates 
were more than 100-fold slower for the Sp-phosphorothioate. Peptide release on near-stop codons 
was similarly affected, suggesting that the kink is critical for the process by which A-site ligands 
interact with the ribosome. In an effort to determine whether the substitutions affect both phases 
of tRNA selection, we measured the rates of GTP hydrolysis by near-cognate ternary complexes 
in the presence of the modifications. Either substitution resulted in a modest two- to threefold 
reduction in the observed rate, suggesting that magnesium coordination by the mRNA is important 
only for the proofreading phase of the selection process. Interestingly, while both substitutions 
appear to have no effect on most cognate aa-tRNA selection, the Sp-phosphorothioate substitution 
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significantly reduced the PT rate for a difficult-to-decode cognate codon. In particular, PT for the 
AUA codon, which is decoded by the anticodon-modified Ile-tRNAIle(k2CAU), is approximately 
fivefold slower in the presence of Sp-modified mRNA relative to the unmodified or the Rp-
modified mRNAs. Finally, to expand on the potential role of the mRNA backbone on tRNA 
selection, we investigated the effect of the deoxy substitutions on peptide-bond formation for 
cognate and near-cognate ternary complexes. Similar to previous observations (37), substitution 
of any of the three 2’-OH of the A-site codon by a deoxy does not alter peptide-bond formation in 
the presence of cognate aa-tRNA. However, peptide-bond formation was drastically inhibited for 
these modified mRNAs in the presence of a near-cognate aa-tRNA. Collectively our findings 
provide some of the first hints at the integral role of the mRNA structure in decoding and how its 







 To investigate the role of the mRNA-kink structure in tRNA selection, we decided to 
destabilize magnesium-binding at the interface of the P and A site of the small subunit. The 
divalent metal ion is held in place by a network of electrostatic interactions that include three non-
bridging oxygen atoms of the mRNA phosphodiester backbone (Fig. 1A). As a starting point, we 
chose to introduce sulfur substitutions right between the initiation codon and the second codon of 
a model mRNA. Namely, we sought to substitute the pro-Sp oxygen of the phosphodiester linkage 
between the third nucleotide of the P-site codon and the first nucleotide of the A-site codon (Fig. 
1A). However, since the smallest model mRNA (~25 nt) is too long to efficiently separate the 
resulting two diastereomers from chemical synthesis, we chose to generate the mRNAs from two 
pieces. This allowed us to synthesize the phosphorothioate-containing RNA as a 9-mer, which is 
readily separated into the Rp and Sp diastereomers using reverse-phase HPLC methods (Fig. 1B). 
Subsequent near quantitative ligation using T4 RNA ligase 2 to an upstream RNA oligonucleotide 




Fig. 4.1 Structure of the mRNA on the ribosome and preparation of phosphorothioate-
modified mRNAs. A) Overview of the mRNA structure (PDB 2J00) highlighting the kink 
structure dividing the P and A sites of the ribosome. The non-briding oxygen atoms (red) 
coordinating a magnesium ion (green) are shown. B) A representative HPLC chromatogram 
showing the separation of the two phosphorothioate diastereoisomers of the downstream RNA 
sequence. C) Schematic of the procedure used to synthesize the full-length modified mRNA. 
Sequence of the two pieces is shown annealed to a DNA splint. The bottom panel shows a 





 The modified mRNA was then used in our in vitro reconstituted system (40) to make 
initiation complexes. Ribosomes were incubated with initiation factors (IFs) 1, 2 and 3, f-[35S]-
Met-tRNAfMet, and GTP in the presence of native or modified mRNAs. The initiation complexes 
were then purified away from the IFs and unbound mRNA through ultracentrifugation over a 
sucrose cushion. The first set of initiation complexes displayed the Glu GAA codon. Peptide-bond 
formation was commenced by incubating initiation complexes with ternary complexes comprised 
of aa-tRNA, EF-Tu, and GTP. Following quenching and hydrolysis of the ester linkage between 
the peptide and the tRNA with KOH, dipeptides were resolved from unreacted fMet using 
electrophoretic TLC and were visualized by phosphorimaging. 
 
Phosphorothioate substitutions at the interface of the P and A site result in stringent tRNA 
selection. 
For our initial studies we conducted a surveying approach (41) in an effort to gain an 
unbiased view of the modifications’ effects on the decoding process. Three initiation complexes 
programmed with the native mRNA or with Rp- or Sp-phosphorothioate modified mRNAs were 
reacted with the 20 canonical aa-tRNA isoacceptors for 30 seconds (Fig. 2). As expected, all three 
complexes, which displayed the GAA codon in the A site, reacted efficiently with the cognate Glu-
tRNAGlu ternary complex. In contrast, replacement of either of the non-bridging oxygen atoms by 
sulfur had a profound effect on the reactivity of near-cognate ternary complexes. In particular, 
whereas dipeptide formation was observed for a number of near-cognate aa-tRNAs (including but 
not limited to Asp-tRNAAsp and Lys-tRNALys) in the presence of the native complex (O), 
significantly less dipeptide was observed in the presence of the Rp complex, and it was nearly 
undetectable for the Sp complex (Fig. 2). These observations suggested that the structure of the 
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mRNA backbone, particularly at the interface of the A and P sites of the ribosome, plays an 





Fig. 4.2 Phosphorothioate mRNAs suppress the incorporation of near-cognate amino acids. 
Phosophorimager scans of electrophoretic TLCs showing the reactivity profile of the initiation 
complexes –programmed with the indicated native and phosphorothioate-modified mRNAs– with 
the 20 aa-tRNA isoacceptors. A schematic of the initiation complex is shown at the top with fMet-
tRNAfMet occupying the P site and the Glu GAA codon occupying the A site. Differential 
reactivities with near-cognate aa-tRNA are marked by asterisks. Note that for this particular 
reactivity survey the formylation of fMet was incomplete and as a result residual Met is observed. 
This does not affect the analysis because of differences in migration on the TLC between fMet and 
Met as well as the corresponding dipeptides.  
 
Although the endpoint of the dipeptide survey reactivities provided some important clues 
about the effect of the substitutions on the accuracy of peptide-bond formation, these assays fail 
to provide more quantitative information about the extent to which fidelity is improved. As a result, 
we resorted to a pre-steady-state kinetics approach to measure the rate of peptidyl transfer (PT) for 
the cognate Glu-tRNAGlu ternary complex as well as for the near-cognate Lys-tRNALys and Asp-
tRNAAsp ternary complexes. Consistent with our end-point analysis in Fig. 2, the modifications 
appear to have little effect on the PT rates for the cognate aa-tRNA (Fig. 3A). More specifically, 
we measure a rate of ~20 s-1 for the O mRNA and ~ 15 s-1 for the Rp- and Sp-phosphorothioate 
mRNAs. In contrast to the cognate reaction, both substitutions had strong effects on the near-
cognate PT rates, with the Sp-phosphorthioate having the most drastic effect. In the presence of 
Lys-tRNALys, PT rates for the O, Rp- and Sp-phosphorothioate mRNA-containing complexes were 
0.10 s-1, 0.0093 s-1, and 0.0055 s-1, respectively. In addition, the Sp-phosphorothioate complex 
displayed a drastic endpoint defect, for which the fraction of fMet that converted to fMet-Lys 
dipeptide was 27% (Fig. 3B). Conversely, the same reactions with the unmodified and Rp-
phosphorothioate went to near completion (~86%). These effects of the phosphorothioate 
substitutions on near-cognate Lys-tRNALys selection were, by and large, similar to those measured 
for Asp-tRNAAsp selection. We measured PT rates of 0.056 s-1, 0.0089 s-1, and 0.017 s-1 for the 
unmodified, Rp- and Sp-phosphorothioate complexes, respectively (Fig. 3C). In addition, similar 
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to the Lys-tRNALys reaction, the modifications appear to significantly improve proofreading by 
the ribosome as evidenced by the reduced end points. The Sp-phosphorothioate complex displayed 
an even better rejection of the Asp-tRNAAsp, for which we measure an end point of 0.035. In 
comparison, the end points for the O and Rp-phosphorothioate complexes were 0.33 and 0.11, 
respectively (Fig. 3C). Collectively these observations suggest that disruption of interactions 
between the phosphodiester backbone of the mRNA and divalent metals induces a hyperaccurate 
phenotype.  
 
Fig. 4.3 The Sp-phosphorothioate substitution of the kink oxygen results in a severe 
hyperaccurate phenotype. A) Representative time courses for PT reactions between the indicated 
complexes and the cognate Glu-tRNAGlu ternary complex. B) Representative time course for PT 
reactions between the indicated complexes and the near-cognate Lys-tRNALys ternary complex. C) 
Representative time courses for PT reactions between the indicated complexes and the near-
cognate Asp-tRNAAsp ternary complex. D) Bar graph showing the observed rate of GTP hydrolysis 
for modified, Rp- and Sp- complexes with the near-cognate Lys-tRNALys ternary complex. Unlike 
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PT reactions, which were all conducted at 37C, these reactions were conducted at 20C. Shown 
are the means of three independent time courses with the error bar representing the standard 
deviation from the mean. E) Representative time courses for RF2-mediated hydrolysis on the 
indicated complexes. F) Representative time courses for RF1-mediated hydrolysis reaction on the 
indicated complexes.  
 
The accuracy of the initial phase of tRNA selection is not significantly impacted by the 
phosphorothioate substitutions. 
 
 As our peptide-formation assays report on the overall process of tRNA selection, the 
observed effects of substitutions could, in principle, be the result of defects in the initial phase or 
proofreading phase of the process. GTP hydrolysis by EF-Tu reports on the GTPase activation of 
the factor, which in turn reports on the accuracy of the overall initial phase. We measured the rate 
for GTP hydrolysis for the native and Rp- and Sp-phosphorothioate complexes in the presence of 
the near-cognate Lys-tRNALys ternary complex. In contrast to our observations for peptide-bond 
formation, the substitution had only a modest effect on the observed rate of GTP hydrolysis (Fig. 
3D). For the Rp-modified complex, the observed rate is merely twofold slower relative to the native 
complex. Similarly, the observed rate for the Sp-modified complex was threefold slower (Fig. 3D). 
Hence, it appears that the kink structure of the mRNA plays little to no role during the initial phase 
of the selection process. Instead, given that we measured rates for peptide-bond formation that are 
almost two order of magnitude slower under the same conditions, the kink structure is likely to 
play an important role during the proofreading phase. Disruption of this structure appears to reduce 
the accommodation rates and increases the rejection rates of near-cognate aa-tRNAs. 
 
Phosphorothioate substitutions increase the fidelity of RFs 
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Next, we sought to explore the effects of phosphorothioate substitutions on the accuracy of 
peptide release by RFs. In particular, we were interested in examining whether the kink structure 
affects protein-mRNA interaction during peptide release misrecognition of sense codons. The 
GAA codon displayed in the A site of our complexes is a near-stop for both RF1 and RF2, as both 
recognize the UAA codon. As a result, we could address the effect of the substitutions on the 
accuracy of both factors. Although the modifications appear to affect both RF1- and RF2-mediated 
hydrolysis (Fig. 3E and F), the extent of these effects was much smaller than those observed for 
PT, and on average they were two- to threefold slower relative to the native mRNA. We measured 
rates of hydrolysis for RF2 of 0.012 s-1, 0.0045 s-1, and 0.0041 s-1 for the unmodified and Rp- and 
Sp-phosphorothioate complexes, respectively (Fig. 3E). Similarly, in the presence of RF1, we 
measured hydrolysis rates of 0.012 s-1, 0.0030 s-1, and 0.0044 s-1 for the unmodified and Rp- and 
Sp-phosphorothioate complexes, respectively (Fig. 3F). Interestingly, and in contrast to tRNA 
selection, peptide release on the Sp complex was faster (ableit only slightly) than its Rp 
counterpart. These observations are consistent with data from our group and others that show the 
process of RF selection to be different than its tRNA selection counterpart (42, 43). For instance, 
whereas certain base modifications appear to be detrimental for peptide-bond formation, they have 
little effect on peptide release (44, 45). Nevertheless, the observation that phosphorothioate 
substitutions affect peptide release (with little distinction between the two diastereomers) 
highlights the importance of the mRNA backbone structure during the recognition of A-site ligands 
regardless of their identity. 
 





Our analysis, so far, has focused on one particular mRNA sequence, so our next logical 
step was to expand our analysis to assess whether the effects of the substitutions we observed are 
specific or general in nature. Our analysis on the GAA mRNA revealed that both the Rp- and Sp-
phosphorothioate substitutions appear to severely reduce the observed PT rates for near-cognate 
aa-tRNAs (Fig.3). To simplify our approach, in the next set of experiments we chose to synthesize 
the modified mRNA in one piece and generate mixed complexes with a racemic mixture of the 
mRNA. The new complexes displayed the CAA Gln codon in the A site. Again, we started our 
analysis by carrying out a survey for all aa-tRNA-isoacceptors reactivities (Fig. S1A). The 
reactivity profile for the new complexes was nearly identical to the one observed for the previous 
complexes (compare Fig. 3A to S1A). The native and phosphorothioate-modified complexes 
reacted efficiently with the cognate Gln-tRNAGln ternary complex. In contrast, the native complex 
reacted much better with the near-cognate Asp-tRNAAsp and His-tRNAHis ternary complexes 
relative to the modified one (Fig. S1A). Furthermore, both RFs 1 and 2 appear to recognize the 
native complex better than the modified one, for which we observe significant fMet release from 
fMet-tRNAfMet only for the native complex. Therefore, our survey analysis suggests that effect of 




Fig. 4.S1 Reactions with a different mRNA yield similar results. A) Reactivity profile of the 
depicted complex, which displays the Gln CAA codon in the A site, with the indicated aa-tRNAs 
and RF. Products were separated on electrophoretic TLCs and visualized using phosphorimaging. 
Differential reactivities are marked by asterisks. B) Representative time courses of PT reactions 
between the indicated complexes (programmed with a native mRNA or racemic mixture of 
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phosphorothioate mRNAs) and the cognate Gln-tRNAGln. C) Representative time courses of PT 
reactions between the indicated complexes and the near-cognate His-tRNAHis. D) Representative 
time courses for RF2-mediated hydrolysis reaction on the indicated complexes. 
 
To gain a more quantitative understanding of the effects on decoding, we measured the PT 
rates for the cognate and a near-cognate tRNA as well as the release rate for RF2. Similar to our 
observations for the previous complexes, the modification had almost no effect on the PT rate for 
the cognate Gln-tRNAGln complex. We measured rates of 17 s-1 and 15 s-1 for the unmodified and 
modified mRNAs, respectively (Fig. S1B). Also in agreement with our surveying analysis, the 
modification had a drastic effect on the His-tRNAHis near-cognate reaction. Although the PT rate 
appears to be unaffected (in fact slightly increased from 0.0037 s-1 to 0.0069 s-1), the end point of 
the reaction was dramatically reduced from ~0.6 to ~0.05 (Fig. S1C). These findings suggest that 
the modification is likely to increase the rate of aa-tRNA rejection during the proofreading phase 
of tRNA selection. Finally, and as expected the modification reduced the rate of RF2-mediated 
peptide release by almost one order of magnitude (Fig. S1D). The observation that modification 
of two independent mRNA sequences has near-identical effects on peptide-bond formation and 
peptide release greatly suggests that the effect of the phosphorothioate substitution is independent 
of the mRNA sequence. This in turn adds more support for the hypothesis that the mRNA-kink 
structure plays a key role in ribosome function. 
 
Phosphorothioate modification reduces peptide-bond formation for a subset of cognate aa-
tRNAs 
To this point, our analysis revealed that perturbation of the mRNA structure results in 
aggressive proofreading by the ribosome with little to no effect on cognate tRNA selection. This 
in turn begs the question as to why the mRNA evolved to adopt this conformation on the ribosome. 
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It is highly likely that the structure plays a role in frame maintenance, as has been suggested by 
structural biologists (39). However, for our next experiments we were motivated by data on 
ribosome variants that showed certain hyperaccurate rRNA variants to also significantly 
compromise PT for a subset of cognate aa-tRNAs, in particular those that exploit unusual base 
pairs at the wobble position (46). For example, to avoid mispairing with the AUG Met codon, the 
AUA Ile codon in E. coli does not base pair with an anticodon using the typical A:U base pair at 
the third position. Instead, the corresponding C in the anticodon is modified to lysidine (k2C). 
Studies by Ortiz-Meoz and Green showed that mutations in helix 69 of the large subunit, while 
having no effect on most cognate tRNAs, significantly slow down the PT rate for tRNAIle(k2C) 
(46). As a result, we wondered whether the mRNA-kink structure is similarly critical for decoding 
the AUA codon by Ile-tRNAIle(k2C).  
To explore this hypothesis, ribosomes were programmed with three mRNAs: native, Rp- 
and Sp-phosphorothioate modified mRNAs, all displaying the AUA codon in the A site. In 
agreement with our earlier observation, the observed PT rate for the Rp-phosphorothioate-
programmed complexes with the cognate Ile-tRNAIle was indistinguishable from that for the native 
complexes (~ 10s-1, Fig. 4A). In contrast, the same rate for the Sp-modified complex was almost 
an order of magnitude slower (Fig. 4A). These findings again suggest that the pro-S oxygen plays 
a more important role in maintaining the mRNA structure. We note that, similar to what we 
observed for the two previous complexes, the AUA complexes exhibited defects in their reactivity 
similar to those in near-cognate aa-tRNAs. In the presence of Met-tRNAMet, we measure rates of 
peptide-bond formation of 0.41 s-1, 0.022 s-1, and 0.0082 s
-1 for the native and Rp- and Sp-modified 
complexes, respectively (Fig. 4B). These observations suggest that the pro-S oxygen, and likely 




Fig. 4.4 Substitution of the pro-S oxygen reduces the rate of peptide-bond formation in the 
presence of atypical tRNA-mRNA interactions. A) Bar graph showing the PT rate for 
unmodified, Rp- and Sp- complexes, all displaying the Ile AUA codon in the A site (depicted 
above), with the cognate Ile-tRNAIle. The corresponding Ile-tRNA harbors the lysidine (k2C) 
modification at the wobble position. B) Observed PT rates for the near-cognate Met-tRNAMet in 
the presence of the indicated complexes. Graphs show the means of three independent time 
courses; error bars represent the SD from the mean.  
 
Peptide release is not impacted by phosphorothioate modification of the mRNA 
 Our analysis thus far has suggested the kink structure to be likely important for decoding a 
subset of sense codons. As a result, the next logical step was to assess its effects on canonical 
peptide release. As before, we prepared unmodified- and phosphorothioate-mRNA-containing 
initiation complexes that displayed the UAA stop codon in the A site. Similar to our observations 
for PT, the rates of peptide release were found to be unaffected by the presence of the 
phosphorothioate modification at the interface of the P and the A site of the mRNA. For RF1 we 
measured rates of 0.35 s-1 and 0.49 s-1 for the native and modified mRNA, respectively (Fig. 5A). 
Likewise, for RF2, we measured rates of 0.76 s-1 and 0.93 s-1 for the same set of mRNAs (Fig. 5B). 
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These observations are in agreement with our model that the kink structure is not important for 
decoding (sense and missense codons) under optimal conditions.  
 
Fig. 4.5 Peptide release is not impacted by phosphorothioate modification at interface of the 
P-site and A-site codons. A) and B) Representative time courses for peptide release between the 
indicated initiation complexes (programmed with either a native mRNA or racemic mixture of 
phosphorothioate mRNAs) and RF1 and RF2, respectively. 
 
Phosphorothioate substitutions between the first and second nucleotide of the A-site codon 
also result in a hyperaccurate phenotype 
In addition to the pro-S oxygen between the P and A site, the kink-stabilizing magnesium 
ion also appears to be coordinated by the pro-R oxygen between the first and second position of 
the A-site codon (39). Consequently, substitution of this oxygen is very likely to perturb the mRNA 
structure and, in turn, produce a phenotype similar to the one we saw with substitutions at the P/A 
interface. We used the same strategy as before to generate native as well as modified complexes 
and assessed the effect of the sulfur substitution on PT rate for cognate and near-cognate aa-tRNAs.  
Consistent with earlier observations, both Rp- and Sp-phosphorothioate substitutions at the 
second position of the A site have minimal effect on peptide-bond formation for the cognate aa-
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tRNA (Fig. 6A). Furthermore, the same substitutions significantly reduced the PT rates for the two 
tested near-cognate ternary complexes, Lys-tRNALys and Asp-tRNAAsp (Fig. 6B and 6C). 
However, whereas the pro-S oxygen at the P/A interface appears to have a larger effect on 
decoding near-cognate aa-tRNAs, at this position in the A site the Rp-phosphorothioate 
substitution had a much more pronounced effect on the selection of these very same aa-tRNAs. In 
particular, PT rates for lys-tRNAlys were 0.080 s-1, 0.0039 s-1, and 0.011 s-1 for the native and Rp- 
and Sp-phosphorothioate complexes, respectively. Similarly, PT rates for Asp-tRNAAsp were 
0.035 s-1, 0.0049 s-1, and 0.0050 s-1 for the native, Rp- and Sp-phosphorothioate complexes, 
respectively. Furthermore, the end points for the same reactions were 0.51, 0.11, and 0.21, 
respectively, suggesting that the modification also increases the rejection rate for the near-cognate 
aa-tRNAs during the proofreading phase of the selection. Interestingly, at this position, the 
substitution does not appear to affect peptide-release by RF1 (Fig. 6D) and only slightly for that 
by RF2 (Fig. 6E). These observations again highlight the distinction between tRNA and RF 
selections, with the latter being more robust to perturbations. Nevertheless, taken together, our 
data suggests that coordination of the magnesium ion by the phosphodiester backbone of the 




Fig. 4.6 Phosphorothioate modification at the second position of the A-site codon results in a 
hyperaccurate phenotype. A) Representative time courses of peptide-bond formation between 
the depicted unmodified or modified complexes with the cognate Glu-tRNAGlu. The 
phosphorothioate modification is between the G and A of the A-site GAA codon (as shown above). 
B) and C) Time courses of PT reactions with the near-cognate Lys-tRNALys and Asp-tRNAAsp 
ternary complexes, respectively. D) and E) Time courses for RF1- and RF2-mediated hydrolysis 
reactions, respectively.   
 
Phosphorothioate substitutions between the second and third nucleotide of the A-site codon 
has little effect on the accuracy of tRNA selection 
 Unlike that of the P/A interface and the first position of A-site codon, the phosphate of the 
second position of the A-site codon does not appear to coordinate a divalent metal (Fig. 1A). 
Therefore, phosphorothioate substitution at this position should serve as a nice control for effects 
resulting from mere sulfur introduction into the backbone of the mRNA versus magnesium-
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structural stabilization effects. We used the same GAA-codon-containing mRNA but introduced 
the sulfur substitution between the last two nucleotides (GA-Sp-A) to generate modified initiation 
complexes. As expected, the substitution had no effect on the observed rate of peptide-bond 
formation by the cognate Glu-tRNAGlu ternary complex (Fig. 7A). In the presence of the near-
cognate Lys-tRNALys ternary complex, we observed a modest threefold decrease for the modified 
complex (Fig. 7B). In comparison, we saw a twentyfold decrease in the observed rate for the same 
mRNA when it was modified at the first position (Fig. 6B), which was also accompanied by a 
fourfold reduction in the end point of the reaction. These observations suggest that while the 
introduction of sulfur on its own has some effects on the accuracy of peptide-bond formation, 
magnesium coordination by the nonbridging oxygen atoms of the mRNA backbone and hence its 
structure plays a far more important role in decoding accuracy. 
 
Fig. 4.7 Phosphorothioate substitution between the second and third nucleotide of the A-site 
codon does not significantly impact peptidyl transfer. A) and B) Representative time courses 
for PT between the indicated initiation complexes and the cognate Glu-tRNAGlu and near-cognate 
Lys-tRNALys, respectively. The phosphorothioate modification is between the second and third 
nucleotide of the A-site codon (as shown above). 
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The presence of a deoxyribose sugar between the A and P-site codons results in a 
hyperaccurate phenotype  
Thus far, our studies have focused on the role of the phosphodiester backbone on the 
accuracy of tRNA selection and suggests an important role for its structure during tRNA selection. 
As a logical next step, we sought to examine the role of the ribose backbone in the accuracy of 
decoding. Initial structural studies of the small subunit highlighted the potential role for the 
chemical structure of ribose in decoding. These studies suggested that the A-site 2’-OH groups to 
be important for distinguishing between cognate and near-cognate tRNAs (31, 32). In particular, 
rRNA residues G530, A1492, and A1493 were shown to monitor the minor groove of the cognate 
codon-anticodon helix by forming hydrogen bonds with the 2’-OH groups. However, recent 
structural studies from a different group suggested that the hydrogen bonding was identical for 
both cognate and near-cognate codons (38) and that accuracy originates from energetic penalties 
associated with base pair mismatches being forced to adopt a Watson-Crick base-pair geometry. 
Previous biochemical studies by Simpson and colleagues explicitly addressed the role of the 2’-
OH groups of the A site in decoding (37). Interestingly, single substitution of any of the 2’-OH 
groups by a deoxy only marginally affected peptide-bond formation. Multiple deoxy substitutions, 
on the other hand, severely inhibited tRNA selection parameters. In contrast, 2’-Fluro substitutions 
of all three hydroxyl groups of the A site has little to no effect on tRNA selection. These findings 
suggested that hydrogen bonds with the ribose backbone are not important for decoding; instead 
shape complementarity of the bases and their partners appears to be paramount. We note that, these 
studies looked at the role of the 2’-OH groups on the accuracy of the decoding process through 
competition assays. These assays suggested that individual substitutions to have no effect on 
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fidelity.  However, their effect on peptide-bond formation in the presence of near-cognate aa-
tRNAs was not directly measured.  
Motivated by these earlier findings, we next explored the role of the 2’OH groups of the 
ribose backbone in discriminating against near-cognate tRNAs. As in the phosphorothioate assays, 
we prepared initiation complexes that displayed the Glu GAA in the A site. In addition to the native 
complex, we generated four more that harbored one deoxy substitution at the third position of the 
P-site codon or at the first, second, or third position of the A-site codon. As had been seen earlier, 
these substitutions had a negligible effect on the rate of peptide-bond formation in the presence of 
the cognate aa-tRNA (Fig. 8A). In contrast, the substitutions had drastic effects on peptidyl transfer 
in the presence of the near-cognate Lys-tRNALys, with the substitutions of the A-site codon having 
the most profound effect (Fig. 8B). More specifically, introducing the deoxy modification to the 
third position of the P-site codon resulted in a tenfold decrease observed rate of peptidyl transfer, 
with no appreciable effect on the end point (Fig. 8B). In contrast, although the observed rates for 
A-site-substituted complexes does not vary much from the unmodified one, the end points for these 
reactions were severely diminished (1-2% of the initiation complexes reacted with the ternary 
complex) (Fig. 8B). Hence, substitution of the hydroxyl groups of the A-site codon appears to 




Fig. 4.8 Deoxyribose substitutions in the A-site codon result in a severe hyperaccurate 
phenotype. A) Representative time courses for PT reactions between the initiation complexes 
programmed with the indicated native and deoxyribose-modified mRNAs and the cognate Glu-
tRNAGlu ternary complex. B) Representative time course for PT between complexes displaying 
the native AUA codon or the deoxy-modified one at the third position of the codon (AUdA) and 
the cognate Ile-tRNAIle ternary complex. The corresponding Ile-tRNA harbors the lysidine (k2C) 






 Decades of biochemical and structural studies on translation have shown almost every 
component of the translational machinery, including the ribosomal RNA and proteins, tRNAs, and 
translation factors, to be important for faithful and rapid decoding (11, 29). In contrast, the role of 
the mRNA substrate itself during the process has been largely overlooked. Beyond its primary role 
in interrogating the incoming tRNA to ensure matched codon-anticodon interactions are 
maintained, the mRNA is arguably perceived as a mere onlooker during elongation. It is worth 
noting that the tRNA substrate was also viewed similarly until structural and biochemical data 
provided compelling evidence to the contrary (28, 36). For instance, the tRNA is very dynamic 
during the selection process, adopting distinct conformations as it moves into the A site and 
eventually participating in peptidyl transfer (47, 48). Perturbance to this conformational flexibility 
has significant consequences on the fidelity of protein synthesis, allowing tRNAs to read the 
incorrect codon (49). In addition to its role in decoding, the tRNA plays an important role in the 
chemistry of peptide-bond formation and peptide release (50-54). The hydroxyl group of the 
terminal ribose (A76) of the tRNA and its ability to form a hydrogen-bonding network is important 
for PT (54) and appears to be absolutely required for peptide release (55, 56). Similar to the 
findings of studies on the functional importance of the tRNA structure, it is highly likely that the 
mRNA structure plays an extensive role in many aspects of protein synthesis.  
 Early structural studies of the decoding process revealed a central role for the ribose 
backbone of the mRNA in maintaining codon-anticodon interactions (31). These include A-minor 
interactions between the mRNA and decoding center rRNA nucleotides. In addition to interacting 
with O2 and N4 of the respective purine and pyrimidine bases of the codon/anticodon, the rRNA 
residues also hydrogen bond with the 2’-OH groups of the mRNA (31). Disruption of these 
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interactions by substituting the ribose groups by 2’-deoxy ribose or 2’-fluoro, as expected, results 
in increased dissociation of the A-site tRNAs (57). However, these substitutions also result in 
increased translocation rates (57) suggesting that disruption of the interactions between the mRNA 
and tRNAs are required to remodel the mRNA during translocation. In contrast to their role in 
translocation, the 2’-OH groups of the A-site codon appear to be dispensable for tRNA selection 
(37); instead, shape complementarity appears to be the driving force for decoding. While these 
limited studies have highlighted the importance of the ribose backbone of mRNA during 
translation, the importance of the phosphodiester backbone has not been explored. In functional 
RNAs, the phosphodiester backbone plays an important role in coordinating divalent metals (58), 
which are important for maintaining the overall structure of the molecule; in certain cases, the 
metal is directly responsible for the function of the RNA (59, 60). In the case of the ribosome, 
atomic-resolution structures have revealed a number of locations where metals appear to play an 
important role (39). However, the contribution of most of these sites to the function of the ribosome 
has not been directly tested. Naturally, the main limitation to carrying out such studies is the 
difficulty of conducting atomic mutagenesis on the rRNA and, in particular, substitutions of 
nonbridging oxygen atoms to interfere with metal binding. In contrast to the ribosome, these types 
of phosphorothioate substitutions approaches have been instrumental in working out mechanisms 
of ribozymes (61). 
 In addition to rRNA, structural studies have shown the mRNA backbone to be directly 
involved in coordinating at least one divalent metal at the interface of the P/A sites of the small 
subunit (38, 39). More important, the metal appears to play a critical role in maintaining an unusual 
structure of the mRNA characterized by a kink. This in turn allows rRNA nucleobases of the small 
subunit to sandwich themselves (through base stacking) between the P and the A site and in the 
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process divide the two sites (38, 39). These initial studies speculated that this structure is important 
for preventing slippage and hence frameshifting during translocation (39). In contrast to its 
supposed role in frame maintenance, the role of the kink in decoding has not been considered 
previously. By disrupting the interaction between the mRNA and the divalent metal (and very 
possibly the kink structure) through phosphorothioate substitutions we were able to show the 
structure to be likely important for uniform decoding. In particular, whereas the substitutions 
appear to have little to no effect on PT for cognate tRNAs that utilize typical Watson-Crick as well 
as G-U wobble base pairs, they dramatically reduced PT for an aa-tRNA that uses atypical base 
pairing at the third position. Substitution of the pro-S oxygen at the kink (one of the atoms involved 
in coordinating the crucial divalent metal) reduced the PT rate for Ile-tRNAIle(k2C) by more than 
fivefold (Fig. 4A). Consistent with its role in boosting tRNA selection under compromised 
conditions, altering the kink structure also resulted in a severe hyperaccurate phenotype (Figs. 3, 
4 and S1). As a case in point, the rate of the peptide bond reaction and the endpoint for the near-
cognate Lys-tRNALys on the Sp-GAA codon is ~twenty fold slower and approximately fourfold 
lower than that for the unmodified mRNA (Figs. 3B and 3C). We note that these observed effects 
of the phosphorothioate substitutions on the tRNA selection, through which the effective accuracy 
is improved by almost two orders of magnitude, are much more dramatic than those observed in 
the hyperaccurate-variant ribosomes. Restrictive mutations in the ribosomal protein S12, for 
instance, have been documented to improve accuracy by less than 10-fold (62). Similarly, 
mutations in H69 have been shown to improve accuracy by only threefold (46). These observations 
argue that, beyond its requirement to base pair with the tRNA, the mRNA structure is at least as 
equally critical for tRNA selection as are the rRNA and ribosomal proteins.  
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 Arguably one of the key questions that came out of this study is how the kink structure 
might be affecting the interaction between the mRNA and the incoming tRNA. While our data 
alone do not answer this question, one could take advantage of the available structural and 
biochemical information to come up with scenarios to explain our findings. Disruption of the kink 
structure appears to affect later steps of tRNA selection more severely than early steps (Fig. 3). In 
particular, in the presence of the Sp-phosphorothioate modification, PT reactions with near-
cognates exhibited drastic end-point defects (Fig. 3B and C), but a modest decrease in observed 
rate of GTP hydrolysis (Fig. 3D). Hence, interfering with magnesium binding at the P/A interface 
appears to increase the rate of near-cognate tRNA rejection. It is plausible that the kink structure 
serves to rigidify the mRNA in the A site; as a result, the mRNA is more dynamic in its absence. 
Consequently, the dissociation rate of the tRNA is likely to increase during the proofreading phase. 
For typical cognate aa-tRNAs, the proceeding step of accommodation is so rapid that the increase 
in the dissociation rate is not realized to an extent that would affect the overall selection process. 
For near-cognate aa-tRNAs, accommodation is much slower; as a result, the effects of the kink 
disruption on codon recognition are felt, reducing the overall rate of peptide-bond formation. These 
ideas are corroborated by the observations that disruption of potential hydrogen bonds with the 2’-
OH of the A-site codon has modest effect on cognate tRNA selection, but drastically diminishes 
peptide-bond formation in the presence of near-cognate aa-tRNAs (Fig. 8).   
In an alternative scenario, the kink structure could play a role relaying signals between the 
P and the A sites of the ribosome. This idea is motivated by earlier studies by our group showing 
that mismatches in the P site severely compromise the fidelity of the next bout of tRNA selection 
(63, 64). These earlier findings as well as the observations we report here are consistent with a 
model in which the extended mRNA-tRNA interaction is important for decoding. 
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Notwithstanding, whatever the mechanism by which the kink affects decoding may be, our 
findings provide some new unappreciated insights into the role of the substrate mRNA in ensuring 
protein synthesis proceeds uniformly. The observation that a mere atomic substitution of one of 
the nonbridging oxygen atoms could drastically modify tRNA selection parameters argues that 
decoding is an intricate process that evolved to take advantage of all available interactions for 
optimal gene expression. In addition to this role in tRNA selection, the mRNA structure is highly 
likely to be important for frame maintenance. Indeed, mutations and perturbations even farther 
from the A site in the E site have been shown to increase frameshifting (64). It will be exciting to 
directly probe the role of the kink in translocation and to explore whether phosphorothioate 




Materials and reagents. 
 
 Unmodified mRNAs were synthesized using in vitro runoff transcription by T7 RNA 
polymerase (66). Double-stranded DNA templates were amplified from single-stranded 














The T7 promoter is italicized, the Shine-Dalgarno sequence is underlined, and the initiation codon 
is in bold. 
 AUG-sCAA (Met-Gln)-modified mRNA with the sequence 
AAGGAGGTAAAAAAAATGsCAAAAGTAA (“s” indicates the site of the phosphorothioate 
modification) was purchased from Dharmacon. AUG-sGAA, AUG-sAUA and AUG-GsAA 
phosphorothioate-modified mRNAs were generated from two chemically synthetized ribo-
oligonucleotides that were purchased from IDT. The upstream sequence of 
AAUAAGGAGGUAUACU was common to all of them. The downstream oligonucleotides had 
the following sequences: AUGsGAAUUU, AUGsAUAUUU and AUGGsAAUUU, respectively. 
Before generating the full-length mRNAs, the modified oligonucleotides were separated into the 
Rp and Sp diastereoisomers using reverse phase chromatography as described earlier (66). In 
particular, 10 nmoles of RNA was injected into an Agilent 1100 HPLC system equipped with a 
C18 column (Zorbax ODS, 5 μm, 4.6 × 250 mm). The following conditions were used for the 
purification: the column was equilibrated with 100 mM ammonium acetate buffer pH 7 containing 
3% acetonitrile; 5 minutes following injection, acetonitrile concentration was linearly increased to 
13% over a 15-minute period and kept there for an additional 5 minutes. During the purification, 
the column was maintained at 45°C. The purified RNA was dried using a SpeedVac concentrator 
at ambient temperature overnight. The purified oligonucleotides were resuspended in water and 
then phosphorylated using polynucleotide kinase (NEB) in the presence of ATP. Prior to initiating 
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the ligation reaction, the upstream and the phosphorylated purified modified oligonucleotides were 
annealed to a DNA splint with final concentrations of 13 μM upstream RNA sequence, 10 μM 
modified phosphorylated oligonucleotide and 11 μM DNA splint. The DNA splints had the 
following sequence: AAATTCCATAGTATACCT for the AUG-sGAA and AUG-GsAA mRNAs 
and AAATAT CATAGTATACCT for the AUG-sAUA mRNA. Ligation was carried out using T4 
RNA ligase 2 (NEB) and incubation at 37°C for 2 hr. The ligated products were purified away 
from the substrate RNA and DNA splint using denaturing PAGE.  
 
 Tight-coupled 70S ribosomes were purified using a double pelleting strategy as described 
(68). Briefly clarified lysate was centrifuged at 107100 × g for 16 hr over a sucrose cushion at 4°C; 
ribosome pellet was resuspended, and the centrifugation step was repeated. Ribosomes were stored 
in polymix buffer (69) (95 mM KCl, 5 mM NH4Cl, 5 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM 
putrescine, 1 mM spermidine, 5 mM potassium phosphate at pH 7.5, 1 mM DTT), aliquoted, flash 
frozen and stored at -80°C. His-tagged IF1, IF3 (45) and IF2 (70) were purified over Ni-NTA resin 
as described earlier (45). Purification of the His-tagged 20 aa-tRNA synthetases, RF1 and RF2 
was carried out as described in (70). EF-Tu and EF-G were also purified over Ni-NTA resin; 
following purification the His tag was removed using TEV protease (71). E. coli tRNAfMet, 
RNAMet, RNAGlu, RNALys , RNAArg, RNAVal, RNAPhe and RNATyr was purchased from 
ChemBlock.  
 
tRNA aminoacylation  
[35S]-fMet-tRNAfMet was prepared as described (72) using Met-tRNA synthetase and 
Methionyl-tRNA formyltransferase in the presence of [35S]-Met (Perkin Elmer) and 10-
155 
 
formyltetrahydrofolate formyl donor at 37C. Purified tRNAs were aminoacylated as described 
(41) by incubating them in the presence of the appropriate tRNA synthetase, the corresponding 
amino acid and ATP. All other tRNAs were charged by incubating E. coli total tRNA (Roche) 
with the applicable tRNA synthetase and the equivalent amino acid in the presence of ATP.  
 
Ribosome complex formation 
 Initiation complex were generated as described previously (45) by mixing 2 µM 70S 
ribosomes with 3 µM IF1, IF2, IF3, [35S]-fMet-tRNAfMet, 6 µM mRNA, and 2 mM GTP in polymix 
buffer. Following incubation at 37°C for 2 minutes, the mixture was placed on ice before adding 
MgCl2 to a final concentration of 10 mM. The complex was purified away from IFs, and unbound 
tRNA and mRNA through centrifugation over a sucrose cushion (1.1 M sucrose, 20 mM Tris pH 
7.5, 500 mM NH4Cl, 10 mM MgCl2, 0.5 mM EDTA) at 223424 × g in an MLA-130 rotor 
(Beckman) for 2 hours at 4°C. The purified pelleted complexes were resuspended in polymix 
buffer (using the original volume). Small aliquots were taken before and after centrifugation for 
scintillation counting to estimate complex recovery and concentration. 
 
Dipeptide-formation and release assays 
 Ternary complexes were generated by first incubating 30 μM EFTu with 2 µM GTP to 
exchange bound GDP at 37°C for 15 minutes before adding the appropriate aa-tRNA to a final 
concentration of 4 µM. The mixture was further incubated for an additional 15 minutes. Peptide-
bond formation was initiated by mixing equal volume of initiation complex and ternary complex 
at 37C. For fast reactions, the mixing was done on an RQF-3 quench flow apparatus (KinTek) at 
37C. The reactions were quenched by the addition of KOH to a final concentration of 1 M. 
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Dipeptides were resolved from unreacted fMet using cellulose TLC plates electrophoresed in a 
PyrAC buffer (3.48 M acetic acid, 62 mMpyridine) and Stoddard’s solvent at 1200 V (40). The 
TLCs were dried and exposed to phosphoscreens before imaging on a Biorad personal imager 
phosphorimager. The fractional reactivity corresponding to the dipeptide was quantified as a 
function of time using Bio-Rad Quantity One software. The resulting data was fit to a single-
exponential function using GraphPad prism software. All reactions were conducted at least in 
duplicates.  
 Peptide release was carried out by mixing 2 µM initiation complex with 10 µM RF1 and 
RF2 in polymix buffer at 37°C. Reactions were stopped through the addition of formic acid to a 
final concentration of 5% or EDTA to a final concentration of 20 mM. Released fMet was resolved 
from fMet-tRNAfMet using electrophoretic TLCs as described above.  
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The focus of my thesis work has been on understanding how changes to mRNA structure 
impact the accuracy and fidelity of translation, which is a vital step in the transmission of genetic 
information. This was accomplished through several in vitro studies designed to understand the 
precise effect each mRNA modification had on the speed and accuracy of decoding, as well as 
changes in specific miscoding events. Through these studies, we uncover the base pairing 
preference of the most common oxidative damage adduct of mRNA, 8-oxoguanosine, in the 
context of the A-site of the ribosome. We confirm that the alkylative damage adduct, N(1)-
methyladenosine, stalls the ribosome and provide evidence to support that it severely distorts the 
codon-anticodon helix. Additionally, we show that alkylative damage of RNA increases the 
activity of trans-translation in bacteria, suggesting that it stalls ribosomes. In another project, we 
show that the kink structure that the mRNA phosphodiester backbone assumes in the A site of 
the ribosome is only important to decoding under non-optimal conditions. Overall, this work has 






The impact of N(1)-methyladenosine on peptidyl transfer in vitro  
 
 N(1)-methyladenosine (m1A) has recently emerged as a potential regulatory modification 
of mRNA; however, no demethylases have been shown to exist specifically for removing m1A 
from mRNA. Additionally, no “reader” proteins that recognize m1A have been identified (1). On 
the contrary, one study shows that the presence of m1A in the coding region of mRNA 
significantly increases ribosome stalling (2) and another study demonstrates that m1A increases 
local duplex melting (3), suggesting that it is detrimental to decoding. To understand the 
magnitude by which m1A decreases the rate of peptidyl transfer as well as to understand if it 
impacts miscoding, in vitro peptide-bond formation assays were performed using our well-
established reconstituted bacterial translation system (4).  
 We show that m1A in the second position of the codon significantly decreases the rate 
and endpoint of peptide-bond formation, confirming its activity as a disruptive adduct of mRNA. 
Furthermore, we demonstrate that the addition of the aminoglycoside antibiotic, paromomycin, 
does not rescue the effect of m1A on peptidyl transfer. This suggests that m1A causes the codon 
to behave more as a non-cognate than a near-cognate codon, because if m1A were only 
disrupting its own ability to form base pairs, the reaction should have at least been partially 
rescued by the addition of the antibiotic (5, 6). From these results, we predict that the positively 
charged resonance structure introduced to adenosine by the addition of the methyl group to N1 
disrupts its neighboring nucleotides from forming base pairs.  
 In order to understand the details of how m1A disrupts interactions between codons and 
aa-tRNAs or release factors, structural studies will need to be performed. These studies will help 
to confirm that m1A is disrupting the codon-anticodon helix and elucidate the details of how 
neighboring hydrogen bonds might be disrupted by this lesion. Additionally, they will reveal 
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how m1A is disrupting the interaction between the codon and release factor. Future kinetic and 
structural studies using stop codons containing m1A may also reveal interesting changes to the 
recognition of stop codons by release factors.  
Several studies in which m1A-sequencing was performed revealed that it is enriched 
around the start codon and 3’ of the first splice site in human cells (7, 8). If these studies are 
accurate, it would be interesting to investigate if m1A has an intentional role to regulate 
translation initiation. We predict that the presence of the adduct would prevent proper translation 
initiation, and potentially cause the ribosome to continue scanning past the m1AUG and initiate at 
a downstream start codon. However, a third study that performed m1A-sequencing showed that 
the adduct is significantly rarer than the previous studies reported, detecting only nine modified 
sites in cytosolic and mitochondrial mRNAs with no enrichment pattern (9). Much work remains 
to be performed to resolve these discrepancies; however, our data supports the theory that m1A is 
primarily a damage adduct that is highly disruptive to decoding.  
Ribosome rescue from alkylated transcripts in bacteria  
 
 While several studies have been performed to investigate the impact of alkylative adducts 
of mRNA on decoding in vitro, less is known about how this damage affects translation in vivo 
(10). Previous work from our group showed that the most common oxidative damage adduct, 8-
oxoguanosine (8-oxoG), significantly reduces the rate of peptide-bond formation in vitro when it 
is present in mRNA. Additionally, this study revealed that when the no-go decay quality control 
pathway in eukaryotes is compromised, 8-oxoG accumulates to higher levels than in wild-type 
cells, suggesting that no-go decay may have evolved to cope with damaged mRNA (11). The 
cellular response to alkylative damage as well as mRNA damage in bacteria had not been 
previously explored. We hypothesized that alkylative damage of mRNA stalls translation in vivo, 
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and that the main bacterial ribosome rescue pathway, known as trans-translation, is responsible 
for rescuing these stalled ribosomes. To address these hypotheses, we introduced alkylative 
damage in vivo and visualized the resulting activity of the trans-translation pathway.  
 We first confirmed that two common alkylating agents, MMS and MNNG, caused 
accumulation of damage adducts in E. coli and identified the specific adducts introduced by each 
agent. Cells were treated with either alkylating agent and the resulting RNA adducts were 
quantified via LC-MS/MS. We measured significant increases in several disruptive adducts, 
including m1A and m3C after treatment with MMS or MNNG, and m6G after treatment with 
MNNG. Our results support previous data demonstrating that mRNA is more susceptible to 
alkylative damage than DNA, as the hydrogen-bonding interface between double-stranded DNA 
impedes the accumulation of m1A and m3C (12, 13).  
 After demonstrating the accumulation of multiple disruptive RNA adducts after 
alkylating agent treatment, we then sought to observe ribosome stalling in vivo. To accomplish 
this, we utilized a previously modified-transfer-messenger RNA (tmRNA) that His6-tags 
incomplete peptides from stalled ribosomes rather than tagging them for degradation by cellular 
proteases (14). We then treated these cells with MMS or MNNG and observed significant 
increases in His6 levels via Western blot, suggesting that trans-translation is being activated upon 
nucleotide damage. To demonstrate that the observed increase in tmRNA activity was due to 
RNA damage rather than the production of truncated transcripts from damaged DNA, we 
performed a transcriptional runoff assay and treated cells with agents that exclusively introduce 
damage to DNA. We then observed His6 levels in each of these samples and observed that while 
double-stranded DNA breaks do increase His6 tagging, these levels significantly decrease after 
transcriptional runoff. Additionally, His6 levels in the MMS and MNNG samples after 
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transcriptional runoff do slightly decrease, but not to the same extent as the samples treated with 
the DNA damaging agent. From these results, we conclude that while some His6 tagging in the 
MMS and MNNG is due to the production of truncated transcripts from damaged DNA, most of 
the activity is due to damaged mRNA, demonstrating that trans-translation is responsible for 
rescuing ribosomes stalled by alkylative damage in vivo.  
 We also hypothesized that the trans-translation pathway is important for bacteria to 
efficiently recover from alkylative damage. To test this, we treated both WT E. coli and those 
lacking tmRNA (∆ssrA) with the alkylating agents and monitored their growth post-treatment. 
While the growth curves of the untreated WT and ∆ssrA cells were indistinguishable, ∆ssrA cells 
after treatment with either MMS or MNNG recovered approximately 1.5 hours after WT cells. 
This demonstrates that a functional trans-translation system is required for efficient recovery 
post-alkylative damage. We predict that the ∆ssrA cells are still able to recover post-alkylative 
damage treatment because E. coli contain two additional ribosome rescue factors, ArfA and 
ArfB. ArfA is known to function as a backup for trans-translation, as its expression increases 
when tmRNA activity is limited. Future experiments can include performing qPCR in the WT 
and ∆ssrA to observe if ArfA activity increases. ArfB does not appear to function solely as a 
backup for tmRNA, so it would be interesting to investigate if it plays a role in rescuing 
ribosomes from damaged transcripts.  
 Here, we provide the first evidence that alkylative damage causes ribosomal stalling in 
vivo, and that trans-translation in bacteria is responsible for rescuing ribosomes stalled on 
alkylated transcripts. Another type of mRNA damage that can cause ribosome stalling is 
oxidative damage. To show that trans-translation is the pathway responsible for rescuing 
ribosomes stalled by other types of nucleotide damage besides alkylative damage, future 
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experiments will include repeating the tmRNA His6-tagging analyses after treatment with 
oxidizing agents, such as hydrogen peroxide.  
 The mechanism through which tmRNA recognizes ribosomes stalled by alkylated 
transcripts is not understood. Previous studies have shown that tmRNA requires that no more 
than six nucleotides are present downstream of the P-site to rescue stalled ribosomes (15, 16). If 
the alkylative adduct exists in the middle of the transcript, we predict that the stalled ribosome 
triggers the cleavage of the mRNA at or within these six nucleotides. Previous reports have 
suggested that the tmRNA-complex recruits RNase R to degrade the non-stop mRNA (17, 18); 
however, RNase R is an exonuclease so it is not able to perform the initial endonucleolytic 
cleavage necessary for tmRNA to act on a ribosome stalled by a damage adduct. A previous 
report from our group shows that the collision of upstream ribosomes with the stalled ribosome 
induces no-go decay in eukaryotes (19). This involves the cleavage of the mRNA between the 
stalled and the colliding ribosome, and the endonuclease that performs this cleavage remains 
unidentified. It is possible that a similar process exists in bacteria, where the colliding ribosomes 
induces cleavage of mRNA so that the complex can become a target for trans-translation. To 
identify this potential endonuclease, a genetic screen could be performed to identify mutants that 
reduce His6-tagging by tmRNA after treatment with alkylative damaging agents.  
 Recent in vitro studies have shown that when mRNA damaged with MMS was treated 
with AlkB, which is a hydroxylase in E. coli that has been shown to demethylate RNA and 
single-stranded DNA (20), translation was enhanced (21). Additionally, the same study showed 
that the treatment of tRNA with an alkylating agent inhibited aminoacylation, but that this 
inhibition was substantially relieved upon treatment with AlkB. To show that AlkB has the same 
effect in vivo, we can overexpress the protein in E. coli expressing tmRNA-His6 and observe 
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differences in His6-levels after treatment with alkylating agents. If there is a reduction in His6-
levels in the cells overexpressing AlkB, this would support the in vitro study that AlkB 
demethylates RNA and restores translation.  
The treatment of E. coli with alkylating agents also revealed that activation of Ada 
increases proportionally to tmRNA activity. Ada is a key player in the adaptive response in E. 
coli, during which it serves as a suicide enzyme that transfers alkyl groups from O6- alkyl 
guanine, O4-alkyl thymine, and the oxygen of the phosphodiester backbone of DNA to one of its 
cysteine residues (22, 23). Once it is methylated, Ada serves as a transcriptional activator, 
inducing the expression of itself and other genes involved in the adaptive response (24, 25). One 
open question is whether Ada can transfer alkyl groups from damaged RNA, such as m6G, 
resulting in the same activation of the adaptive response. One ongoing study in our group 
involves damaging mRNA with MMS and subsequently transfecting the mRNA into E. coli and 
observing if Ada is activated. If Ada activation is observed, this will provide evidence to support 
the hypothesis that Ada responds to both DNA as well as mRNA damage.  
The base pairing preference of 8-oxoguanosine on the ribosome 
 
 8-oxoguanosine (8-oxoG) is the most common oxidative damage adduct of DNA and 
RNA (26, 27). Studies investigating 8-oxodG in DNA have shown that the lesion is mutagenic, 
as it has dual-coding potential due to its ability to change from an anti to a syn conformation and 
reveal an alternate hydrogen-bonding interface where is can form a Hoogsteen base pair with 
adenosine (28). This change in conformation relieves the steric hindrance that the O8 
experiences with the phosphate backbone when 8-oxoG is in the anti conformation. A previous 
report by our group demonstrated that 8-oxoG in mRNA drastically reduced the rate of peptidyl 
transfer in vitro in the presence of an 8-oxoG•C base pair while slightly increasing the rate of 
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miscoding for 8-oxoG•A (11). However, the underlying mechanism for this disruption of tRNA 
selection was unaddressed. Here, in vitro peptidyl transfer studies in the presence of error-prone 
conditions demonstrate that 8-oxoG predominantly adopts a syn conformation in the A site.  
 We initially hypothesized that 8-oxoG is interfering with initial codon selection rather 
than the steps further downstream in tRNA selection. The irreversible hydrolysis of GTP 
separates initial codon selection and downstream reactions (29), so to test our initial hypothesis, 
we performed GTP hydrolysis assays in the presence and absence of 8-oxoG at all three 
positions of the codon. We observe a decrease in the rate of GTP hydrolysis that is similar to the 
decrease we previously observed for the rate of peptidyl-transfer in the presence of 8-oxoG. 
From this, we conclude that 8-oxoG is predominantly interfering with early-stage tRNA 
selection, likely during initial codon selection.  
 We then set out to investigate the preferred base pairing conformation of 8-oxoG in both 
the first and second position of the codon. To accomplish this, we took advantage of the ability 
of aminoglycoside antibiotics to relax tRNA selection conditions (5, 6, 30, 31). We performed in 
vitro peptidyl transfer reactions in the presence or absence of aminoglycoside antibiotics as well 
as in the presence of the cognate and all possible near-cognate aa-tRNAs. We observed that the 
average rate and endpoint of peptidyl transfer in the presence of 8-oxoG•A base pairs exceeded 
that of 8-oxoG•C base pairs in both the first and second positions of the codon. We also 
performed peptidyl transfer reactions in the presence of error prone ribosomes and observed 
higher rate and endpoint values for 8-oxoG•A than 8-oxoG•C. These results support the 
hypothesis that 8-oxoG primarily exists in the syn conformation on the ribosome, but that the 8-




 The next steps of investigating the base pairing preference of 8-oxoG on the ribosome 
include performing structural studies to investigate not only the changes that occur in the codon-
anticodon helix in the presence of 8-oxoG, but also how the hydrogen bonds of the rRNA 
residues that are important for monitoring this interaction are altered by 8-oxoG in both the syn 
and anti conformation. Structural studies of DNA polymerases with templates containing 8-
oxodG in the active site demonstrate that the fidelity of the polymerase determines how 
frequently the adduct codes for dC or for dA. Lower fidelity polymerases can incorporate bulkier 
base pairs, such as 8-oxodG•dC, in their active sites so they less frequently miscode for dA. On 
the contrary, high fidelity polymerases have a smaller active site, and the 8-oxodG•A base pair 
adopts a geometry that is very similar to that of a Watson Crick base pair, so these polymerases 
are more likely to miscode in the presence of the adduct (32–35). Similar structural studies of 8-
oxoG in the A site of the ribosome will help to elucidate why this lesion generally causes stalling 
rather than bypass under normal conditions.  
 Additionally, we hypothesized that E. coli containing error-prone ribosomes would be 
better able to survive oxidative stress conditions due to their ability to bypass oxidative lesions 
rather than stall protein synthesis. This would provide a selective advantage for organisms living 
in highly oxidative environments, such as pathogens that deal with the reactive oxygen species 
associated with immune responses. To test this, we treated either WT E. coli or cells expressing 
error-prone ribosomes with hydrogen peroxide and observed recovery either by performing spot 
assays or monitoring growth curves. No significant difference in ability to recovery post-
oxidative treatment was observed between the strains. Interestingly, one previous study did 
observe a 30% - 70% decrease in survival rates during oxidative damage of WT E. coli 
compared to those expressing error-prone ribosomes post-oxidative treatment (36), but the 
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mutations to generate error-prone ribosomes in this study were in the same ribosomal protein but 
at a different locus than the mutation we utilized. Overall, the results of this study were 
inconclusive but do not support the conclusion that all error-prone ribosomes provide a selective 
advantage for bacterial recovery following oxidative stress.  
The importance of the phosphodiester backbone kink structure during decoding  
 
 While much is known about the importance of rRNA and tRNA structure with regards to 
the decoding process, less is known about how mRNA structure impacts translation. Structural 
studies have revealed that the mRNA adopts a kink-like structure in the context of the ribosome 
between the P and A sites (37, 38). A magnesium ion stabilizes this structure through 
electrostatic interactions with the non-bridging oxygens of the phosphodiester backbone of the 
mRNA (38). Whether or not this structure contributes to tRNA selection remained unknown. To 
address this question, we utilized our reconstituted in vitro translation system in combination 
with an mRNA construct that contains stereospecific phosphorothioate substitutions to disrupt 
this kink structure.  
 When we substituted either of the non-bridging oxygen atoms between the A- and P-site 
codons with sulfur to disrupt the coordination of the magnesium ion, we observed that tRNA 
selection became more stringent. The phosphorothioate-modified mRNAs were less reactive 
with near-cognate tRNAs than the unmodified mRNA control. Interestingly, reactivity with 
cognate aa-tRNAs remained unaffected. This suggested that the structure of the mRNA 
backbone at the interface of the A and P sites plays an important role in tRNA selection. When 
extended reactions were performed, both the Sp- and Rp- phosphorothioate substitutions reduced 
the rate of peptide-bond formation in the presence of near-cognate aa-tRNAs, but the Sp 
substitution resulted in a more severe endpoint defect, suggesting that the pro-S oxygen is more 
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important for coordinating the kink structure than the pro-R oxygen. We also analyzed the rate of 
peptide release for these constructs, and while there was a slight decrease in rate for the Sp and 
Rp-phosphorothioate-modified mRNA compared to the control, it was not as significant as the 
effects observed on tRNA selection.  
To investigate the phase of tRNA selection impacted by the substitution, we performed 
GTP hydrolysis assays and demonstrated that the initial phase of tRNA selection is not 
significantly impacted by the substitutions. This suggests that the kink structure plays an 
important role during the later proofreading phase. Additionally, we investigated the impact of 
phosphorothioate substitutions between the first and second position as well as the second and 
third positions of the A-site codon on tRNA selection. Structural studies show that the kink-
stabilizing magnesium ion also appears to be coordinated by the pro-R oxygen between the first 
and second position of the A-site codon, but not by oxygens in the backbone between the second 
and third position of the A-site codon [38, 39]. For the phosphorothioate substitutions between 
the first and second position but not the second and third position, we observed effects on tRNA 
selection that were similar to those observed for the substitutions at the P/A interface. This 
served as a control to show that the effects on tRNA selection were due to the disruption of 
magnesium coordination which likely also disrupts the kink structure.  
 The results that the disruption of the kink structure decreases the rate of miscoding in the 
presence of near-cognate aa-tRNAs while having no effect on the rate of the reaction in the 
presence of the cognate aa-tRNA begs the question as to why the mRNA evolved to adopt this 
kink structure if it makes decoding less accurate. We hypothesized that a subset of cognate aa-
tRNAs that exploit unusual base pairs at the wobble position would be negatively impacted by 
the loss of this kink structure, as the substitution might not provide promiscuous enough 
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conditions to allow for tRNA selection to occur. To this end, we utilized the AUA Ile codon 
which does not base pair with the anticodon in the typical A•U base pair at the third position. 
Instead, the C in the anticodon is modified to lysidine (k2C) in order to avoid base pairing with 
the AUG Met codon (39). When we perform the peptidyl transfer reactions with unmodified or 
Rp- phosphorothioate-programmed complexes in the presence of the cognate Ile-tRNAIle, the 
rates were indistinguishable. However, the rate for the Sp-modified complex was about an order 
of magnitude slower. This supports the hypotheses that the kink structure is critical for decoding 
under less-than-ideal conditions and that the pro-S oxygen is more important for coordinating the 
kink structure than the pro-R oxygen.  
 While our study shows that the kink structure is important for tRNA selection, previous 
studies speculated that this structure is important for preventing slippage during translocation 
(40). This slippage of the mRNA template causes frameshifting, which can lead to the improper 
decoding of the template. It is possible that the structure also plays a role in frame maintenance. 
Future studies can focus on measuring the rates of frameshifting in the presence of the 
phosphorothioate-substituted templates.  
Conclusions of the thesis 
 
 The overall goal of my dissertation was to expand on the understanding of how mRNA 
structure impacts tRNA selection. For my research, I focused on understanding the effects of 
chemical damage of mRNA on tRNA selection, as well as elucidating a role for the structure of 
the phosphodiester backbone of mRNA during decoding. In addition to refining and redefining 
what is known about mRNA structure during decoding, these findings demonstrate that chemical 
damage of mRNA can stall ribosomes in vivo and elicit cellular responses. The studies 
performed in this thesis demonstrate that mRNA is more than just a passive template during 
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decoding, and I believe future studies will continue to demonstrate the important role mRNA 
structure plays throughout the various steps in translation.  
 To further understand the importance of mRNA structure during translation, we explored 
how both oxidative as well as alkylative damage alters the way in which nucleotides are 
decoded. Additionally, we explored the previously underappreciated role of the mRNA 
phosphodiester backbone during tRNA selection. We also provide the first evidence that the 
trans-translation ribosome rescue pathway in bacteria is responsible for rescuing ribosomes 
stalled by RNA damage. As the field progresses, this data will be integral to our understanding of 
how cells deal with structural alterations to mRNA.  
Moving forward, there are still many questions remaining as to how organisms tolerate 
mRNA damage as well as how mRNA might be specifically modified to regulate cellular 
processes. Our studies support the idea that the preservation of mRNA structure is important to 
maintaining the speed and fidelity of decoding and elude to the possibility that mRNA structure 
can be intentionally regulated to modulate this process. I am confident that, over time, additional 
alterations to mRNA structure will identify further roles for mRNA in the regulation as well as 
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Chapter 2 Rate and Endpoint Data  
 
Table 1: m1A Glu Rate and Endpoint Data  
 
Glu Codon: GAA 
m1AGlu Codon: Gm1AA 
 
Codon  tRNA/RF Treatment Rate Endpoint 
Glu Glu NT 65.89 0.807 
   
49.22 0.8614 
m1A Glu NT 0.1347 0.126 
   
0.1618 0.07675 
m1A Glu Paromo 0.1624 0.1726 
   
0.243 0.04352 
Glu Lys NT 0.01676 0.06504 
   
0.01988 0.06279 
m1A Lys NT 0.04841 0.01304 
   
0.06531 0.01988 
Glu RF1 NT 0.001309 0.6147 
   
0.001525 0.9687 
m1A RF1 NT 0.1047 0.001309 
   
0.1099 0.001785 
Glu RF2 NT 0.003196 0.03785 
   
0.03537 0.01446 
m1A RF2 NT 0.3265 0.000638 





Chapter 3 Rate and Endpoint Data 
  
Table 2: 8-oxoG Val Rate and Endpoint Data  
 
Val Codon: GUU 
8oxoVal Codon: 8oxoGUU 
 




8oxoG Val NT 0.0474 0.3011 0.04369 0.30825    
0.03998 0.3154 
  
8oxoG Val Strep 0.08455 0.5521 0.080465 0.56635    
0.07638 0.5806 
  
8oxoG Val Paromo 0.2025 0.609 0.19075 0.5931    
0.179 0.5772 
  
G Ile NT 0.08125 0.02796 0.049925 0.14523    
0.0186 0.2625 
  
G Ile Strep 0.08165 0.6934 0.07821 0.68285    
0.07477 0.6723 
  
G Ile Paromo 0.07731 0.6789 0.07268 0.67135    
0.06805 0.6638 
  
8oxoG Ile NT 0.0816 0.02899 0.081225 0.02782    
0.08085 0.02665 
  
8oxoG Ile Strep 0.01849 0.06192 0.01528 0.11976    
0.01207 0.1776 
  
8oxoG Ile Paromo 0.02389 0.08755 0.022375 0.113575    
0.02086 0.1396 
  
8oxoG Phe NT 0.01956 0.1015 0.018155 0.11265    
0.01675 0.1238 
  
8oxoG Phe Strep 0.3361 0.6393 0.29145 0.65565    
0.2468 0.672 
  
8oxoG Phe Paromo 0.2534 0.5937 0.2207 0.60375    
0.188 0.6138 
  
G Phe NT 0.1872 0.01531 0.18695 0.016395    
0.1867 0.01748 
  
G Phe Strep 0.1504 0.7181 0.12895 0.72225    
0.1075 0.7264 
  
G Phe Paromo 0.2108 0.6519 0.1871 0.6749    
0.1634 0.6979 
  
8oxoG Leu NT 0.07894 0.005643 0.072675 0.0063375    
0.06641 0.007032 
  





8oxoG Leu Paromo 0.1048 0.01161 0.080325 0.01422    
0.05585 0.01683 
  
G Leu NT 0.1318 0.004502 0.09455 0.0049815    
0.0573 0.005461 
  
G Leu Strep 0.02859 0.01089 0.026535 0.01099    
0.02448 0.01109 
  
G Leu Paromo 0.05557 0.01259 0.051935 0.01137    
0.0483 0.01015 
  
G Val NT 31.39 0.6868 28.95 0.729    
26.51 0.7712 
  
G Val Strep 26.77 0.8663 23.79 0.795    
20.81 0.7237 
  







Table 3: 8-oxoG Arg Rate and Endpoint Data  
 
Arg: CGC 
8oxoVal Codon: C8oxoGC 
 
Codon  tRNA Treatment Rate Endpoint Average Rate Average Endpoint 
8oxoG-
Arg 
Leu NT 0.02064 0.3555 0.015645 0.47645 





Leu Strep 0.03287 0.7419 0.030825 0.6412 





Leu Paromo 0.08754 0.6805 0.074255 0.66565 





His NT 0.02932 0.009227 0.02801 0.010874 





His Strep 0.07271 0.02029 0.036867 0.073995 





His Paromo 0.03536 0.04542 0.0182 0.20316 





Pro NT 0.1513 0.001144 0.09327 0.002369 





Pro Strep 0.01943 0.003755 0.014225 0.004578 





Pro Paromo 0.07701 0.002805 0.04913 0.003337 





Arg NT 0.018 0.02483 0.009748 0.027685 





Arg Strep 0.03647 0.4865 0.022026 0.37025 





Arg Paromo 0.08517 0.5697 0.04868 0.5221 
   
0.01219 0.4745 
  
G Leu NT 0.115 0.03705 0.073975 0.020229    
0.03295 0.003407 
  
G Leu Strep 0.03705 0.003785 0.020832 0.008468 
185 
 
   
0.004614 0.01315 
  
G Leu Paromo 0.02586 0.07102 0.024835 0.04507    
0.02381 0.01912 
  
G His NT 0.0181 0.06442 0.010725 0.18076    
0.003349 0.2971 
  
G His Strep 0.2457 0.1624 0.1796 0.4935    
0.1135 0.8246 
  
G His Paromo 0.9127 0.5836 0.8262 0.58525    
0.7397 0.5869 
  
G Pro NT 0.138 0.000745 0.109185 0.001686    
0.08037 0.002626 
  
G Pro Strep 0.02478 0.01144 0.015234 0.039575    
0.005687 0.06771 
  
G Pro Paromo 0.02645 0.03292 0.024145 0.02519    
0.02184 0.01746 
  
G Arg NT 33.47 0.7557 22.365 0.6392    
11.26 0.5227 
  
G Arg Strep 44.39 0.8139 37.08 0.8226    
29.77 0.8313 
  







Table 4: 8-oxoG Arg Ribosomal Mutant Rate and Endpoint Data 
 
8oxoVal Codon: C8oxoGC 
 












EP 0.01313 0.3776 0.007773 0.25655   
0.002415 0.1355 
  























Table 1: Specifications for Mass Spectrometry  
 












A 268.1 136 1.92 18 15600 259 
C 244.1 112 0.48 14 9000 271 
G 284.2 152 2.4 16 13700 252 
U 245.2 152.1 1 14 10000 262        
m1A 282.2 150.1 0.9 16 14600 258 
m6A 282 150 4.08 16 15567 265        
m3C 258.2 126 0.8 8 7008 254        
m7G 298.2 166 1.5 10 9056 260 
m1G 298 166 4.623 4.143 12948 254 
m6G 298 166 4.84 4.84 7100 280 
8oxoG 300 168.1 2.956 2.956 7868 296 
